
<html lang="en"     class="pb-page"  data-request-id="88ef7cec-368a-4cb7-9f09-0025f0c306e0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b01296;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer" /></meta><meta name="dc.Creator" content="Jina  Kim" /></meta><meta name="dc.Creator" content="Jaeyoung  Song" /></meta><meta name="dc.Creator" content="Hyun Dong  Ji" /></meta><meta name="dc.Creator" content="Eun Kyung  Yoo" /></meta><meta name="dc.Creator" content="Jae-Eon  Lee" /></meta><meta name="dc.Creator" content="Sang Bong  Lee" /></meta><meta name="dc.Creator" content="Ji Min  Oh" /></meta><meta name="dc.Creator" content="Seungmi  Lee" /></meta><meta name="dc.Creator" content="Ji Sun  Hwang" /></meta><meta name="dc.Creator" content="Heeseok  Yoon" /></meta><meta name="dc.Creator" content="Dong-Su  Kim" /></meta><meta name="dc.Creator" content="Su-Jeong  Lee" /></meta><meta name="dc.Creator" content="Minseon  Jeong" /></meta><meta name="dc.Creator" content="Sungwoo  Lee" /></meta><meta name="dc.Creator" content="Kyung-Hee  Kim" /></meta><meta name="dc.Creator" content="Hueng-Sik  Choi" /></meta><meta name="dc.Creator" content="Sang Woo  Lee" /></meta><meta name="dc.Creator" content="Keun-Gyu  Park" /></meta><meta name="dc.Creator" content="In-Kyu  Lee" /></meta><meta name="dc.Creator" content="Seong Heon  Kim" /></meta><meta name="dc.Creator" content="Hayoung  Hwang" /></meta><meta name="dc.Creator" content="Yong Hyun  Jeon" /></meta><meta name="dc.Creator" content="Jungwook  Chin" /></meta><meta name="dc.Creator" content="Sung Jin  Cho" /></meta><meta name="dc.Description" content="An inverse agonist of estrogen-related receptor-γ (ERRγ), an orphan nuclear receptor encoded by Esrrg, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC..." /></meta><meta name="Description" content="An inverse agonist of estrogen-related receptor-γ (ERRγ), an orphan nuclear receptor encoded by Esrrg, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 18, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01296" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01296" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01296" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01296" /></link>
        
    
    

<title>Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01296" /></meta><meta property="og:title" content="Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0005.jpeg" /></meta><meta property="og:description" content="An inverse agonist of estrogen-related receptor-γ (ERRγ), an orphan nuclear receptor encoded by Esrrg, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC) cells, thereby facilitating responsiveness to radioiodine therapy in vitro. We synthesized potent, selective, and orally bioavailable ERRγ-inverse agonists and evaluated their activity by analyzing in vitro pharmacology and absorption, distribution, metabolism, excretion, and toxicity profiles. X-ray crystallographic analysis of the ligand and ERRγ complex showed that 35 completely binds to the target protein (PDB 6A6K). Our results showed improved radioiodine avidity in ATC cells through compound 35-mediated upregulation of iodide-handling genes, leading to enhanced responsiveness to radioiodine therapy in vitro. Importantly, in vivo 124I-positron emission tomography/computed tomography imaging revealed that 35 increases radioiodine avidity in CAL62 tumors. Collectively, these results demonstrated that 35 can be developed as a promising treatment for ERRγ-related cancer in the future." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01296"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01296">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01296&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01296&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01296&amp;href=/doi/10.1021/acs.jmedchem.8b01296" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1837-1858</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01765" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01300" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jina Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jina Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jina++Kim">Jina Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jaeyoung Song</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaeyoung Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaeyoung++Song">Jaeyoung Song</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyun Dong Ji</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyun Dong Ji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, School of Medicine, Kyungpook National University Hospital, Daegu 41404, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyun+Dong++Ji">Hyun Dong Ji</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eun Kyung Yoo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eun Kyung Yoo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eun+Kyung++Yoo">Eun Kyung Yoo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jae-Eon Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jae-Eon Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomaterials Science, College of Natural Resources and Life Science/Life and Industry Convergence Research Institute, Pusan National University, Pusan 50463, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jae-Eon++Lee">Jae-Eon Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sang Bong Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sang Bong Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sang+Bong++Lee">Sang Bong Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ji Min Oh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ji Min Oh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, School of Medicine, Kyungpook National University Hospital, Daegu 41404, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ji+Min++Oh">Ji Min Oh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Seungmi Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seungmi Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seungmi++Lee">Seungmi Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ji Sun Hwang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ji Sun Hwang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ji+Sun++Hwang">Ji Sun Hwang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heeseok Yoon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heeseok Yoon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heeseok++Yoon">Heeseok Yoon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong-Su Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong-Su Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Su++Kim">Dong-Su Kim</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0388-4633" title="Orcid link">http://orcid.org/0000-0003-0388-4633</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Su-Jeong Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Su-Jeong Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Su-Jeong++Lee">Su-Jeong Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minseon Jeong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minseon Jeong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minseon++Jeong">Minseon Jeong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sungwoo Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sungwoo Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sungwoo++Lee">Sungwoo Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kyung-Hee Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyung-Hee Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyung-Hee++Kim">Kyung-Hee Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hueng-Sik Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hueng-Sik Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Creative Research Initiatives Center for Nuclear Receptor Signals and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 61186, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hueng-Sik++Choi">Hueng-Sik Choi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sang Woo Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sang Woo Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, School of Medicine, Kyungpook National University Hospital, Daegu 41404, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sang+Woo++Lee">Sang Woo Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keun-Gyu Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keun-Gyu Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keun-Gyu++Park">Keun-Gyu Park</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">In-Kyu Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">In-Kyu Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, South Korea</div><div class="loa-info-affiliations-info">Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In-Kyu++Lee">In-Kyu Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Seong Heon Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seong Heon Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seong+Heon++Kim">Seong Heon Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hayoung Hwang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hayoung Hwang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#92fae5f3fcf5faebd2f6f5fffbf4bce0f7bcf9e0"><span class="__cf_email__" data-cfemail="f79f809699909f8eb793909a9e91d98592d99c85">[email protected]</span></a>. Phone: +82-53-790-5208 (H.H.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hayoung++Hwang">Hayoung Hwang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yong Hyun Jeon</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yong Hyun Jeon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, School of Medicine, Kyungpook National University Hospital, Daegu 41404, South Korea</div><div class="loa-info-affiliations-info">Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#442e212b2a7d747570042329252d286a272b29"><span class="__cf_email__" data-cfemail="b8d2ddd7d68188898cf8dfd5d9d1d496dbd7d5">[email protected]</span></a>. Phone: +82-53-790-5726 (Y.H.J.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yong+Hyun++Jeon">Yong Hyun Jeon</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3161-7698" title="Orcid link">http://orcid.org/0000-0003-3161-7698</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jungwook Chin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jungwook Chin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#98f2effbf0f1f6d8fcfff5f1feb6eafdb6f3ea"><span class="__cf_email__" data-cfemail="8fe5f8ece7e6e1cfebe8e2e6e9a1fdeaa1e4fd">[email protected]</span></a>. Phone: +82-53-790-5257. Fax: +82-53-790-5219 (J.C.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jungwook++Chin">Jungwook Chin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6060-0508" title="Orcid link">http://orcid.org/0000-0001-6060-0508</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sung Jin Cho</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sung Jin Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, South Korea</div><div class="loa-info-affiliations-info">New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4f3c252c27200f2b28222629613d2a61243d"><span class="__cf_email__" data-cfemail="60130a03080f2004070d09064e12054e0b12">[email protected]</span></a>. Phone: +82-53-790-5226. Fax: +82-53-790-5219 (S.J.C.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sung+Jin++Cho">Sung Jin Cho</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4786-8830" title="Orcid link">http://orcid.org/0000-0002-4786-8830</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01296&amp;href=/doi/10.1021%2Facs.jmedchem.8b01296" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1837–1858</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 18, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 August 2018</li><li><span class="item_label"><b>Published</b> online</span>18 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01296</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1837%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJina%2BKim%252C%2BJaeyoung%2BSong%252C%2BHyun%2BDong%2BJi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D4%26contentID%3Dacs.jmedchem.8b01296%26title%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BEstrogen-Related%2BReceptor-%25CE%25B3%2BInverse%2BAgonists%2BTo%2BRestore%2Bthe%2BSodium%2BIodide%2BSymporter%2BFunction%2Bin%2BAnaplastic%2BThyroid%2BCancer%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1858%26publicationDate%3DFebruary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01296"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1316</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01296" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jina&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Jaeyoung&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Hyun&quot;,&quot;last_name&quot;:&quot;Dong Ji&quot;},{&quot;first_name&quot;:&quot;Eun&quot;,&quot;last_name&quot;:&quot;Kyung Yoo&quot;},{&quot;first_name&quot;:&quot;Jae-Eon&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Sang&quot;,&quot;last_name&quot;:&quot;Bong Lee&quot;},{&quot;first_name&quot;:&quot;Ji&quot;,&quot;last_name&quot;:&quot;Min Oh&quot;},{&quot;first_name&quot;:&quot;Seungmi&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Ji&quot;,&quot;last_name&quot;:&quot;Sun Hwang&quot;},{&quot;first_name&quot;:&quot;Heeseok&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Dong-Su&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Su-Jeong&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Minseon&quot;,&quot;last_name&quot;:&quot;Jeong&quot;},{&quot;first_name&quot;:&quot;Sungwoo&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Kyung-Hee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hueng-Sik&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Sang&quot;,&quot;last_name&quot;:&quot;Woo Lee&quot;},{&quot;first_name&quot;:&quot;Keun-Gyu&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;In-Kyu&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Seong&quot;,&quot;last_name&quot;:&quot;Heon Kim&quot;},{&quot;first_name&quot;:&quot;Hayoung&quot;,&quot;last_name&quot;:&quot;Hwang&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Hyun Jeon&quot;},{&quot;first_name&quot;:&quot;Jungwook&quot;,&quot;last_name&quot;:&quot;Chin&quot;},{&quot;first_name&quot;:&quot;Sung&quot;,&quot;last_name&quot;:&quot;Jin Cho&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1837-1858&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01296&quot;},&quot;abstract&quot;:&quot;An inverse agonist of estrogen-related receptor-γ (ERRγ), an orphan nuclear receptor encoded by Esrrg, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC) cells, thereby facilitating responsiveness to radioiodine therapy in vitro. We synthesized potent, selective, and orally bioavailable ERRγ-inverse agonists and evaluated their activity by analyzing in vitro pharmacology and absorption, distribution, metabolism, excretion, and toxicity profiles. X-ray crystallographic analysis of the ligand and ERRγ complex showed that 35 completely binds to the target protein (PDB 6A6K). Our results showed improved radioiodine avidity in ATC cells through compound 35-mediated upregulation of iodide-handling genes, leading to enhanced responsiveness to radioiodine therapy in vitro. Importantly, in vivo 124I-positron emission tomography/computed tomography imaging revealed that 35 increases radioiodine avidity in CAL62 tumors. Collectively, these results demonstrated that 35 can be &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01296&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01296" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01296&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01296" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01296&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01296" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01296&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01296&amp;href=/doi/10.1021/acs.jmedchem.8b01296" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01296" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01296" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01296%26sid%3Dliteratum%253Aachs%26pmid%3D30657313%26genre%3Darticle%26aulast%3DKim%26date%3D2019%26atitle%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BEstrogen-Related%2BReceptor-%25CE%25B3%2BInverse%2BAgonists%2BTo%2BRestore%2Bthe%2BSodium%2BIodide%2BSymporter%2BFunction%2Bin%2BAnaplastic%2BThyroid%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D4%26spage%3D1837%26epage%3D1858%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/jmcmar.2019.62.issue-4/20190228/jmcmar.2019.62.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An inverse agonist of estrogen-related receptor-γ (ERRγ), an orphan nuclear receptor encoded by E<i>srrg</i>, enhances sodium iodide symporter-mediated radioiodine uptake in anaplastic thyroid cancer (ATC) cells, thereby facilitating responsiveness to radioiodine therapy in vitro. We synthesized potent, selective, and orally bioavailable ERRγ-inverse agonists and evaluated their activity by analyzing in vitro pharmacology and absorption, distribution, metabolism, excretion, and toxicity profiles. X-ray crystallographic analysis of the ligand and ERRγ complex showed that <b>35</b> completely binds to the target protein (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>). Our results showed improved radioiodine avidity in ATC cells through compound <b>35</b>-mediated upregulation of iodide-handling genes, leading to enhanced responsiveness to radioiodine therapy in vitro. Importantly, in vivo <sup>124</sup>I-positron emission tomography/computed tomography imaging revealed that <b>35</b> increases radioiodine avidity in CAL62 tumors. Collectively, these results demonstrated that <b>35</b> can be developed as a promising treatment for ERRγ-related cancer in the future.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The nuclear receptor (NR) superfamily consists of ligand-dependent receptors and orphan receptors for which no endogenous ligands have been identified yet and both of which are involved in cellular metabolism, energy expenditure, and inflammation.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In 2009, NR modulators accounted for approximately 13% of all U.S. pharmaceutical sales and a considerable global share.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Orphan receptors, which constitute approximately half of the NR superfamily, provide a rich source of targets suitable for the development of NR-based small-molecule therapeutics for various human diseases.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9">(4−9)</a> The estrogen-related receptor-γ (ERRγ), encoded by E<i>srrg</i>, is an orphan NR that belongs to the NR3B subfamily of structurally related transcription factors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The NR3B subfamily includes three members commonly known as estrogen-related receptors (ERRs; ERRα, β, and γ).<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Among them, ERRγ was the last to be identified, whereas the other two members, ERRα and β, were identified first in a screen designed to clone the estrogen receptor α (ERα)-related steroid hormone receptors.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> ERRγ is a constitutively active NR that interacts with either peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) or the corepressors of small heterodimer partner, DAX-1, and SMILE, in a ligand-independent manner and controls gene expression in response to the binding of endogenous small lipophilic ligands, such as estrogen, to a specific sequence in the regulatory regions of a target gene.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17−21)</a> ERRγ is abundantly expressed in various tissues associated with the CNS, circadian clock, and basal metabolic function, including the brain, heart, kidney, skeletal muscle, and liver;<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> thus, it not only regulates ion homeostasis in related tissues but also controls metabolic processes such as mitochondrial biogenesis and hepatic gluconeogenesis.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a></div><div class="NLM_p">Anaplastic thyroid cancer (ATC) is a rare and deadly disease with a poor prognosis. ATC is the least common type of undifferentiated cancer and accounts for less than 2% of all thyroid cancers in the United States.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> A clinical review of 1771 patients between 1949 and 2007 revealed that ATC patients have a median survival of only 5 months and their 1 year survival rate is approximately 20%.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, a standard chemotherapy regimen for most ATC patients is not currently available, although several studies of radiosensitizing agents such as cisplatin or paclitaxel have reported better 1 year survival rates for patients with nonmetastatic ATC.<a onclick="showRef(event, 'ref29 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref32 ref33">(29,32,33)</a></div><div class="NLM_p">Radioactive iodine still remains the mainstay therapy for those with undifferentiated thyroid cancers including follicular and papillary thyroid cancers and those at high risk of recurrence.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Unfortunately, tumors in many ATC patients do not take up enough iodine for proper therapy, resulting in radioiodine refractory character and dismal prognosis. Sodium iodide symporter (NIS) is a transmembrane glycoprotein that induces iodide uptake in thyroid follicular cells by stimulating thyroid stimulating hormone (TSH).<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Radioiodine therapy with a nuclear medicine imaging technique utilizing NIS has been widely used in clinical settings for the treatment and diagnosis of well-differentiated thyroid cancers and their metastasis with minimal adverse effects.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Practical application of radioiodine therapy is restricted to poorly differentiated thyroid cancers, such as ATC exhibiting a progressive dedifferentiation with resistance to anticancer treatments and aggressive metastasis to other tissues including the lung, bone, and regional lymph nodes because of insufficient expression and poor function of NIS. Thus, some attempts have been made to restore the NIS function in ATC and other dedifferentiated thyroid cancers, such as enhancing the poor responsiveness to radioiodine, which includes the introduction of gene delivery and some small-molecule agents such as demethylating agents, nuclear receptor agonists, kinase inhibitors, and histone deacetylase inhibitors.<a onclick="showRef(event, 'ref36 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref39">(36,39)</a> However, satisfactory therapeutic outcomes have not been achieved so far.</div><div class="NLM_p">In addition to the involvement of ERRγ in various metabolic diseases and cancers, we have broadened the therapeutic scope of the selective inverse agonist of ERRγ, GSK5182 (<b>1</b>), based on our findings that it enhances the NIS-mediated radioiodine uptake in ATC cells with either KRAS or BRAF mutation, facilitating responsiveness to radioiodine therapy in vitro.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">With the aim of discovering novel ERRγ inverse agonists, several repetitive lead optimization studies were performed including the synthesis and pharmacological evaluation of 4-hydroxytamoxifen (4-OHT, <b>2</b>) analogs.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The interesting findings from these studies provided the rationale for the development of new small-molecule therapeutics that can effectively enhance the NIS function in vivo with the potential to provide a clinical treatment option for ATC patients who do not respond to radioiodine therapy. Recently, a potent inverse agonist of ERRγ, DY40 (<b>3</b>), that suppressed the transcriptional functions of both ERRγ and ERRβ with superior half-maximal inhibitory concentration (IC<sub>50</sub>, 0.01 μM) in a cell-based reporter assay system was identified (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the three previously disclosed estrogen-related receptor-γ (ERRγ) inverse agonists: GSK5182 (<b>1</b>), a selective ERRγ inverse agonist; 4-hydroxytamoxifen (4-OHT, <b>2</b>), an estrogen receptor α (ERα) antagonist/ERRγ inverse agonist; and DY40 (<b>3</b>), a potent ERRγ inverse agonist with mixed ERRγ/ERRβ functional activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From the perspective of medicinal chemistry, in this study, synthetic strategies for further optimization of B/C-phenyl rings of the core scaffold with focused substituents were mainly studied to improve the in vitro pharmacological and absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles for subsequent in vivo assessments. Therefore, our objective was to further optimize the new ERRγ inverse agonists that possess a tetrasubstituted scaffold similar to that of compound <b>2</b> with better druggablility profiles applicable for in vivo experiments.</div><div class="NLM_p last">Herein, we report the discovery of a candidate ERRγ inverse agonist (<b>35</b>) that is highly selective and orally bioavailable with reasonably good biocompatibility. To explore the potential of the candidate in an ATC model in vitro and in vivo, we investigated changes in the expression of iodide-handling genes such as NIS, thyroid stimulating hormone receptor (TSHR), thyroperoxidase (TPO), and thyroglobulin (TG) at mRNA and protein levels in ATC cells. Furthermore, the effects of the novel ERRγ inverse agonist on radioiodine avidity as well as radioiodine therapy in vitro were assessed. Finally, <sup>124</sup>I-positron emission tomography/computed tomography (PET/CT) imaging was performed to determine the change in radioiodine incorporation in ATC tumor by oral administration of the novel ERRγ inverse agonist.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">A short and efficient synthesis of key tetrasubstituted olefinic intermediates (<b>3a</b>–<b>m</b>) was initiated by the palladium-catalyzed three-component coupling reaction of iodobenzene, alkynes, and arylboronic esters. Compounds <b>3a</b>–<b>m</b> were subsequently converted to their corresponding alcohols using several reducing agents followed by the addition of 1 M HCl with a solvent mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1) to produce hydrochloride salt forms of target compounds (<b>7</b>–<b>18</b>). Compounds <b>3k</b>–<b>m</b> were deprotected by trifluoroacetyl (TFA), and the resulting compounds (<b>4k</b>–<b>m</b>) were treated with reducing agents and 1 M HCl solution to yield compounds <b>4</b>–<b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4</b>–<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF)/H<sub>2</sub>O (2:1), 45 °C, 5–79%; (b) LiAlH<sub>4</sub> or diisobutylaluminium hydride (DIBAL-H) or LiBH<sub>4</sub>, tetrahydrofuran (THF), 0 °C, 10–98%; (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 39–99%; and (e) Zn, NH<sub>4</sub>Cl, MeOH/THF (1:1), 100%.</p></p></figure><div class="NLM_p">Compounds <b>19</b>–<b>22</b> and <b>30</b> were synthesized as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compounds <b>5a</b>–<b>d</b> were obtained using conventional reductive amination between <b>4k</b> and the corresponding ketones. The deprotection of hydroxyl group and reduction of methyl ester group were carried out using LiAlH<sub>4</sub> followed by the addition of 1 M HCl solution to produce <b>19</b>–<b>22</b>. Facile guanylation of intermediate <b>4k</b> with bis-Boc-thiourea produced compound <b>6a</b>. The two Boc-protecting groups were removed using TFA, giving <b>7a</b>. Finally, compound <b>30</b> was synthesized under the same conditions as those employed for compounds <b>19</b>–<b>22</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>19</b>–<b>22</b> and <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH(OAc)<sub>3</sub> or NaBH<sub>3</sub>CN, acetic acid, ketones, 1,2-dichloroethane (DCE) or THF/MeOH, rt, 37%–quant.; (b) LiAlH<sub>4</sub>, THF, 0 °C, 12–53%; (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (d) bis-Boc-thiourea, triethylamine (TEA), HgCl<sub>2</sub>, DMF, 0 °C, 36%; and (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, quant.</p></p></figure><div class="NLM_p">Compound <b>12</b> was sulfonylated with alkyl sulfonyl chloride in the presence of TEA or Hünig’s base, the obtained products were separated by preparative high-performance liquid chromatography (HPLC), and then the desired compounds were treated with 1 M HCl to give the phenol derivatives <b>23</b>–<b>25</b>, as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23</b>–<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Hünig’s base or TEA, <i>R</i>-sulfonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4–40% and (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>26</b>–<b>29</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Acetylation of <b>16</b> with acetic anhydride afforded compound <b>8a</b>, which was then treated with 1 M HCl at 0 °C to yield compound <b>26</b>. Sulfonylation of <b>16</b> with sulfonyl chlorides provided monosulfonamide compounds <b>9a</b> and <b>9b</b>, and the resulting compounds were treated with 1 M HCl to yield compounds <b>27</b> and <b>28</b>. Compound <b>10a</b> was formed by guanylation of compound <b>16</b> with bis-Boc-thiourea in the presence of mercury(II) chloride, followed by removal of the Boc group with TFA to furnish <b>10b</b>. Subsequently, compound <b>10b</b> was treated with 1 M HCl to yield compound <b>29</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>26</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) acetic anhydride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 7%; (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (c) <i>R</i>-sulfonyl chloride, TEA or pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 17–26%; (d) bis-Boc-thiourea, TEA, HgCl<sub>2</sub>, DMF, 84%; and (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 9%.</p></p></figure><div class="NLM_p">Pivalate protection of <b>7</b> with pivaloyl chloride afforded compounds <b>11a</b> and <b>11b</b> (monopivalation) and <b>11c</b> (dipivalation) simultaneously. The mixed product was separated by preparative HPLC. The HCl salts were formed by treatment with 1 M HCl, as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>31</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) pivaloyl chloride, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8–72% and (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><div class="NLM_p">The reaction between alkynes substituted on o- or m-position of the B-ring, 4-isopropylpiperazine phenylboronic ester (<b>2b</b>), and iodobenzene yielded several other tetrasubstituted olefins, as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The treatment with LiAlH<sub>4</sub> or DIBAL-H yielded the reduced forms, which were treated with 1 M HCl to yield compounds <b>34</b>–<b>36</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>34</b>–<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 45 °C, 2–28%; (b) LiAlH<sub>4</sub> or DIBAL-H THF, 0 °C, 17–94%; and (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><div class="NLM_p">To explore the modification of the piperazine position on the C-ring, two representative <i>p</i>- or <i>m</i>-piperazine-incorporated compounds <b>37</b> and <b>38</b> were prepared (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Compounds <b>16a</b> and <b>16b</b> were synthesized in a similar fashion, as mentioned in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The piperazine group was alkylated with an isopropyl group via reductive amination (compound <b>17a</b> and <b>17b</b>). Compounds <b>37</b> and <b>38</b> were formed via the simultaneous reduction of the methyl ester group and the removal of the pivaloyl group by LiAlH<sub>4</sub> followed by treatment with 1 M HCl.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>37</b>–<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 45 °C, 24–29%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 98–100%; (c) NaBH(OAc)<sub>3</sub>, acetic acid, acetone, DCE, 60 °C, rt, 62%; (d) LiAlH<sub>4</sub>, THF, 0 °C, 35–36%; and (e) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Activity Relationship (SAR) Exploration</h3><div class="NLM_p">Optimization studies of novel ERRγ inverse agonists were performed to increase their inverse agonistic potency, druglike property, and selectivity. We recently reported the structure-based rational design and synthesis of novel ERRγ inverse agonists exhibiting excellent druglike profiles comparable to those of 4-OHT (<b>2</b>) based on in vitro assays and ADMET evaluations.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In the previous study,<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> we investigated well-defined structural modifications to advance the therapeutic index based on our results in hand while adhering to accessible modern synthetic strategies. In this study, novel and advanced ERRγ inverse agonists were synthesized and selected through two strategic goals. First, the focus of this study was to investigate the SAR of novel compounds with a tetrasubstituted backbone similar to that of GSK5182 (<b>1</b>) with increased in vitro potency and selectivity. Second, we explored the role of B- and C-ring substitutions in controlling the overall druglike property of the derivatives by applying other small functional groups such as −Br and −Me to the B-ring or altering the phenolic position in the B-ring and by incorporating various piperazine functionalities to the C-ring. As a result, novel ERRγ inverse agonists with good activity and selectivity that expressed better in vitro ADMET and in vivo pharmacokinetics (PK) properties were obtained. Ultimately, we synthesized more advanced ERRγ inverse agonists to validate efficacy in pathological disease models related to ERRγ.</div><div class="NLM_p">First, our aim was to fix the oxidized state (<i>p</i>-OH) of the B-ring in R<sup>1</sup> of GSK5182 (<b>1</b>) and then optimize it according to the changes in R<sup>2</sup> and R<sup>3</sup> groups. The synthesis of an oxidized state (<i>p</i>-OH) of the B-ring, which is highly likely to be caused by a major phase I metabolic reaction by cytochrome P450 (CYP) enzymes, gives much information. As a result, these initial modifications produced several modest to potent ERRγ compounds <b>4</b>, <b>7</b>, <b>12</b>, <b>17</b>, <b>19</b>–<b>22</b>, and <b>30</b>, one of which exhibited promising binding potency against ERRγ (IC<sub>50</sub> = 0.040 μM; compound <b>12</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Detailed analysis of this series with R<sup>1</sup> = <i>p</i>-OH group (<b>4</b>, <b>7</b>, <b>12</b>, <b>17</b>, <b>19</b>–<b>22</b>, and <b>30</b>) gave an insight into the initial SAR of the R<sup>2</sup> group of which the piperazine structure incorporated by short chain alkyl groups (<b>7</b>, <b>12</b>, <b>17</b>, <b>19</b>; C<sub>1</sub>–C<sub>3</sub>) has a relatively good binding activity (IC<sub>50</sub> = 0.040–0.060 μM) compared to that of the non (<b>4</b>)- or bigger cyclic alkyl (<b>20</b>–<b>22</b>)-substituted piperazine moieties in the C-ring. When a carboximidamide group was tried for R<sup>2</sup> by adopting guanidine, which has a higher hydrophilic property, on this position (<b>30</b>), it resulted in poor binding and functional activity unlike the other <i>p</i>-phenolic compounds. This suggests that strong base or electron-rich functional groups should not be incorporated into piperazine for key interaction with the target protein.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures, ERRγ Binding, and Functional Screening of 36 Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0003.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Binding assays of ERRγ were conducted in duplicates using the time-resolved fluorescence energy transfer (TR-FRET) assay as shown in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>; the binding activity in the presence of compounds was represented as the percentage of control binding activity, and the IC<sub>50</sub> value was calculated with nonlinear regression fit with four parameters using Prism 6 software; all IC<sub>50</sub> values were statistically evaluated by the <i>R</i><sup>2</sup> value of goodness of fit, which was greater than 0.9 (see raw data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Molecular Formula Strings file</a> for more details); IC<sub>50</sub>, half-maximal inhibitory concentration.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Normalized luciferase activity of ERRγ at 10 μM tested compounds; data are expressed as percentage activity relative to the absence of compound; measurements reported are the mean of three determinations; the standard deviation (SD) is not shown as all of the three assays were found to be reproducible on repeated testing (see raw data including SD in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Molecular Formula Strings file</a> for more details).</p></div></div><div></div></div><div class="NLM_p">In the case of the SAR study in the R<sup>1</sup> group, the substitution of <i>p</i>-OH by <i>p</i>-Br (<b>5</b>, <b>8</b>, and <b>13</b>) exhibited relatively good activity, although the IC<sub>50</sub> trend of the corresponding R<sup>2</sup> group was different. Especially, the <i>p</i>-Br-substituted compound <b>13</b> bearing the isopropyl R<sup>2</sup> group showed the highest activity among them (IC<sub>50</sub> = 0.021 μM; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The <i>p</i>-Me group substitution for R<sup>1</sup> (<b>6</b>, <b>9</b>, and <b>14</b>) resulted in a higher binding potency (IC<sub>50</sub> = 0.017–0.027 μM) in general. Among them, <i>p</i>-Me-substituted compound <b>14</b> with the isopropyl R<sup>2</sup> group also showed the most excellent binding activity. For the compounds having an electron-withdrawing nitro R<sup>1</sup> group on the B-ring, the binding assay showed only moderate activity for both methyl and isopropyl R<sup>2</sup> derivatives (<b>10</b> and <b>15</b>). Next, the two aniline-type compounds of the B-ring (<b>11</b> and <b>16</b>) with an electron-donating effect were tested. Their binding potency was also only moderate, although the methyl R<sup>2</sup> substitution gave a slightly better binding activity than that of the isopropyl R<sup>2</sup> group in this case.</div><div class="NLM_p">To obtain more information on the functional group varieties of the B-rings, the R<sup>1</sup> group was converted into several bioisosteres by simple modifications, keeping the isopropyl R<sup>2</sup> group of the piperazine structure on the C-ring. The sulfonate group changes for R<sup>1</sup> (<b>23</b>–<b>25</b>) were not found to be effective compared to those of the original oxidized <i>p</i>-OH derivatives of the B-ring. Amide group changes for R<sup>1</sup> (<b>26</b>–<b>28</b>) also showed poor overall binding affinity even compared to that of the moderately active <i>p</i>-NH<sub>2</sub> derivative (<b>16</b>). In addition, guanidine substitution for the R<sup>1</sup> group led to nonbinding result for the assay of compound <b>29</b>.</div><div class="NLM_p">As a prodrug approach, we additionally produced three derivatives of compound <b>7</b> by applying pivalate functional groups to R<sup>1</sup> and/or R<sup>3</sup> (compounds <b>31</b>–<b>33</b>); this approach was not effective in the in vitro binding assay as expected, but it also did not work in further in vivo PK study (data not shown).</div><div class="NLM_p">A comprehensive SAR in the in vitro binding assay showed that the R<sup>1</sup> modification of the phenolic group in the B-ring was tolerable to −Br and −Me groups and was generally most active when a middle-sized isopropyl group with piperazine functionality (<b>12</b>–<b>14</b>) was introduced into the C-ring. To further understand the SAR by the R<sup>1</sup> substitution position, a small group of derivatives (<b>34</b>–<b>36</b>) of the two previous compounds (<b>12</b> and <b>13</b>) were synthesized. The C-ring functional group was fixed with the best isopropylpiperazine structure for direct comparison. Compounds <b>12</b> (<i>p</i>-OH) and <b>35</b> (<i>m</i>-OH) showed marginal differences in good binding potency, whereas the derivative with <i>ortho</i>-OH positional change (<b>34</b>) in the B-ring completely lost its activity (IC<sub>50</sub> = 6.619 μM). The <i>m</i>-Br substitution for R<sup>1</sup> of the B-ring (<b>36</b>) also showed good binding potency compared to that of the previously described <i>p</i>-Br compound (<b>13</b>).</div><div class="NLM_p">Finally, to look into the binding potency of the <i>m</i>-piperazine isomer rather than the para position to the C-ring, we also synthesized two compounds (<b>37</b> and <b>38</b>). The change of a piperazine position from para to meta in the C-ring did not yield good results and revealed that the <i>p</i>-piperazine-substituted structure showed the optimal efficacy overall.</div><div class="NLM_p">Through a funnel-like process based on in vitro potency, 16 leading compounds were selected and screened for subtype selectivity in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, such that their selectivity for each isoform should be greater than that for ERRγ. Their IC<sub>50</sub> criteria should also be less than those of the reference compound <b>1</b> (0.110 μM). Among the 16 leading compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, several compounds such as <b>6</b>, <b>9</b>, and <b>35</b> showed relatively good selectivity results.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Binding Selectivity of the 16 Screened Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">binding assay, IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compds</th><th class="colsep0 rowsep0" align="center" char=".">ERRγ</th><th class="colsep0 rowsep0" align="center">ERRα</th><th class="colsep0 rowsep0" align="center">ERRβ</th><th class="colsep0 rowsep0" align="center">ERα</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.110</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">0.104</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4.540</td><td class="colsep0 rowsep0" align="left">2.500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="left">8.650</td><td class="colsep0 rowsep0" align="left">0.980</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.097</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.980</td><td class="colsep0 rowsep0" align="left">1.700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.800</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">0.026</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.017</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.330</td><td class="colsep0 rowsep0" align="left">1.240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.990</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.861</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">3.040</td><td class="colsep0 rowsep0" align="left">1.142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.045</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">0.053</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.002</td><td class="colsep0 rowsep0" align="left">1.658</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0.099</td><td class="colsep0 rowsep0" align="left">9.700</td><td class="colsep0 rowsep0" align="left">1.648</td><td class="colsep0 rowsep0" align="left">2.116</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.943</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.440</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Binding assays of ERRγ and other nuclear receptors were conducted in duplicates using the TR-FRET assay as shown in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>; the binding activity in the presence of compounds was represented as the percentage of control binding activity, and the IC<sub>50</sub> value was calculated with nonlinear regression fit with four parameters using Prism 6 software; all IC<sub>50</sub> values were statistically evaluated by the <i>R</i><sup>2</sup> value of goodness of fit, which was greater than 0.9; IC<sub>50</sub>, half-maximal inhibitory concentration.</p></div></div></div><div class="NLM_p">Compounds with good in vitro potency and subtype selectivity should be identified in the ADMET profile for structure–property relationships (SPR). SPR, including ADMET profiles, can be approached in harmony with potency and selectivity optimization for the candidate leads for in vivo validations. The hit compounds were identified and selected based on ERRγ binding potency and selectivity for selecting the lead compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The next step was to verify in vitro functional activities and the ADMET properties of compounds <b>5</b>–<b>6</b>, <b>9</b>, <b>12</b>–<b>14</b>, <b>18</b>, <b>35</b>, and <b>36</b>.</div><div class="NLM_p">The properties of compounds that exhibited promising activities and selectivities in in vitro screening tests were subsequently determined using cytochrome P450 (CYP) screening, liver microsomal metabolic stability test, and parallel artificial membrane permeability assay (PAMPA), and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Functional Activity Analysis and Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Profiles of the Representative 10 Compounds<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">CYP inhibition (% inhibition at 10 μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">MS (% of remaining)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compds</th><th class="colsep0 rowsep0" align="center">ERRγ functional assay, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">PAMPA (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hERG, IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="left">0.077</td><td class="colsep0 rowsep0" align="left">16.4</td><td class="colsep0 rowsep0" align="char" char=".">27.1</td><td class="colsep0 rowsep0" align="left">21.8</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">42.8</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="char" char=".">26.0</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">15.0</td><td class="colsep0 rowsep0" align="char" char=".">24.0</td><td class="colsep0 rowsep0" align="left">38.1</td><td class="colsep0 rowsep0" align="char" char=".">29.3</td><td class="colsep0 rowsep0" align="char" char=".">45.0</td><td class="colsep0 rowsep0" align="char" char=".">65.1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">84.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="left">0.065</td><td class="colsep0 rowsep0" align="left">28.7</td><td class="colsep0 rowsep0" align="char" char=".">39.3</td><td class="colsep0 rowsep0" align="left">57.7</td><td class="colsep0 rowsep0" align="char" char=".">38.5</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td><td class="colsep0 rowsep0" align="char" char=".">44.0</td><td class="colsep0 rowsep0" align="left">58.0</td><td class="colsep0 rowsep0" align="char" char=".">71.5</td><td class="colsep0 rowsep0" align="left">28.8</td><td class="colsep0 rowsep0" align="left">3.61</td><td class="colsep0 rowsep0" align="left">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">0.069</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">37.7</td><td class="colsep0 rowsep0" align="left">27.2</td><td class="colsep0 rowsep0" align="char" char=".">31.8</td><td class="colsep0 rowsep0" align="char" char=".">29.1</td><td class="colsep0 rowsep0" align="char" char=".">79.2</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">65.7</td><td class="colsep0 rowsep0" align="left">47.6</td><td class="colsep0 rowsep0" align="left">4.84</td><td class="colsep0 rowsep0" align="left">18.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">12.0</td><td class="colsep0 rowsep0" align="char" char=".">13.9</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="char" char=".">36.5</td><td class="colsep0 rowsep0" align="char" char=".">33.6</td><td class="colsep0 rowsep0" align="char" char=".">26.6</td><td class="colsep0 rowsep0" align="left">49.7</td><td class="colsep0 rowsep0" align="char" char=".">32.5</td><td class="colsep0 rowsep0" align="left">19.9</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left">18.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">0.064</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="left">13.7</td><td class="colsep0 rowsep0" align="char" char=".">28.5</td><td class="colsep0 rowsep0" align="char" char=".">35.5</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">64.4</td><td class="colsep0 rowsep0" align="char" char=".">74.2</td><td class="colsep0 rowsep0" align="left">48.5</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">15.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="char" char=".">26.6</td><td class="colsep0 rowsep0" align="left">30.3</td><td class="colsep0 rowsep0" align="char" char=".">31.1</td><td class="colsep0 rowsep0" align="char" char=".">47.0</td><td class="colsep0 rowsep0" align="char" char=".">54.2</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">40.0</td><td class="colsep0 rowsep0" align="left">19.7</td><td class="colsep0 rowsep0" align="left">2.09</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="left">26.0</td><td class="colsep0 rowsep0" align="char" char=".">13.4</td><td class="colsep0 rowsep0" align="char" char=".">22.4</td><td class="colsep0 rowsep0" align="char" char=".">67.9</td><td class="colsep0 rowsep0" align="left">58.0</td><td class="colsep0 rowsep0" align="char" char=".">62.8</td><td class="colsep0 rowsep0" align="left">54.9</td><td class="colsep0 rowsep0" align="left">4.47</td><td class="colsep0 rowsep0" align="left">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="left">0.020</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">24.1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">34.0</td><td class="colsep0 rowsep0" align="char" char=".">53.3</td><td class="colsep0 rowsep0" align="char" char=".">65.4</td><td class="colsep0 rowsep0" align="left">61.2</td><td class="colsep0 rowsep0" align="char" char=".">54.9</td><td class="colsep0 rowsep0" align="left">26.9</td><td class="colsep0 rowsep0" align="left">1.29</td><td class="colsep0 rowsep0" align="left">24.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="char" char=".">27.0</td><td class="colsep0 rowsep0" align="left">56.1</td><td class="colsep0 rowsep0" align="char" char=".">70.4</td><td class="colsep0 rowsep0" align="char" char=".">60.1</td><td class="colsep0 rowsep0" align="char" char=".">53.6</td><td class="colsep0 rowsep0" align="left">68.4</td><td class="colsep0 rowsep0" align="char" char=".">53.7</td><td class="colsep0 rowsep0" align="left">31.0</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Cytochrome P450 (CYP) enzyme activity was measured by the incubation of CYP enzyme isotype-specific substrates and liver microsomes in the presence of the test compound for 15 min; data are expressed as percentage inhibitory activity relative to that in the absence of compound.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">MS, microsomal stability; the test compound was incubated with microsomes for 30 min, and the percentage of the remaining compound was measured by liquid chromatography (LC)–mass spectrometry (MS)/MS.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">The effective permeability after 5 h was calculated as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Supporting Information</a>; the measurements reported are the mean of four determinations (see raw data including SD in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Molecular Formula Strings file</a> for more details).</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">The hERG channel binding assay was performed using the predictor hERG fluorescence polarization assay; IC<sub>50</sub> value was calculated with nonlinear regression fit with four parameters.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">ND, not determined.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">For three assays (a, b, and d), the measurements reported are the mean of duplications; the standard deviation is not shown as the two assays were found to be reproducible on repeated testing.</p></div></div></div><div class="NLM_p">The relatively poor hERG (<b>6</b>) and PAMPA (<b>5</b>, <b>12</b>, and <b>13</b>) results for toxicity and permeability were preferentially excluded. Based on the functional potency and ADMET results of the 10 representative compounds in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the final four PK test compounds (<b>9</b>, <b>14</b>, <b>18</b>, and <b>35</b>) having a good druglikeness were selected in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Considering the PK efficacy of the four compounds tested, compound <b>35</b> has the best pharmacokinetic properties and bioavailability (BA).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Pharmacokinetics Data on Compounds <b>9</b>, <b>14</b>, <b>18</b>, and <b>35</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">compds</th><th class="colsep0 rowsep0" align="left">AUC<sub>all</sub> (μM h)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">AUCINF (μM h)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">BA (%)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>obs</sub>(mL/min/kg)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t4fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" char=".">FW</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" valign="middle"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">IV</td><td class="colsep0 rowsep0" align="center">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">18.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">139</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">30.3</td><td class="colsep0 rowsep0" align="char" char=".">426.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0" align="char" char=".">PO</td><td class="colsep0 rowsep0" align="center">0.45</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" valign="middle"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">IV</td><td class="colsep0 rowsep0" align="center">0.58</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">17.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">454.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0" align="char" char=".">PO</td><td class="colsep0 rowsep0" align="center">1.02</td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" valign="middle"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">IV</td><td class="colsep0 rowsep0" align="center">0.55</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">19.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">482.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0" align="char" char=".">PO</td><td class="colsep0 rowsep0" align="center">1.07</td><td class="colsep0 rowsep0" align="char" char=".">1.61</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" valign="middle"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">IV</td><td class="colsep0 rowsep0" align="center">0.99</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">42.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">456.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0" align="char" char=".">PO</td><td class="colsep0 rowsep0" align="center">4.18</td><td class="colsep0 rowsep0" align="char" char=".">4.71</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Rats (<i>n</i> = 4) were dosed with 1 mg/kg iv and 9 or 10 mg/kg po; parameters were calculated from composite mean plasma concentration–time data. Formulation included ethanol 10% dimethyl sulfoxide (DMSO), 15% water, and 75% poly(ethylene glycol) (PEG)400.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Area under the plasma concentration–time curve.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Area under the plasma concentration–time curve from time zero to infinity.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Bioavailability.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Peak plasma concentrations.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">Time for peak plasma concentrations.</p></div><div class="footnote" id="t4fn8"><sup><sup>h</sup></sup><p class="last">Terminal half-life.</p></div><div class="footnote" id="t4fn9"><sup><sup>i</sup></sup><p class="last">Volume in steady state.</p></div></div></div><div class="NLM_p">Based on the results of binding potency, selectivity, and ADMET, we determined that compound <b>35</b> was the optimal compound; 10 μM <b>35</b> exhibited 53, 24, and 34% of mild inhibition for corresponding CYP enzymes but did not measurably inhibit the other two CYP subtypes, whereas the control compound <b>1</b> inhibited the CYP enzymes by 15–27%. We compared the permeability of compound <b>1</b> with that of the newly synthesized compound using PAMPA. Compound <b>35</b> had a much greater permeability (1.29 10<sup>–6</sup> cm/s) than that of compound <b>1</b>, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Compound <b>35</b> also improved metabolic stability in four types of liver microsomes, whereas compound <b>1</b> had a considerably low metabolic stability in dog and mouse.</div><div class="NLM_p">The in vivo PK results were obtained by selecting some of the newly synthesized potent ERRγ inverse agonists (<b>9</b>, <b>14</b>, <b>18</b>, and <b>35</b>) shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Compound <b>35</b> showed the highest bioavailability. After selecting compound <b>35</b> based on a careful consideration of the profiles of all of the candidate compounds given in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, the results were compared with those of the reference compound <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Compound <b>35</b> showed a slightly lower clearance (CL = 37 ± 7.7 mL/min/kg) than <b>1</b> (CL = 44 ± 9.7 mL/min/kg) and had a volume distribution of 3.0 ± 4.9 L/kg in the rat PK study; it showed much improved PK profiles in general, including enhanced bioavailability (<i>F</i>% = 42.4) even with reduced half-life (<i>t</i><sub>1/2</sub> = 1.2 ± 0.5 h). Based on all of the results, compound <b>35</b> was selected for further in vivo animal studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Data on the Best Compound <b>35</b> Compared with GSK5182 (<b>1</b>)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">GSK5182 (<b>1</b>)</th><th class="colsep0 rowsep0" align="center"><b>35</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phys. properties</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">417.6</td><td class="colsep0 rowsep0" align="left">456.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro pharmacology</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">binding selectivity</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERRγ (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">0.110</td><td class="colsep0 rowsep0" align="left">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERRα (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERRβ (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERα (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">2.000</td><td class="colsep0 rowsep0" align="left">1.943</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERRγ functional assay (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">0.077</td><td class="colsep0 rowsep0" align="left">0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro safety</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition (% inhibition) 1A2, 2C9, 2C19, 2D6, 3A4</td><td class="colsep0 rowsep0" align="left">no issue all <30</td><td class="colsep0 rowsep0" align="left">no issue all <53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG binding IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">24.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG current IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">not tested</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mini-Ames (at 2 mM max)</td><td class="colsep0 rowsep0" align="left">not tested</td><td class="colsep0 rowsep0" align="left">no issue (negative)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (rat)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv, 1 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po, 9 or 10 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">970</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM h)</td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">4.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability (%)</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">42.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo safety</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">single dose tox (mg/kg)</td><td class="colsep0 rowsep0" align="left">not tested</td><td class="colsep0 rowsep0" align="left">NOEL > 2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 week repeated dose tox</td><td class="colsep0 rowsep0" align="left">not tested</td><td class="colsep0 rowsep0" align="left">not significant</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Rats (<i>n</i> = 4) were dosed with 1 mg/kg iv and 9 or 10 mg/kg po (9 mg/kg for <b>1</b> and 10 mg/kg for <b>35</b>); parameters were calculated from composite mean plasma concentration–time data. Formulation included ethanol 10% DMSO, 15% water, and 75% PEG400.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Improved Radioiodine Avidity by Compound 35</h3><div class="NLM_p">Compound <b>35</b> increased radioiodine avidity in ATC cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). The maximum iodide uptake of CAL62 and BHT101 cells was observed at 6 and 12 μM concentrations of compound <b>35</b>, respectively. To examine whether the increased radioiodine avidity is related to modulation of NIS function by compound <b>35</b>, KClO<sub>4</sub>, a specific inhibitor of NIS, was coincubated with compound <b>35</b>-treated ATC cells and the change in radioiodine uptake levels was determined. The iodide uptake assay showed that the enhanced radioiodine uptake was completely inhibited by KClO<sub>4</sub> treatments (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). These results indicated that the enhanced radioiodine avidity is due to compound <b>35</b>-mediated increase of NIS functional activity.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Increased radioiodine avidity by compound <b>35</b> in CAL62 and BHT101 cells. (A, B) <sup>125</sup>I uptake assay in compound <b>35</b>-treated cells. (C, D) Inhibition study with 300 μM KClO<sub>4</sub> in compound <b>35</b>-treated cells. Each cell line was incubated with compound <b>35</b> for 24 h, and radioiodine uptake was conducted. For inhibition study, the compound <b>35</b>-treated cell line was further incubated with KClO<sub>4</sub> for 30 min, followed by radioiodine uptake. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound 35-Mediated Upregulation of Crucial Gene Expression Related to Iodine Metabolism and Increased Cytotoxicity of I-131 in ATC Cells</h3><div class="NLM_p">We investigated the effects of compound <b>35</b> on the mRNA and protein levels of ERRγ in CAL62 and BHT101 cells. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Figure S41A</a>, a change in the mRNA expression level of ERRγ was not observed in <b>35</b>-treated CAL62 and BHT101 cells. However, there was a dose-dependent reduction in the protein level of ERRγ in <b>35</b>-treated CAL62 and BHT101 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Figure S41B</a>), which is consistent with our previous reports.<a onclick="showRef(event, 'ref40 ref43'); return false;" href="javascript:void(0);" class="ref ref40 ref43">(40,43)</a></div><div class="NLM_p">Next, we examined whether the increase in radioiodine avidity is related to compound <b>35</b>-mediated regulation of iodide-handling genes such as NIS, thyroid stimulating hormone receptor (TSHR), thyroperoxidase (TPO), and thyroglobulin (TG). Quantitative polymerase chain reaction (PCR) analysis demonstrated that compound <b>35</b> increased <i>NIS</i>, <i>TSHR</i>, <i>TPO</i>, and <i>TG</i> mRNA expression in CAL62 and BHT101 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). In the case of CAL62 cells, a dose-dependent increase in the mRNA expression was observed. For BHT101 cells, higher expression of the iodide-handling genes was observed at 6 μM than at 12 μM. Furthermore, western blot analysis demonstrated that compound <b>35</b> increased the protein expression of iodide-handling genes in ATC cells in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Importantly, compound <b>35</b> increased membranous NIS protein in ATC cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Next, we further investigated changes in iodide-handling-gene expression at various time points after compound <b>35</b> treatment. Quantitative polymerase chain reaction analysis showed a time-dependent increase in the mRNA expression of <i>NIS</i>, <i>TG</i>, <i>TPO</i>, and <i>TSHR</i> in compound <b>35</b>-treated CAL62 cell and BHT101 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Figure S42</a>), consistent with the results of western blotting analysis (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Upregulation of protein expression of iodide-handling genes by compound <b>35</b> in CAL62 and BHT101 cells and enhanced cytotoxic effects of radioiodine therapy. mRNA expression levels of <i>NIS</i>, <i>TPO</i>, <i>TG</i>, and <i>TSHR</i> in <b>35</b>-treated (A) CAL62 cells and (B) BHT101 cells. (C) Dose-dependent change in NIS, TSHR, TG, and TPO proteins in <b>35</b>-treated CAL62 and BHT101 cells. (D) Membranous NIS protein expression in <b>35</b>-treated CAL62 and BHT101 cells. (E) Time-dependent change in the protein expression of iodide-handling genes in compound <b>35</b>-treated CAL62 and BHT101 cells. Each cell line was incubated with compound <b>35</b> for 24 h, and RNA and protein samples were prepared for real-time PCR and western blotting analysis. (F) Clonogenic assay showing enhanced cytotoxicity of <sup>131</sup>I by compound <b>35</b> in CAL62 and BHT101 cells. Cells were pretreated with compound <b>35</b> for 24 h, followed by incubation with <sup>131</sup>I for 6 h. Colonies were stained with 0.1% crystal violet solution, and the number of colonies was counted. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Most ATC cells do not express iodide-handling genes; therefore, effective radioiodine uptake cannot be achieved, thereby resulting in the failure of radioiodine therapy. Based on the effective increase in radioiodine uptake in compound <b>35</b>-treated ATC cells, enhanced susceptibility of ATC cells to radioiodine therapy could be expected. The in vitro clonogenic assay revealed that <sup>131</sup>I or compound <b>35</b> alone cannot decrease colony formation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F). However, a drastic reduction in the colony formation of ATC cells was confirmed when I-131 was combined with compound <b>35</b>. Collectively, these results indicate that compound <b>35</b> is an attractive re-differentiator that restores the downregulated iodide-handling genes in ATC, thereby enhancing radioiodine therapeutic effects.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Imaging of Compound 35-Mediated Increase in Radioiodine Avidity in CAL62 Tumors</h3><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, compound <b>35</b> increased radioiodine avidity in CAL62 tumors as demonstrated by <sup>124</sup>I-PET/CT imaging. Increased accumulation of iodine was not found in the tumor of the vehicle-treated group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). However, a significant increase in radioiodine avidity was detectable in the tumor of the compound <b>35-</b>treated group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), implying that compound <b>35</b> does enhance the radioiodine avidity in vivo.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Restoration of radioiodine avidity in CAL62 tumors in response to compound <b>35</b> treatment. (A) Schematic for <sup>124</sup>I-PET/CT imaging. Prior to compound <b>35</b> treatment of tumor-bearing mice, <sup>124</sup>I-PET/CT imaging was performed to determine the basal uptake of radioiodine in CAL62 tumors. After image acquisition, CAL62-tumor-bearing mice received either vehicle or 200 mg/kg compound <b>35</b> via oral administration once a day for 6 days. After the last treatment, PET/CT imaging was performed to determine the change in radioiodine avidity in tumors. (B, C) Three-dimensional (3D)-reconstructed <sup>124</sup>I-PET/CT images of increased radioiodine avidity in CAL62 tumors following compound <b>35</b> treatment (left panel). Quantification of radioactivity in tumors of vehicle- or compound <b>35</b>-treated mice before and after treatment (right panel). The red arrow indicates the tumor. * <i>P</i> < 0.05, NS; not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> ERRγ and Compound 35 Binding</h3><div class="NLM_p">To understand how a ligand binds to the ERRγ ligand-binding domain (LBD) (222–458), we solved the ERRγ crystal structure in complex with compound <b>35</b> at 2.9 Å resolution by molecular replacement. The collected data were refined and converged to final <i>R</i><sub>work</sub> = 20.09% and <i>R</i><sub>free</sub> = 26.33% using cystallographic object-oriented toolkit (COOT) and Python-based hierarchical environment for integrated xtallography (PHENIX) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Table S1</a>). All figures were generated by Chimera (version 1.11.2, build 41376).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Analysis of the structure confirmed that compound <b>35</b> binds to the ligand-binding pocket of ERRγ. The affinity of compound <b>35</b> for the ERRγ ligand-binding pocket is enhanced owing to its proximity to the key residues (Tyr326, Asn346, Asp273) of the ligand (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The alcohol functional group of compound <b>35</b> interacts with Tyr326 at 2.08 Å and Asn346 at 2.31 Å by hydrogen bonding. Additionally, the benzene ring of compound <b>35</b> and His434 ring form π stacking in a parallel-displaced pattern, and the basic chain of compound <b>35</b> interacts with Asp273 at 3.0 Å. Previously, we solved the crystal structure of ERRγ in complex with DN200434 (the paper under revision), and Glu275 was one of the key residues binding the <i>para</i>-hydroxyl group of the phenyl ring in close proximity at 2.46 Å. In the case of ERRγ in complex with compound <b>35</b>, the hydrogen interaction between Glu275 and the <i>meta</i>-hydroxyl group of the phenyl ring is weakened at 3.86 Å, and it induces the alcohol functionality of compound <b>35</b> to move toward Tyr326 and Asn346. Consequently, compound <b>35</b> interacts with the key ERRγ binding pocket residues via hydrogen bonding, ion interactions, and pi stacking, enhancing its potency.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of the ERRγ and compound <b>35</b> complex (Protein Data Bank (PDB) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a tetrasubstituted olefin analogue (compound <b>35</b>) was synthesized, and its SAR was studied to enhance its ERRγ inverse agonist potency, selectivity, and bioavailability. The analogue synthesized in this study showed better in vitro ADMET profiles and PK parameters than those of the reference compound GSK5182 (<b>1</b>). Compound <b>35</b> increased radioiodine avidity in ATC cells, and the mechanism underlying this was found to involve regulation of iodide-handling genes. It also increased avidity in CAL62 tumors, as demonstrated by in vivo nuclear medicine imaging. X-ray crystallographic analysis of the ligand–ERRγ complex clearly demonstrated that <b>35</b> bound to the ERRγ protein. Therefore, this compound can be used as a potential therapeutic agent for ERRγ-related cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General</h3><div class="NLM_p last">All NMR experiments were carried out using an Avance III 400 MHz NMR spectrometer equipped with a 5 mm broadband-observed probe head (Bruker, Billerica, MA). The NMR spectrum optimization was conducted using Bruker TopSpin 3.1 software, and all parameters were set in it. The compounds were dissolved in CDCl<sub>3</sub> or CD<sub>3</sub>OD, and the spectra were acquired at 25 °C. Mass spectra were measured in positive electrospray ionization (ESI) mode on an LC–MS system (Shimadzu, Tokyo, Japan). Column chromatography was performed using a CombiFlash Rf system with RediSep Rf (Teledyne Isco, Lincoln, NE). For the final compounds, further purification was performed by preparative HPLC on Kinetex 5 μm biphenyl 100 Å (GX-281 HPLC system, Gilson, Middleton, WI; column tube: 250 mm × 21.2 mm ID) with acetonitrile (ACN)/H<sub>2</sub>O as eluent. Reverse-phase HPLC was conducted on Agilent Technologies 1290 Infinity, which was equipped with a C18 column (Kinetex 1.7 μm EVO C18, 100 × 2.1 mm<sup>2</sup>). Mobile phase A was water with 0.1% TFA, and mobile phase B was acetonitrile with 0.1% TFA. A gradient of 20–100% B was run at a flow rate of 0.6 mL/min over 5 min. The purity of the target compounds was determined to be >95% by analytical HPLC. Starting materials were obtained from Aldrich (St. Louis, MO) or Alfa Aesar (Ward Hill, MA). Solvents were obtained from Fisher Scientific (Hampton, NH) or Aldrich and were used without further purification unless noted otherwise.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthetic Procedure for 3a–m</h3><div class="NLM_p">To a solution of corresponding acetylene (B-ring) in DMF/H<sub>2</sub>O (2:1) was added corresponding boronic ester (1.2–3 equiv) (A ring), iodobenzene (1.2–3 equiv) (C-ring), and 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (0.01 equiv). The contents were heated at 45 °C. After 10 min, Cs<sub>2</sub>CO<sub>3</sub> (1.2–3 equiv) was added. The reaction mixture was heated at 45 °C for 12 h and quenched with saturated NaCl solution, and the aqueous (aq) layer was extracted with EtOAc. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under reduced pressure. The product was isolated by column chromatography.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>E</i>)-Methyl 5-(4-(4-Methylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>3a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1a</b> (0.14 g, 0.5 mmol), <b>2a</b> (0.23 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.21 g, 1.50 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (0.13 g, 48% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>41</sub>N<sub>2</sub>O<sub>4</sub> 541; found 541.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-Methyl 5-(4-Bromophenyl)-5-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenylpent-4-enoate (<b>3b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1b</b> (0.13 g, 0.5 mmol), <b>2a</b> (0.23 g, 0.75 mmol), iodobenzene (168 μL, 1.5 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.21 g, 1.50 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (13 mg, 5% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.25–7.01 (m, 11H), 4.13 (s, 3H), 3.56 (s, 3H), 2.90–2.68 (m, 6H), 2.36–2.21 (m, 4H), 1.96–1.81 (m, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>BrN<sub>2</sub>O<sub>2</sub> 519; found 519.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>Z</i>)-Methyl 5-(4-(4-Methylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-enoate (<b>3c</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1c</b> (0.1 g, 0.5 mmol), <b>2a</b> (0.23 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.21 g, 1.50 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (31 mg, 14% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18–7.07 (m, 9H), 6.78 (d, <i>J</i> = 8.4 Hz, 2H), 6.65 (d, <i>J</i> = 8.4 Hz, 2H), 3.70 (d, <i>J</i> = 13.5 Hz, 2H), 3.52 (d, <i>J</i> = 5.8 Hz, 5H), 3.16 (t, <i>J</i> = 11.6 Hz, 2H), 2.91 (t, <i>J</i> = 12.0 Hz, 5H), 2.73 (t, <i>J</i> = 7.7 Hz, 2H), 2.35 (s, 3H), 2.26 (t, <i>J</i> = 8.3 Hz, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub> 455; found 455.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>E</i>)-Methyl 5-(4-(4-Methylpiperazin-1-yl)phenyl)-5-(4-nitrophenyl)-4-phenylpent-4-enoate (<b>3d</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1d</b> (0.12 g, 0.5 mmol), <b>2a</b> (0.23 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.21 g, 1.50 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (37 mg, 15% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>N<sub>3</sub>O<sub>4</sub> 486; found 486.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>E</i>)-Methyl 5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>3e</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1a</b> (72 mg, 0.25 mmol), <b>2b</b> (0.12 g, 0.375 mmol), iodobenzene (42 μL, 0.375 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.1 g, 0.75 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (42 mg, 30% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.26 (d, <i>J</i> = 8.5 Hz, 2H), 7.21–7.10 (m, 5H), 7.07 (d, <i>J</i> = 8.5 Hz, 2H), 6.75 (d, <i>J</i> = 8.8 Hz, 3H), 6.63 (d, <i>J</i> = 8.9 Hz, 2H), 3.53 (s, 3H), 3.12–3.05 (m, 4H), 2.79–2.73 (m, 2H), 2.70–2.64 (m, 4H), 2.39–2.32 (m, 1H), 2.32–2.25 (m, 2H), 1.36 (d, <i>J</i> = 4.7 Hz, 9H), 1.10 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E</i>)-Methyl 5-(4-Bromophenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-enoate (<b>3f</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1b</b> (0.13 g, 0.5 mmol), <b>2b</b> (0.2 g, 0.6 mmol), iodobenzene (67 μL, 0.6 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.2 g, 0.6 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (53 mg, 19% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 7.21–7.08 (m, 7H), 6.69 (d, <i>J</i> = 8.7 Hz, 2H), 6.55 (d, <i>J</i> = 8.8 Hz, 2H), 3.55 (s, 3H), 3.12–3.04 (m, 4H), 2.77–2.70 (m, 2H), 2.68–2.63 (m, 1H), 2.62–2.57 (m, 4H), 1.05 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>36</sub>BrN<sub>2</sub>O<sub>2</sub> 548; found 548.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>Z</i>)-Methyl 5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-enoate (<b>3g</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1c</b> (0.1 g, 0.5 mmol), <b>2b</b> (0.25 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.24 g, 0.7 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (48 mg, 20% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20–7.13 (m, 6H), 7.12–7.09 (m, 3H), 6.72 (d, <i>J</i> = 8.6 Hz, 2H), 6.55 (d, <i>J</i> = 8.7 Hz, 2H), 3.54 (s, 3H), 3.11–3.06 (m, 4H), 2.79–2.73 (m, 2H), 2.69–2.63 (m, 1H), 2.62–2.58 (m, 4H), 2.36 (s, 3H), 2.32–2.27 (m, 2H), 1.05 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>39</sub>N<sub>2</sub>O<sub>2</sub> 483; found 483.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>E</i>)-Methyl 5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-5-(4-nitrophenyl)-4-phenylpent-4-enoate (<b>3h</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1d</b> (0.12 g, 0.5 mmol), <b>2b</b> (0.25 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.24 g, 0.7 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (0.2 g, 79% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>36</sub>N<sub>3</sub>O<sub>4</sub> 514; found 514.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-Methyl 5-(4-(4-Acetylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>3i</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1a</b> (72 mg, 0.25 mmol), <b>2c</b> (0.12 g, 0.38 mmol), iodobenzene (42 μL, 0.38 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.1 g, 0.75 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (44 mg, 31% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.27 (d, <i>J</i> = 8.6 Hz, 2H), 7.21–7.10 (m, 5H), 7.07 (d, <i>J</i> = 8.6 Hz, 2H), 6.94 (m, 4H), 3.79–3.71 (m, 4H), 3.53 (s, 3H), 3.24 (s, 4H), 2.83–2.72 (m, 2H), 2.34–2.24 (m, 2H), 2.12 (s, 3H), 1.36 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub> 569; found 569.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>Z</i>)-Methyl 5-(4-(4-Acetylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-enoate (<b>3j</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1c</b> (51 mg, 0.25 mmol), <b>2c</b> (0.12 g, 0.38 mmol), iodobenzene (42 μL, 0.38 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.1 g, 0.75 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (69 mg, 57% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.19–7.07 (m, 8H), 6.89–6.82 (m, 4H), 3.88 (m, 2H), 3.74 (m, 2H), 3.54 (s, 3H), 3.25 (m, 2H), 3.20 (m, 2H), 2.78 (m, 2H), 2.36 (s, 3H), 2.30 (m, 2H), 2.15 (s, 3H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>35</sub>N<sub>2</sub>O<sub>3</sub> 483; found 483.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>E</i>)-<i>tert</i>-Butyl 4-(4-(5-Methoxy-5-oxo-2-phenyl-1-(4-(pivaloyloxy)phenyl)pent-1-en-1-yl)phenyl)piperazine-1-carboxylate (<b>3k</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1a</b> (0.14 g, 0.5 mmol), <b>2d</b> (0.29 g, 0.75 mmol), iodobenzene (84 μL, 0.75 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.24 g, 0.75 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (93 mg, 30% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.23–7.13 (m, 5H), 7.12–7.11 (m, 3H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.73 (d, <i>J</i> = 8.8 Hz, 2H), 6.54 (d, <i>J</i> = 8.9 Hz, 2H), 3.54 (s, 3H), 3.50–3.48 (m, 4H), 3.02–3.00 (m, 4H), 2.76 (m, 2H), 2.29 (m, 2H), 1.46 (s, 9H), 1.36 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>47</sub>N<sub>2</sub>O<sub>6</sub> 627; found 627.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>E</i>)-<i>tert</i>-Butyl 4-(4-(1-(4-Bromophenyl)-5-methoxy-5-oxo-2-phenylpent-1-en-1-yl)phenyl)piperazine-1-carboxylate (<b>3l</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1b</b> (67 mg, 0.25 mmol), <b>2d</b> (0.15 g, 0.38 mmol), iodobenzene (42 μL, 0.38 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.1 g, 0.75 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (18 mg, 12% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.47 (d, <i>J</i> = 8.2 Hz, 2H), 7.20–7.16 (m, 2H), 7.14–7.08 (m, 5H), 6.70 (d, <i>J</i> = 8.6 Hz, 2H), 6.55 (d, <i>J</i> = 8.7 Hz, 2H), 3.55 (s, 3H), 3.50–3.48 (m, 4H), 3.01 (m, 4H), 2.74 (t, <i>J</i> = 7.9 Hz, 2H), 2.28 (t, <i>J</i> = 8.4 Hz, 2H), 1.45 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 173.3, 154.6, 149.0, 142.2, 141.1, 138.8, 137.7, 133.5, 131.5, 131.4, 131.0, 129.5, 128.1, 126.5, 120.8, 115.0, 79.9, 51.5, 48.7, 33.2, 31.2, 28.4. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>38</sub>BrN<sub>2</sub>O<sub>4</sub> 605; found 605.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>Z</i>)-<i>tert</i>-Butyl 4-(4-(5-Methoxy-5-oxo-2-phenyl-1-(<i>p</i>-tolyl)pent-1-en-1-yl)phenyl)piperazine-1-carboxylate (<b>3m</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1c</b> (51 mg, 0.25 mmol), <b>2d</b> (0.15 g, 0.38 mmol), iodobenzene (42 μL, 0.38 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.1 g, 0.75 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (78 mg, 58% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18–7.08 (m, 9H), 6.74 (d, <i>J</i> = 8.5 Hz, 2H), 6.61 (d, <i>J</i> = 8.6 Hz, 2H), 3.54 (s, 3H), 3.49 (s, 4H), 2.99 (t, <i>J</i> = 4.9 Hz, 4H), 2.74 (t, <i>J</i> = 7.6 Hz, 2H), 2.36 (s, 3H), 2.28 (t, <i>J</i> = 8.4 Hz, 2H), 1.47 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>41</sub>N<sub>2</sub>O<sub>4</sub> 541; found 541.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>E</i>)-4-(5-Hydroxy-2-phenyl-1-(4-(piperazin-1-yl)phenyl)pent-1-en-1-yl)phenol Dihydrochloride Salt (<b>4</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4k</b> (19 mg, 0.04 mmol) and 1 M LiAlH<sub>4</sub> in THF (72 μL, 0.07 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (4 mg, 29% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.20–7.11 (m, 7H), 7.04 (m, 4H), 6.80 (d, <i>J</i> = 8.5 Hz, 2H), 3.83 (m, 2H), 3.70 (m, 6H), 3.62 (t, <i>J</i> = 5.2 Hz, 2H), 2.51 (m, 2H), 1.56 (m, 2H). High-resolution mass spectrometry (HRMS) (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub> 415.2380; found 415.2373. HPLC purity: 98.8%, retention time = 2.74 min.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-Methyl 4-Phenyl-5-(4-(piperazin-1-yl)phenyl)-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>4k</b>)</h4><div class="NLM_p last">To a solution of <b>3k</b> (54 mg, 0.09 mmol) was dissolved CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and added TFA (0.13 mL, 1.72 mmol) dropwise at 0 °C. The solution was stirred at rt for 1 h and was quenched by adding water. The resulting solution was extracted with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered and concentrated under reduced pressure to give the desired compound (21 mg, 46% yield).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>E</i>)-Methyl 5-(4-Bromophenyl)-4-phenyl-5-(4-(piperazin-1-yl)phenyl)pent-4-enoate (<b>4l</b>)</h4><div class="NLM_p last">To a solution of <b>3l</b> (18 mg, 0.03 mmol) was dissolved CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and added TFA (0.05 mL, 0.59 mmol) dropwise at 0 °C. The solution was stirred at rt for 1 h and was quenched by adding water. The resulting solution was extracted with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the desired compound (15 mg, 99% yield).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>Z</i>)-Methyl 4-Phenyl-5-(4-(piperazin-1-yl)phenyl)-5-(<i>p</i>-tolyl)pent-4-enoate (<b>4m</b>)</h4><div class="NLM_p last">To a solution of <b>3m</b> (78 mg, 0.14 mmol) was dissolved CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and added TFA (0.22 mL, 2.89 mmol) dropwise at 0 °C. The solution was stirred at rt for 1 h and was quenched by adding water. The resulting solution was extracted with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the desired compound (25 mg, 39% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.17–7.08 (m, 9H), 6.77 (d, <i>J</i> = 8.6 Hz, 2H), 6.54 (d, <i>J</i> = 8.6 Hz, 2H), 3.55 (s, 3H), 3.29 (s, 4H), 3.26 (s, 4H), 2.82–2.76 (m, 2H), 2.36 (s, 3H), 2.33–2.29 (m, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub> 441; found 441.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>E</i>)-5-(4-Bromophenyl)-4-phenyl-5-(4-(piperazin-1-yl)phenyl)pent-4-en-1-ol Dihydrochloride Salt (<b>5</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4l</b> (15 mg, 0.03 mmol) and 1 M DIBAL-H in THF (59 μL, 0.06 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (6 mg, 41% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.40 (d, <i>J</i> = 8.2 Hz, 2H), 7.08–6.99 (m, 7H), 6.68 (d, <i>J</i> = 8.5 Hz, 2H), 6.57 (d, <i>J</i> = 8.6 Hz, 2H), 3.30 (t, <i>J</i> = 6.5 Hz, 2H), 3.17 (m, 8H), 2.38 (t, <i>J</i> = 5.8 Hz, 2H), 1.46–1.38 (m, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 148.10, 142.59, 142.15, 140.29, 137.78, 135.26, 131.36, 131.07, 131.00, 129.33, 127.64, 126.01, 120.20, 115.43, 61.42, 46.14, 43.32, 32.03, 31.49. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>30</sub>BrN<sub>2</sub>O 479.1521; found 479.1506. HPLC purity: 97.7%, retention time = 3.50 min.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>E</i>)-Methyl 5-(4-(4-Cyclobutylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>5a</b>)</h4><div class="NLM_p last">To a solution of <b>4k</b> (10 mg, 0.02 mmol) was dissolved DCE (1 mL) and added sodium triacetoxyborohydride (12 mg, 0.06 mmol) and cyclobutanone (4 mg, 0.06 mmol) at 0 °C. The solution was heated at 50 °C for 12 h and was quenched by adding water. The resulting solution was extracted with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure (11 mg, quant.). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 581; found 581.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>E</i>)-Methyl 5-(4-(4-Cyclopentylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>5b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4k</b> (10 mg, 0.02 mmol), sodium triacetoxyborohydride (12 mg, 0.06 mmol), and cyclopentanone (5 mg, 0.06 mmol) in DCE (1 mL) according to the synthetic procedure for <b>5a</b> (6 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.26 (d, <i>J</i> = 8.5 Hz, 2H), 7.21–7.11 (m, 5H), 7.09–7.05 (m, 2H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 6.69 (d, <i>J</i> = 8.8 Hz, 2H), 3.75 (d, <i>J</i> = 13.7 Hz, 2H), 3.59 (d, <i>J</i> = 12.4 Hz, 2H), 3.53 (s, 3H), 3.26–3.19 (m, 2H), 3.17–3.04 (m, 2H), 2.96–2.87 (m, 2H), 2.80–2.73 (m, 3H), 2.30 (m, 2H), 2.15 (s, 4H), 1.40 (m, 2H), 1.37 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>47</sub>N<sub>2</sub>O<sub>4</sub> 595; found 595.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>E</i>)-Methyl 5-(4-(4-Cyclohexylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>5c</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4k</b> (10 mg, 0.02 mmol), sodium triacetoxyborohydride (12 mg, 0.06 mmol), and cyclohexanone (6 μL, 0.06 mmol) in DCE (1 mL) according to the synthetic procedure for <b>5a</b> (4 mg, 37% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>49</sub>N<sub>2</sub>O<sub>4</sub> 609; found 609.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-Methyl 5-(4-(4-(Oxetan-3-yl)piperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>5d</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4k</b> (70 mg, 0.13 mmol), sodium cyanoborohydride (21 mg, 0.33 mmol), acetic acid (15 μL, 0.27 mmol), and 3-oxetanone (17 μL, 0.27 mmol) in THF/MeOH (5:0.5 mL) according to the synthetic procedure for <b>5a</b> (42 mg, 54% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23–7.10 (m, 6H), 7.06 (d, <i>J</i> = 8.4 Hz, 2H), 6.72 (d, <i>J</i> = 8.6 Hz, 2H), 6.55 (d, <i>J</i> = 8.7 Hz, 2H), 4.74–4.53 (m, 4H), 3.54 (s, 3H), 3.15–3.09 (m, 4H), 2.80–2.74 (m, 2H), 2.54–2.47 (m, 1H), 2.44–2.39 (m, 4H), 2.33–2.24 (m, 2H), 1.36 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>43</sub>N<sub>2</sub>O<sub>5</sub> 583; found 583.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>Z</i>)-4-Phenyl-5-(4-(piperazin-1-yl)phenyl)-5-(<i>p</i>-tolyl)pent-4-en-1-ol Dihydrochloride Salt (<b>6</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>4m</b> (25 mg, 0.06 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.11 mL, 0.11 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (7 mg, 30% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.16–7.06 (m, 9H), 6.71 (d, <i>J</i> = 8.8 Hz, 2H), 6.64 (d, <i>J</i> = 8.8 Hz, 2H), 3.38 (t, <i>J</i> = 6.8 Hz, 2H), 3.19 (s, 8H), 2.47 (m, 2H), 2.34 (s, 3H), 1.52 (m, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 148.94, 142.68, 140.71, 139.10, 138.95, 136.00, 135.23, 131.26, 129.44, 129.04, 128.40, 127.57, 125.73, 115.02, 61.61, 48.43, 44.47, 32.01, 31.69, 19.82. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>33</sub>N<sub>2</sub>O 413.2587; found 413.2580. HPLC purity: 97.8%, retention time = 3.12 min.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>E</i>)-Methyl 5-(4-(4-((<i>Z</i>)-<i>N</i>,<i>N</i>′-Bis(<i>tert</i>-butoxycarbonyl)carbamimidoyl)piperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>6a</b>)</h4><div class="NLM_p last">To a solution of <b>4k</b> (10 mg, 0.02 mmol), bis-Boc-thiourea (5 mg, 0.02 mmol), and TEA (8 μL, 0.06 mmol) in DMF (1 mL) was added mercury(II) chloride (6 mg, 0.02 mmol) at 0 °C. The resulting reaction mixture was allowed to stir at room temperature overnight. The reaction mixture was poured into aq NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. The extract was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The product was isolated by column chromatography (5 mg, 36% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>57</sub>N<sub>4</sub>O<sub>8</sub> 769; found 769.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Synthetic Procedure for 7–18</h3><div class="NLM_p">To a solution of <b>3a</b>–<b>m</b> was dissolved THF and added 1 M LiAlH<sub>4</sub>, 1 M DIBAL-H, or 2 M LiBH<sub>4</sub> in THF (1.5–3 equiv) dropwise at 0 °C. The solution was stirred at rt for 1 h and was quenched by adding water. The resulting solution was extracted with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude compound was purified by preparative HPLC using eluent A (0.1% TFA H<sub>2</sub>O) and eluent B (0.1% TFA ACN) (A/B = 70/30). To a solution of this compound in MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1) was added a 1 M solution of hydrochloric acid (1.2 equiv) in water at 0 °C. After stirring for 10 min, the volatiles were removed in vacuum to yield the desired compound.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-methylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>7</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3a</b> (0.13 g, 0.24 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.72 mL, 0.72 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (38 mg, 98% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.20–7.07 (m, 7H), 7.04 (d, <i>J</i> = 8.5 Hz, 2H), 6.83 (d, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.5 Hz, 2H), 3.74 (m, 2H), 3.57 (m, 2H), 3.42 (t, <i>J</i> = 6.7 Hz, 2H), 3.23 (m, 2H), 3.04 (m, 2H), 2.95 (s, 3H), 2.53 (m, 2H), 1.55 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub> 429.2464; found 429.2529.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>E</i>)-Methyl 5-(4-(4-Carbamimidoylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>7a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>6a</b> (5 mg, 7 μmol) and TFA (10 μL, 0.14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to the synthetic procedure for <b>4k</b> (4 mg, quant.). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>41</sub>N<sub>4</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>E</i>)-5-(4-Bromophenyl)-5-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>8</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3b</b> (35 mg, 0.067 mmol) and 1 M DIBAL-H in THF (0.27 mL, 0.27 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (16 mg, 48% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.26 (d, <i>J</i> = 8.7 Hz, 2H), 7.49 (d, <i>J</i> = 8.8 Hz, 2H), 7.22–7.14 (m, 5H), 6.82 (d, <i>J</i> = 8.7 Hz, 2H), 6.73 (d, <i>J</i> = 8.8 Hz, 2H), 3.75 (m, 2H), 3.56 (m, 2H), 3.44 (t, <i>J</i> = 6.4 Hz, 2H), 3.20 (t, <i>J</i> = 11.6 Hz, 2H), 2.98 (m, 5H), 2.52 (m, 2H), 1.57 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>32</sub>BrN<sub>2</sub>O 491.1693; found 491.1684. HPLC purity: 96.3%, retention time = 3.08 min.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>Z</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)acetamide (<b>8a</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (5 mg, 11 μmol) and pyridine (1 μL, 13 μmol) in CHCl<sub>2</sub> (1 mL) was added acetic anhydride (2 μL, 22 μmol) at 0 °C. The resulting reaction mixture was allowed to stir at room temperature overnight. The reaction mixture was poured into aq sat. NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. The extract was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude mixture was purified by preparative HPLC using eluent A (0.1% TFA H<sub>2</sub>O) and eluent B (0.1% TFA ACN) (A/B = 70/30) (0.4 mg, 7% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>40</sub>N<sub>3</sub>O<sub>2</sub> 498; found 498.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>Z</i>)-5-(4-(4-Methylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-en-1-ol Dihydrochloride Salt (<b>9</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3c</b> (31 mg, 0.068 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.21 mL, 0.21 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (17 mg, 56% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.16–7.07 (m, 9H), 6.72 (d, <i>J</i> = 8.6 Hz, 2H), 6.60 (d, <i>J</i> = 8.6 Hz, 2H), 3.38 (t, <i>J</i> = 6.8 Hz, 2H), 3.06 (t, <i>J</i> = 4.5 Hz, 4H), 2.55 (t, <i>J</i> = 4.8 Hz, 4H), 2.47 (m, 2H), 2.34 (s, 3H), 2.31 (s, 3H), 1.56–1.49 (m, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 147.33, 142.58, 140.56, 139.37, 138.89, 136.11, 136.09, 131.40, 129.42, 129.00, 128.43, 127.58, 125.78, 115.31, 61.58, 53.26, 46.47, 42.08, 32.02, 31.63, 19.79. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>35</sub>N<sub>2</sub>O 427.2744; found 427.2739. HPLC purity: 95.5%, retention time = 3.11 min.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>E</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)methanesulfonamide (<b>9a</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (5 mg, 10 μmol) and triethylamine (3 μL, 20 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added methanesulfonyl chloride (1 μL, 12 μmol) at 0 °C. The resulting reaction mixture was allowed to stir at room temperature overnight. The reaction mixture was poured into aq NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. The extract was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude residue was purified by column chromatography (1 mg, 17% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>40</sub>N<sub>3</sub>O<sub>3</sub>S 534; found 534.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>E</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)cyclopropanesulfonamide (<b>9b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>16</b> (5 mg, 10 μmol), cyclopropanesulfonyl chloride (2 mg, 12 μmol), and pyridine (1 μL, 12 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) according to the synthetic procedure for <b>9a</b> (2 mg, 26% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>42</sub>N<sub>3</sub>O<sub>3</sub>S 560; found 560.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>E</i>)-5-(4-(4-Methylpiperazin-1-yl)phenyl)-5-(4-nitrophenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>10</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3d</b> (5 mg, 0.01 mmol) and 1 M DIBAL-H in THF (0.41 μL, 0.041 mmol) in THF (0.5 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (2.7 mg, 55% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.25 (d, <i>J</i> = 8.7 Hz, 2H), 7.47 (d, <i>J</i> = 8.7 Hz, 2H), 7.21–7.13 (m, 5H), 6.81 (d, <i>J</i> = 8.7 Hz, 2H), 6.71 (d, <i>J</i> = 8.8 Hz, 2H), 3.74 (m, 2H), 3.54 (m, 2H), 3.42 (t, <i>J</i> = 6.4 Hz, 2H), 3.19 (t, <i>J</i> = 9.8 Hz, 2H), 2.93 (m, 5H), 2.50 (m, 2H), 1.55 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> 458.2438; found 458.2430. HPLC purity: 95.6%, retention time = 2.92 min.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>Z</i>)-1-(4-((<i>Z</i>)-5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)-2,3-di-boc-guanidine (<b>10a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>16</b> (5 mg, 11 μmol), bis-Boc-thiourea (3 mg, 12 μmol), TEA (5 μL, 33 μmol), and mercury(II) chloride (3 mg, 12 μmol) in DMF (1 mL) according to the synthetic procedure for <b>6a</b> (6 mg, 84% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>56</sub>N<sub>5</sub>O<sub>5</sub> 698; found 698.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>Z</i>)-1-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)guanidine (<b>10b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>10a</b> (8 mg, 11 μmol) and TFA (34 μL, 0.44 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) according to the synthetic procedure for <b>4k</b> (0.5 mg, 9% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>40</sub>N<sub>5</sub>O 498; found 498.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>Z</i>)-5-(4-Aminophenyl)-5-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>11</b>)</h4><div class="NLM_p last">To a mixture of <b>10</b> (10 mg, 0.022 mmol) and ammonium chloride (14 mg, 0.22 mmol) in a mixture of methanol and tetrahydrofuran (2 mL, v/v = 1:1) was added zinc (12 mg, 0.22 mmol) dust in portions at 0 °C. After the addition, the reaction mixture was stirred at room temperature overnight. The reaction mixture was filtered, and the filtrate was concentrated to give the crude product, which was purified by column chromatography. To a solution of afforded compound in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) was added a solution of 1 M hydrochloric acid at 0 °C. After stirring for 10 min, the volatiles were removed in vacuum to yield the desired compound (9 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.43 (s, 4H), 7.21–7.14 (m, 5H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 6.71 (d, <i>J</i> = 8.8 Hz, 2H), 3.70 (m, 2H), 3.55 (m, 2H), 3.44 (m, 2H), 3.17 (m, 2H), 3.14 (m, 5H), 2.49 (m, 2H), 1.55 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>34</sub>N<sub>3</sub>O 428.2696; found 428.2689. HPLC purity: 95.1%, retention time = 2.41 min.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-methylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl Pivalate (<b>11a</b>), (<i>E</i>)-5-(4-Hydroxyphenyl)-5-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-yl Pivalate (<b>11b</b>), and (<i>E</i>)-4-(1-(4-(4-Methylpiperazin-1-yl)phenyl)-2-phenyl-5-(pivaloyloxy)pent-1-en-1-yl)phenyl Pivalate (<b>11c</b>)</h4><div class="NLM_p last">To a solution of <b>7</b> (5 mg, 10 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL), pivaloyl chloride (1 μL, 11 μmol) and triethylamine (6 μL, 0.04 mmol) were added at 0 °C. The mixture was stirred for 20 min, quenched by brine, and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration, the solution was concentrated under vacuum and the product was purified by preparative HPLC using eluent A (0.1% TFA H<sub>2</sub>O) and eluent B (0.1% TFA ACN) (A/B = 70/30) <b>11a</b>; (4 mg, 72% yield), MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>3</sub> 513; found 513, <b>11b</b>; (0.5 mg, 0.8% yield), MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>3</sub> 513; found 513, <b>11c</b>; (0.8 mg, 13% yield), MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>49</sub>N<sub>2</sub>O<sub>4</sub> 597; found 597.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>12</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3e</b> (42 mg, 0.07 mmol) and 1 M LiALH<sub>4</sub> in THF (0.22 mL, 0.22 mmol) in THF (4 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (20 mg, 58% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18 (m, 5H), 7.03 (d, <i>J</i> = 8.5 Hz, 2H), 6.83–6.77 (m, 4H), 6.70 (d, <i>J</i> = 8.8 Hz, 2H), 3.78 (m, 2H), 3.58–3.53 (m, 2H), 3.43 (t, <i>J</i> = 6.8 Hz, 2H), 3.24 (t, <i>J</i> = 9.7 Hz, 2H), 2.97 (t, <i>J</i> = 11.8 Hz, 2H), 2.53 (m, 2H), 1.55 (m, 2H), 1.41 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 156.07, 145.18, 142.60, 139.74, 138.73, 138.59, 134.39, 131.69, 130.26, 129.44, 127.61, 125.81, 116.27, 114.60, 61.62, 58.46, 32.10, 31.64, 15.64. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 457.2850; found 457.2849. HPLC purity: 99.5%, retention time = 2.63 min.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>E</i>)-5-(4-Bromophenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>13</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3f</b> (96 mg, 0.18 mmol) and 1 M DIBAL-H in THF (0.35 mL, 0.35 mmol) in THF (4 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (60 mg, 66% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.50 (d, <i>J</i> = 8.1 Hz, 2H), 7.19–7.09 (m, 7H), 6.75 (d, <i>J</i> = 8.5 Hz, 2H), 6.63 (d, <i>J</i> = 8.6 Hz, 2H), 3.42 (t, <i>J</i> = 6.5 Hz, 2H), 3.17 (m, 4H), 2.91–2.90 (m, 4H), 2.52–2.48 (m, 2H), 1.58–1.51 (m, 2H), 1.20 (d, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 148.56, 142.72, 142.25, 139.92, 137.93, 134.36, 131.28, 131.14, 130.99, 129.35, 127.66, 125.99, 120.15, 114.90, 61.47, 55.87, 32.06, 31.55, 16.71. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>36</sub>BrN<sub>2</sub>O 519.2006; found 519.2000. HPLC purity: 98.8%, retention time = 3.19 min.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>E</i>)-Methyl 5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(2-(pivaloyloxy)phenyl)pent-4-enoate (<b>13a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12a</b> (72 mg, 0.25 mmol), <b>2b</b> (0.12 g, 0.38 mmol), iodobenzene (42 μL, 0.38 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (100 μL, 2.5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.12 g, 0.38 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (3 mg, 2% yield). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>E</i>)-Methyl 5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(3-(pivaloyloxy)phenyl)pent-4-enoate (<b>13b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12b</b> (0.14 g, 0.5 mmol), <b>2b</b> (0.18 g, 0.55 mmol), iodobenzene (61 μL, 0.55 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.16 g, 0.55 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (65 mg, 23% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (m, 3H), 7.18–7.06 (m, 6H), 6.99 (d, <i>J</i> = 9.8 Hz, 2H), 6.76–6.69 (m, 2H), 3.53 (s, 3H), 3.13–3.05 (m, 4H), 2.80–2.67 (m, 3H), 2.65–2.58 (m, 4H), 2.32–2.23 (m, 2H), 1.11 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>E</i>)-Methyl 5-(3-Bromophenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-enoate (<b>13c</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12c</b> (0.27 g, 1 mmol), <b>2b</b> (0.4 g, 1.2 mmol), iodobenzene (134 μL, 1.2 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (400 μL, 10 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.39 g, 1.2 mmol) in DMF/H<sub>2</sub>O (8:4 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (74 mg, 14% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.44 (d, <i>J</i> = 7.9 Hz, 1H), 7.35 (s, 1H), 7.29 (dd, <i>J</i> = 7.8, 7.7 Hz, 1H), 7.23–7.10 (m, 6H), 6.73 (d, <i>J</i> = 8.6 Hz, 2H), 6.62 (d, <i>J</i> = 8.7 Hz, 2H), 3.54 (s, 3H), 3.29–3.09 (m, 4H), 2.99–2.87 (m, 5H), 2.72 (dd, <i>J</i> = 8.2, 7.6 Hz, 2H), 2.26 (dd, <i>J</i> = 8.2, 7.6 Hz, 2H), 1.18 (d, <i>J</i> = 6.6 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>36</sub>BrN<sub>2</sub>O<sub>2</sub> 547; found 547.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>Z</i>)-5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-en-1-ol Dihydrochloride Salt (<b>14</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3g</b> (48 mg, 0.1 mmol) and 1 M LiALH<sub>4</sub> in THF (0.2 mL, 0.2 mmol) in THF (5 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (43 mg, 95% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18–7.14 (m, 6H), 7.10 (m, 3H), 6.75 (d, <i>J</i> = 8.6 Hz, 2H), 6.66 (d, <i>J</i> = 8.6 Hz, 2H), 3.41 (t, <i>J</i> = 6.8 Hz, 2H), 3.12 (m, 4H), 2.84–2.76 (m, 5H), 2.49 (m, 2H), 2.36 (s, 3H), 1.55 (m, 2H), 1.15 (d, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 148.66, 142.71, 140.75, 139.13, 138.85, 135.97, 134.94, 131.24, 129.45, 129.06, 128.40, 127.57, 125.72, 114.74, 61.63, 55.12, 32.02, 31.70, 19.83, 17.02. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>39</sub>N<sub>2</sub>O 455.3057; found 455.3048. HPLC purity: 98.2%, retention time = 3.07 min.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>E</i>)-5-(4-(4-Isopropylpiperazin-1-yl)phenyl)-5-(4-nitrophenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>15</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3h</b> (0.1 g, 0.2 mmol) and 2 M LiBH<sub>4</sub> in THF (0.2 mL, 0.39 mmol) in THF (5 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (53 mg, 56% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.25 (d, <i>J</i> = 8.7 Hz, 2H), 7.47 (d, <i>J</i> = 8.7 Hz, 2H), 7.21–7.13 (m, 5H), 6.81 (d, <i>J</i> = 8.7 Hz, 2H), 6.72 (d, <i>J</i> = 8.8 Hz, 2H), 3.78 (m, 2H), 3.53 (m, 3H), 3.42 (t, <i>J</i> = 6.5 Hz, 2H), 3.21 (m, 2H), 2.93 (m, 2H), 2.50 (m, 2H), 1.55 (m, 2H), 1.39 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>36</sub>N<sub>3</sub>O<sub>3</sub> 486.2751; found 486.2742. HPLC purity: 97.2%, retention time = 2.95 min.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>Z</i>)-<i>tert</i>-Butyl 4-(3-(5-Methoxy-5-oxo-2-phenyl-1-(4-(pivaloyloxy)phenyl)pent-1-en-1-yl)phenyl)piperazine-1-carboxylate (<b>15a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>1a</b> (0.14 g, 0.5 mmol), <b>14a</b> (0.23 g, 0.6 mmol), iodobenzene (67 μL, 0.6 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.19 g, 0.6 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (89 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25–7.21 (m, 2H), 7.16 (d, <i>J</i> = 6.3 Hz, 2H), 7.11 (d, <i>J</i> = 6.9 Hz, 3H), 7.06 (s, 2H), 6.94 (t, <i>J</i> = 7.9 Hz, 1H), 6.56 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 6.44 (s, 1H), 6.39 (d, <i>J</i> = 7.7 Hz, 1H), 3.55 (s, 3H), 3.44–3.38 (m, 4H), 2.86–2.76 (m, 3H), 2.76–2.69 (m, 4H), 2.35–2.26 (m, 2H), 1.47 (s, <i>J</i> = 5.4 Hz, 9H), 1.36 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>47</sub>N<sub>2</sub>O<sub>6</sub> 627; found 627.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>E</i>)-<i>tert</i>-Butyl 4-(3-(5-Methoxy-5-oxo-2-phenyl-1-(3-(pivaloyloxy)phenyl)pent-1-en-1-yl)phenyl)piperazine-1-carboxylate (<b>15b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12b</b> (0.14 g, 0.5 mmol), <b>14a</b> (0.23 g, 0.6 mmol), iodobenzene (67 μL, 0.6 mmol), 0.025 M PdCl<sub>2</sub>(PhCN)<sub>2</sub> in DMF (200 μL, 5 μmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.19 g, 0.6 mmol) in DMF/H<sub>2</sub>O (4:2 mL) according to the synthetic procedure for <b>3a</b>–<b>m</b> (75 mg, 24% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 7.9 Hz, 1H), 7.20–7.15 (m, 2H), 7.11 (d, <i>J</i> = 7.5 Hz, 4H), 7.02–6.92 (m, 3H), 6.57 (dd, <i>J</i> = 7.9, 2.1 Hz, 1H), 6.47–6.39 (m, 2H), 3.54 (s, 3H), 3.44–3.36 (m, 4H), 2.82–2.70 (m, 6H), 2.35–2.26 (m, 2H), 1.47 (s, 9H), 1.34 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>47</sub>N<sub>2</sub>O<sub>6</sub> 627; found 627.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>Z</i>)-5-(4-Aminophenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>16</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>15</b> (10 mg, 0.023 mmol), ammonium chloride (11 mg, 0.23 mmol), and zinc (12 mg, 0.23 mmol) in a mixture of methanol and tetrahydrofuran (2 mL, v/v=1:1) according to the synthetic procedure for <b>11</b> (10 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.17–7.11 (m, 4H), 7.08–7.04 (m, 1H), 6.96 (d, <i>J</i> = 8.2 Hz, 2H), 6.74 (dd, <i>J</i> = 8.4, 8.1 Hz, 4H), 6.62 (d, <i>J</i> = 8.6 Hz, 2H), 3.42 (t, <i>J</i> = 6.8 Hz, 2H), 3.17–3.04 (m, 4H), 2.78–2.64 (m, 5H), 2.53 (dd, <i>J</i> = 10.6, 8.1 Hz, 2H), 1.59–1.52 (m, 2H), 1.12 (d, <i>J</i> = 6.5 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>38</sub>N<sub>3</sub>O 456.3009; found 456.3008. HPLC purity: 97.6%, retention time = 2.29 min.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>Z</i>)-Methyl 4-Phenyl-5-(3-(piperazin-1-yl)phenyl)-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>16a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>15a</b> (0.18 g, 0.29 mmol) and TFA (0.44 mL, 5.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) according to the synthetic procedure for <b>4l</b> (0.15 g, 98% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24 (d, <i>J</i> = 8.6 Hz, 2H), 7.19–7.14 (m, 2H), 7.13–7.09 (m, 3H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.93 (t, <i>J</i> = 7.9 Hz, 1H), 6.57 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 6.46–6.42 (m, 1H), 6.37 (d, <i>J</i> = 7.7 Hz, 1H), 3.55 (s, 3H), 2.92–2.86 (m, 4H), 2.82–2.71 (m, 6H), 2.35–2.27 (m, 2H), 1.36 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub> 527; found 527.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>Z</i>)-Methyl 4-Phenyl-5-(3-(piperazin-1-yl)phenyl)-5-(3-(pivaloyloxy)phenyl)pent-4-enoate (<b>16b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>15b</b> (0.15 g, 0.24 mmol) and TFA (0.37 mL, 4.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) according to the synthetic procedure for <b>4l</b> (0.13 g, quant.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 7.9 Hz, 1H), 7.19–7.15 (m, 2H), 7.13–7.09 (m, 4H), 7.01–6.92 (m, 3H), 6.57 (dd, <i>J</i> = 8.0, 2.2 Hz, 1H), 6.46–6.44 (m, 1H), 6.39 (d, <i>J</i> = 7.7 Hz, 1H), 3.54 (s, 3H), 2.91–2.86 (m, 4H), 2.81–2.72 (m, 6H), 2.34–2.27 (m, 2H), 1.34 (s, 9H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub> 527; found 527.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>E</i>)-4-(1-(4-(4-Ethylpiperazin-1-yl)phenyl)-5-hydroxy-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>17</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3i</b> (10 mg, 0.02 mmol) and 1 M LiAlH<sub>4</sub> in THF (21 μL, 0.02 mmol) in THF (1 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (0.8 mg, 10% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.16–7.07 (m, 5H), 7.01 (d, <i>J</i> = 7.6 Hz, 2H), 6.77 (m, 4H), 6.67 (d, <i>J</i> = 8.5 Hz, 2H), 3.73 (m, 2H), 3.58 (m, 2H), 3.41 (t, <i>J</i> = 6.8 Hz, 2H), 3.23 (m, 2H), 3.14 (m, 2H), 2.93 (m, 2H), 2.51 (m, 2H), 1.53 (m, 2H), 1.37 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub> 443.2693; found 443.2684. HPLC purity: 95.7%, retention time = 2.68 min.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>Z</i>)-Methyl 5-(3-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(4-(pivaloyloxy)phenyl)pent-4-enoate (<b>17a</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>16a</b> (75 mg, 0.14 mmol), sodium triacetoxyborohydride (36 mg, 0.17 mmol), acetic acid (16 μL, 0.29 mmol), and acetone (21 μL, 0.29 mmol) in DCE (8 mL) according to the synthetic procedure for <b>5a</b> (50 mg, 62% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28–7.20 (m, 3H), 7.19–7.13 (m, 2H), 7.13–7.09 (m, 2H), 7.06 (d, <i>J</i> = 8.5 Hz, 2H), 6.92 (t, <i>J</i> = 7.9 Hz, 1H), 6.57 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.45 (s, 1H), 6.35 (d, <i>J</i> = 7.7 Hz, 1H), 3.55 (s, 3H), 2.87–2.75 (m, 6H), 2.68–2.60 (m, 1H), 2.58–2.49 (m, 4H), 2.36–2.25 (m, 2H), 1.36 (s, 9H), 1.05 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-Methyl 5-(3-(4-Isopropylpiperazin-1-yl)phenyl)-4-phenyl-5-(3-(pivaloyloxy)phenyl)pent-4-enoate (<b>17b</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>16b</b> (75 mg, 0.14 mmol), sodium triacetoxyborohydride (36 mg, 0.17 mmol), acetic acid (16 μL, 0.29 mmol), and acetone (21 μL, 0.29 mmol) in DCE (8 mL) according to the synthetic procedure for <b>5a</b> (50 mg, 62% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 7.9 Hz, 1H), 7.19–7.13 (m, 2H), 7.13–7.06 (m, 4H), 7.01–6.91 (m, 3H), 6.58 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 6.45 (s, 1H), 6.38 (d, <i>J</i> = 7.7 Hz, 1H), 3.54 (s, 3H), 2.87–2.74 (m, 6H), 2.68–2.60 (m, 1H), 2.56–2.50 (m, 4H), 2.34–2.26 (m, 2H), 1.34 (s, 9H), 1.05 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>2</sub>O<sub>4</sub> 569; found 569.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>Z</i>)-5-(4-(4-Ethylpiperazin-1-yl)phenyl)-4-phenyl-5-(<i>p</i>-tolyl)pent-4-en-1-ol Dihydrochloride Salt (<b>18</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>3j</b> (20 mg, 0.04 mmol) and 1 M LiAlH<sub>4</sub> in THF (83 μL, 0.083 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (2.2 mg, 12% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.19–7.14 (m, 5H), 7.10 (m, 2H), 6.76 (d, <i>J</i> = 8.6 Hz, 2H), 6.62 (d, <i>J</i> = 8.7 Hz, 2H), 3.42–3.34 (m, 4H), 3.21–3.15 (m, 2H), 3.09–3.03 (m, 2H), 2.92–2.84 (m, 4H), 2.52–2.48 (m, 2H), 2.37 (s, 3H), 1.59–1.51 (m, 2H), 1.29 (t, 7.2 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 148.28, 142.71, 140.75, 139.12, 138.83, 135.97, 134.75, 131.27, 129.44, 129.05, 128.39, 127.57, 125.72, 114.30, 61.62, 56.47, 43.26, 32.00, 31.70, 19.81. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O 441.2900; found 441.2901. HPLC purity: 95.9%, retention time = 3.10 min.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>E</i>)-4-(1-(4-(4-Cyclobutylpiperazin-1-yl)phenyl)-5-hydroxy-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>19</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>5a</b> (11 mg, 0.02 mmol) and 1 M LiAlH<sub>4</sub> in THF (76 μL, 0.11 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (1 mg, 12% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.16–7.07 (m, 7H), 7.02 (d, <i>J</i> = 8.8 Hz, 2H), 6.78 (m, 2H), 6.66 (m, 2H), 3.72 (m, 2H), 3.49 (m, 2H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 2.95 (m, 5H), 2.51 (m, 2H), 2.34 (m, 2H), 2.25 (m, 2H), 1.91 (m, 2H), 1.53 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 469.2850; found 469.2850. HPLC purity: 98.1%, retention time = 2.82 min.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (<i>E</i>)-4-(1-(4-(4-Cyclopentylpiperazin-1-yl)phenyl)-5-hydroxy-2-phenylpent-1-en-1-yl)phenol Hydrochloride Salt (<b>20</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>5b</b> (6 mg, 0.01 mmol) and 1 M LiAlH<sub>4</sub> in THF (20 μL, 0.02 mmol) in THF (1 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (3 mg, 53% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.17–7.07 (m, 7H), 7.03 (m, 2H), 6.77 (m, 2H), 6.66 (m, 2H), 3.72 (m, 2H), 3.63 (m, 2H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 3.16 (m, 2H), 2.95 (m, 2H), 2.50 (m, 2H), 2.21 (m, 3H), 1.86 (m, 2H), 1.74 (m, 4H), 1.55 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>39</sub>N<sub>2</sub>O<sub>2</sub> 483.3006; found 483.2998. HPLC purity: 95.8%, retention time = 2.75 min.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (<i>E</i>)-4-(1-(4-(4-Cyclohexylpiperazin-1-yl)phenyl)-5-hydroxy-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>21</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>5c</b> (4 mg, 0.01 mmol) and 1 M LiAlH<sub>4</sub> in THF (14 μL, 0.14 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (1 mg, 29% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18–7.08 (m, 7H), 7.02 (m, 2H), 6.78 (m, 2H), 6.65 (m, 2H), 3.74 (m, 2H), 3.65 (m, 2H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 3.23 (m, 2H), 3.11 (m, 2H), 2.96 (m, 2H), 2.51 (m, 2H), 2.17 (m, 2H), 1.95 (m, 2H), 1.72 (m, 2H), 1.52 (m, 3H), 1.42 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>2</sub> 497.3163; found 497.3159. HPLC purity: 96.2%, retention time = 2.93 min.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>22</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>5d</b> (42 mg, 0.07 mmol) and 1 M LiAlH<sub>4</sub> in THF (108 μL, 0.11 mmol) in THF (5 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (5 mg, 15% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.18–7.08 (m, 5H), 7.04 (d, <i>J</i> = 8.4 Hz, 2H), 6.83–6.77 (m, 4H), 6.68 (d, <i>J</i> = 8.7 Hz, 2H), 4.92–4.84 (m, 4H), 4.48–4.44 (m, 1H), 3.42 (t, <i>J</i> = 6.7 Hz, 2H), 3.33 (m, 8H), 2.53 (t, <i>J</i> = 7.9 Hz, 2H), 1.55 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>35</sub>N<sub>2</sub>O<sub>3</sub> 471.2648; found 471.2631. HPLC purity: 95.3%, retention time = 2.78 min.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl Methanesulfonate Dihydrochloride Salt (<b>23</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (10 mg, 0.02 mmol) and Hünig’s base (8 μL, 0.04 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added methanesulfonyl chloride (8 μL, 0.04 mmol) at 0 °C. The resulting reaction mixture was allowed to stir at room temperature overnight. The reaction mixture was poured into aq NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. The extract was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude compound was purified by preparative HPLC using eluent A (0.1% TFA H<sub>2</sub>O) and eluent B (0.1% TFA ACN) (A/B = 70/30). To a solution of this compound in MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1) was added a 1 M solution of hydrochloric acid (2.2 equiv) in water at 0 °C. After stirring for 10 min, the volatiles were removed in vacuum to yield the desired compound (1 mg, 9% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.32 (m, 4H), 7.19–7.10 (m, 5H), 6.81 (d, <i>J</i> = 8.7 Hz, 2H), 6.70 (d, <i>J</i> = 8.8 Hz, 2H), 3.77 (m, 2H), 3.53 (m, 3H), 3.41 (t, <i>J</i> = 6.6 Hz, 2H), 3.25 (s, 3H), 3.20 (m, 2H), 2.92 (m, 2H), 2.49 (m, 2H), 1.54 (m, 2H), 1.38 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub>S 535.2625; found 535.2624. HPLC purity: 96.1%, retention time = 2.99 min.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl Cyclopropanesulfonate Dihydrochloride Salt (<b>24</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12</b> (10 mg, 0.02 mmol), cyclopropanesulfonyl chloride (4 mg, 0.03 mmol), and pyridine (2 μL, 0.03 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) according to the synthetic procedure for <b>23</b> (5 mg, 40% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.35–7.29 (m, 4H), 7.19–7.10 (m, 5H), 6.81 (d, <i>J</i> = 8.8 Hz, 2H), 6.71 (d, <i>J</i> = 8.8 Hz, 2H), 3.77 (m, 2H), 3.54 (m, 3H), 3.41 (t, <i>J</i> = 6.6 Hz, 2H), 3.21 (m, 2H), 2.97 (m, 2H), 2.82 (m, 1H), 2.49 (m, 2H), 1.53 (m, 2H), 1.38 (d, <i>J</i> = 6.6 Hz, 6H), 1.14 (m, 4H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>4</sub>S 561.2782; found 561.2780. HPLC purity: 98.2%, retention time = 3.07 min.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl Trifluoromethanesulfonate Dihydrochloride Salt (<b>25</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>12</b> (10 mg, 0.02 mmol), trifluoromethanesulfonyl chloride (4 mg, 0.02 mmol), and Hünig’s base (8 μL, 0.04 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) according to the synthetic procedure for <b>23</b> (0.5 mg, 4% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.38 (m, 4H), 7.18–7.11 (m, 5H), 6.81 (d, <i>J</i> = 8.8 Hz, 2H), 6.70 (d, <i>J</i> = 8.8 Hz, 2H), 3.77 (m, 2H), 3.51 (m, 3H), 3.41 (t, <i>J</i> = 6.4 Hz, 2H), 3.21 (m, 2H), 2.92 (m, 2H), 2.48 (m, 2H), 1.53 (m, 2H), 1.38 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>36</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S 589.2342; found 589.2340. HPLC purity: 95.3%, retention time = 3.71 min.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (<i>Z</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)acetamide Dihydrochloride Salt (<b>26</b>)</h4><div class="NLM_p last">To a solution of <b>8a</b> (0.4 mg, 11 μmol) in MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v=1:1) was added a solution of 1 M hydrochloric acid (33 μL, 33 μmol) at 0 °C, and the mixture was stirred for 10 min. Then, the solution was concentrated to give the desired compound (0.5 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.33 (m, 4H), 7.19–7.12 (m, 5H), 6.83 (d, <i>J</i> = 8.7 Hz, 2H), 6.70 (d, <i>J</i> = 8.8 Hz, 2H), 4.11 (t, <i>J</i> = 6.0 Hz, 2H), 3.77 (m, 2H), 3.53 (m, 3H), 3.20 (m, 2H), 2.95 (m, 5H), 2.58 (m, 2H), 1.73 (m, 2H), 1.38 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>40</sub>N<sub>3</sub>O<sub>2</sub> 498.3115; found 498.3114. HPLC purity: 95.1%, retention time = 2.78 min.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>E</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)methanesulfonamide Dihydrochloride Salt (<b>27</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>9a</b> (1 mg, 1.7 μmol) and a solution of 1 M hydrochloric acid (5 μL, 5 μmol) in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) according to the synthetic procedure for <b>26</b> (1 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.26–7.08 (m, 9H), 6.75 (d, <i>J</i> = 8.5 Hz, 2H), 6.62 (d, <i>J</i> = 8.6 Hz, 2H), 3.42 (t, <i>J</i> = 6.6 Hz, 2H), 3.14–3.03 (m, 4H), 2.99 (s, 3H), 2.73–2.64 (m, 5H), 2.52 (dd, <i>J</i> = 10.4, 8.1 Hz, 2H), 1.59–1.52 (m, 2H), 1.10 (d, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 149.02, 142.54, 139.99, 139.29, 138.51, 136.69, 134.40, 131.23, 130.23, 129.41, 127.61, 125.81, 119.81, 114.69, 61.56, 54.55, 37.83, 32.02, 31.65, 17.28. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>40</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S 534.2785; found 534.2775. HPLC purity: 98.3%, retention time = 2.36 min.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>E</i>)-<i>N</i>-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)cyclopropanesulfonamide Dihydrochloride Salt (<b>28</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>9b</b> (2 mg, 2.9 μmol) and a solution of 1 M hydrochloric acid (9 μL, 9 μmol) in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) according to the synthetic procedure for <b>26</b> (2 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.27 (d, <i>J</i> = 8.5 Hz, 2H), 7.19–7.09 (m, 7H), 6.81 (d, <i>J</i> = 8.6 Hz, 2H), 6.68 (d, <i>J</i> = 8.7 Hz, 2H), 3.76 (m, 2H), 3.51 (m, 2H), 3.41 (t, <i>J</i> = 6.5 Hz, 2H), 3.21 (m, 2H), 2.92 (m, 2H), 2.57 (m, 1H), 2.50 (m, 2H), 1.52 (m, 2H), 1.39 (d, <i>J</i> = 6.6 Hz, 6H), 1.29 (s, 1H), 1.04 (m, 2H), 0.96 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>42</sub>N<sub>3</sub>O<sub>3</sub>S 560.2941; found 560.2938. HPLC purity: 95.8%, retention time = 2.86 min.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (<i>Z</i>)-1-(4-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl)guanidine Dihydrochloride Salt (<b>29</b>)</h4><div class="NLM_p last">To a solution of <b>10b</b> (0.5 mg, 1 μmol) in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) was added a 1 M solution of hydrochloric acid (3 μL, 3 μmol) at 0 °C. After stirring for 10 min, the volatiles were removed in vacuum to yield the desired compound (1 mg, quant.). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>40</sub>N<sub>5</sub>O 498.3227; found 498.3213. HPLC purity: 96.2%, retention time = 2.56 min.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (<i>E</i>)-4-(4-(5-Hydroxy-1-(4-hydroxyphenyl)-2-phenylpent-1-en-1-yl)phenyl)piperazine-1-carboximidamide Dihydrochloride Salt (<b>30</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>7a</b> (4 mg, 7 μmol) and 1 M LiAlH<sub>4</sub> in THF (20 μL, 0.02 mmol) in THF (2 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (0.7 mg, 23% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.16–7.07 (m, 5H), 7.01 (m, 2H), 6.78 (m, 2H), 6.67 (m, 2H), 6.40 (d, <i>J</i> = 8.6 Hz, 2H), 3.67 (m, 2H), 3.28 (m, 2H), 3.48 (m, 1H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 3.19 (m, 2H), 3.13 (m, 1H), 2.51 (m, 2H), 1.54 (m, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> 457.2598; found 457.2599. HPLC purity: 95.6%, retention time = 2.86 min.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (<i>E</i>)-4-(5-Hydroxy-1-(4-(4-methylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenyl Pivalate Dihydrochloride Salt (<b>31</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>11a</b> (4 mg, 7 μmol) and a solution of 1 M hydrochloric acid (14 μL, 14 μmol) in mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) according to the synthetic procedure for <b>26</b> (4 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.25 (d, <i>J</i> = 8.6 Hz, 2H), 7.15 (m, 5H), 7.05 (d, <i>J</i> = 8.5 Hz, 2H), 6.81 (d, <i>J</i> = 8.8 Hz, 2H), 6.68 (d, <i>J</i> = 8.8 Hz, 2H), 3.72 (m, 2H), 3.52 (m, 2H), 3.39 (t, <i>J</i> = 6.7 Hz, 2H), 3.18 (m, 2H), 2.92 (m, 5H), 2.51 (m, 2H), 1.54 (m, 2H), 1.36 (s, 9H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>3</sub> 513.3112; found 513.3104. HPLC purity: 98.9%, retention time = 3.07 min.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (<i>E</i>)-5-(4-Hydroxyphenyl)-5-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-yl Pivalate Dihydrochloride Salt (<b>32</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>11b</b> (0.5 mg, 0.8 μmol) and a solution of 1 M hydrochloric acid (9 μL, 9 μmol) in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v=1:1) according to the synthetic procedure for <b>26</b> (0.5 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.20–7.16 (m, 5H), 7.12 (d, <i>J</i> = 7.2 Hz, 2H), 7.04 (d, <i>J</i> = 8.7 Hz, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 2H), 6.68 (d, <i>J</i> = 8.7 Hz, 2H), 3.89 (m, 2H), 3.62 (m, 2H), 3.42 (t, <i>J</i> = 6.7 Hz, 2H), 3.28 (m, 2H), 3.07 (m, 2H), 2.98 (s, 3H), 2.54 (m, 2H), 1.56 (m, 2H), 1.28 (s, 9H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>3</sub> 513.3112; found 513.3113. HPLC purity: 95.8%, retention time = 3.19 min.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (<i>E</i>)-4-(1-(4-(4-Methylpiperazin-1-yl)phenyl)-2-phenyl-5-(pivaloyloxy)pent-1-en-1-yl)phenyl Pivalate Dihydrochloride Salt (<b>33</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>11c</b> (0.8 mg, 1.3 μmol) and a solution of 1 M hydrochloric acid (9 μL, 9 μmol) in a mixture of MeOH and CH<sub>2</sub>Cl<sub>2</sub> (2 mL, v/v = 1:1) according to the synthetic procedure for <b>26</b> (0.8 mg, quant.). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.24 (m, 2H), 7.18–7.06 (m, 7H), 6.82 (d, <i>J</i> = 6.9 Hz, 2H), 6.69 (d, <i>J</i> = 8.8 Hz, 2H), 3.93 (t, <i>J</i> = 6.1 Hz, 2H), 3.72 (m, 2H), 3.52 (m, 2H), 3.19 (m, 2H), 2.95 (m, 5H), 2.52 (m, 2H), 1.63 (m, 2H), 1.37 (s, 9H), 1.08 (s, 9H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>49</sub>N<sub>2</sub>O<sub>4</sub> 597.3687; found 597.3684. HPLC purity: 98.6%, retention time = 3.44 min.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (<i>E</i>)-2-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>34</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>13a</b> (3 mg, 5 μmol) and 1 M LiAlH<sub>4</sub> in THF (11 μL, 11 μmol) in THF (1 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (0.4 mg, 17% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.17–7.07 (m, 7H), 6.89 (d, <i>J</i> = 8.7 Hz, 2H), 6.85 (m, 2H), 6.65 (d, <i>J</i> = 8.8 Hz, 2H), 3.73 (m, 2H), 3.50 (m, 2H), 3.35 (m, 2H), 3.20 (m, 2H), 2.91 (m, 2H), 2.39 (t, <i>J</i> = 7.9 Hz, 2H), 1.57 (m, 2H), 1.38 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 457.2850; found 457.2848. HPLC purity: 97.8%, retention time = 2.37 min.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (<i>E</i>)-3-(5-Hydroxy-1-(4-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>35</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>13b</b> (65 mg, 0.11 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.34 mL, 0.34 mmol) in THF (8 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (26 mg, 50% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.20–7.09 (m, 6H), 6.83 (d, <i>J</i> = 8.6 Hz, 2H), 6.72–6.69 (m, 4H), 6.65 (m, 1H), 3.78 (m, 2H), 3.55 (m, 3H), 3.42 (t, <i>J</i> = 6.8 Hz, 2H), 3.24 (m, 2H), 2.93 (m, 2H), 2.51 (m, 2H), 1.54 (m, 2H), 1.40 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 157.02, 146.79, 144.73, 142.39, 139.51, 138.84, 136.47, 131.36, 129.42, 128.84, 127.60, 125.86, 120.33, 115.93, 115.57, 113.27, 61.61, 58.32, 46.84, 32.04, 31.57, 15.66. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 457.2850; found 457.2850. HPLC purity: 99.6%, retention time = 2.48 min.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (<i>E</i>)-5-(3-Bromophenyl)-5-(4-(4-isopropylpiperazin-1-yl)phenyl)-4-phenylpent-4-en-1-ol Dihydrochloride Salt (<b>36</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>13c</b> (74 mg, 0.14 mmol) and 1 M DIBAL-H in THF (1.35 mL, 1.35 mmol) in THF (10 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (22 mg, 37% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.32 (d, <i>J</i> = 7.8 Hz, 1H), 7.24 (s, 1H), 7.18 (dd, <i>J</i> = 7.8, 7.7 Hz, 1H), 7.12 (d, <i>J</i> = 7.6 Hz, 1H), 7.13–7.00 (m, 5H), 6.63 (d, <i>J</i> = 8.6 Hz, 2H), 6.53 (d, <i>J</i> = 8.6 Hz, 2H), 3.30 (t, <i>J</i> = 6.7 Hz, 2H), 3.06–2.93 (m, 4H), 2.67–2.57 (m, 5H), 2.37 (dd, <i>J</i> = 8.1, 7.8 Hz, 2H), 1.46–1.39 (m, 2H), 1.00 (d, <i>J</i> = 6.5 Hz, 6H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 149.12, 145.96, 142.09, 140.08, 137.83, 133.75, 132.01, 131.14, 129.63, 129.35, 129.30, 128.00, 127.64, 126.01, 121.76, 114.76, 61.44, 54.69, 48.40, 31.94, 31.50, 17.20. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>36</sub>BrN<sub>2</sub>O 521.1991; found 521.1972. HPLC purity: 95.9%, retention time = 3.16 min.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (<i>Z</i>)-4-(5-Hydroxy-1-(3-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>37</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>17a</b> (50 mg, 0.09 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.27 mL, 0.27 mmol) in THF (3 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (17 mg, 36% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.20–7.11 (m, 5H), 7.06 (m, 2H), 7.00 (m, 1H), 6.79 (m, 2H), 6.74–6.68 (m, 1H), 6.62–6.53 (m, 2H), 3.54–3.42 (m, 7H), 3.19 (m, 2H), 2.93 (m, 2H), 2.56 (m, 2H), 1.58 (m, 2H), 1.40 (d, <i>J</i> = 6.3 Hz, 6H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 457.2855; found 457.2849. HPLC purity: 96.5%, retention time = 2.87 min.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (<i>E</i>)-3-(5-Hydroxy-1-(3-(4-isopropylpiperazin-1-yl)phenyl)-2-phenylpent-1-en-1-yl)phenol Dihydrochloride Salt (<b>38</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>17b</b> (50 mg, 0.09 mmol) and 1 M LiAlH<sub>4</sub> in THF (0.27 mL, 0.27 mmol) in THF (3 mL) according to the synthetic procedure for <b>7</b>–<b>18</b> (16 mg, 35% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.22–7.11 (m, 6H), 7.02 (t, <i>J</i> = 8.0 Hz, 1H), 6.75–6.72 (m 3H), 6.69 (m, 1H), 6.57 (m, 2H), 3.58–3.42 (m, 7H), 3.18 (m, 2H), 2.94 (m, 2H), 2.54 (m, 2H), 1.57 (m, 2H), 1.40 (d, <i>J</i> = 6.6 Hz, 2H). HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub> 457.2855; found 457.2850. HPLC purity: 98.8%, retention time = 2.90 min.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> ERRγ Binding Assay</h3><div class="NLM_p last">The ERRγ binding assay was conducted with a LanthaScreen assay system (Life Technologies, Grand Island, NY), which was based on TR-FRET, following manufacturer’s instruction. Briefly, compounds were serially diluted 2-fold starting from 10 μM and 10 μL of each diluent was added in 384-well plates. Then, glutathione S-transferase (GST)-conjugated ERRγ ligand-binding domain (LBD) was added to be 5 nM. Next, the mixture of fluorescein-conjugated coactivator PGC-1α (final concentration to be 500 nM) and Tb-a-GST antibody (final concentration to be 5 nM) was added. The reaction mixture was incubated at rt in a dark state for 1 h. TR-FRET activity was measured at 340 nm excitation and 495/520 nm dual emission using a microplate reader (Biotek, SynergyNeo, Winooski, VT), and IC<sub>50</sub> value was calculated with Prism 6 software.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> ERRα and ERRβ and ERα Binding Assay</h3><div class="NLM_p last">ERRs and ERα binding assay used the same assay system as that used by ERRγ’s, LanthaScreen assay system. Therefore, the procedure was the same as that for the ERRγ binding assay except tested enzymes (ERRα, ERRβ, ERα). Used reference compounds were 4-OHT (<b>2</b>) for ERα and the ERRβ binding assay and XCT790 for the ERRα binding assay.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> ERRγ Functional Assay</h3><div class="NLM_p last">AD293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM), high glucose, supplemented with 0.5% fetal bovine serum (FBS) (Hyclone, Logan, UT). After 24 h, culture media were replaced with DMEM, high glucose, containing 10% FBS. DNA constructs, which include pCMX-Gal4-ERRγ, pFR-luciferase reporter plasmid, and pCMV-β-gal, were transiently transfected into AD293 cells using the TransIT-LT1 transfection reagent (Mirus, Madison, WI) for 24 h. Then, transfected cells were treated with compounds for 24 h and harvested for detection of luciferase activity and β-gal activity. All cells were incubated at 37 °C under 5% CO<sub>2</sub> in a humidified incubator.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> <sup>125</sup>I Uptake Assay</h3><div class="NLM_p last">Cells were plated in 24-well plates for 24 h and then treated with compound <b>35</b>. After aspirating drug-containing medium, the cells were washed with 1 mL of Hank’s balanced salt solution (HBSS) and incubated with 500 μL of HBSS containing 0.5% bovine serum albumin (bHBSS), 3.7 kBq carrier-free <sup>125</sup>I (PerkinElmer Life and Analytical Sciences), and 10 μmol/L solution of sodium iodide (specific activity of 740 MBq/mmol) at 37 °C for 30 min. The cells were then washed twice with ice-cold bHBSS and lysed with 500 μL of 2% sodium dodecyl sulfate. The radioactivity was measured using a γ counter (Cobra II; Canberra Packard, Packard Bioscience). The radioactivity of the cells was normalized using total protein concentrations determined by a bicinchoninic acid kit (Pierce Protein Biology, CA). To inhibit the iodide uptake, cells were pre-incubated with 300 μM KClO<sub>4</sub> (as a specific inhibitor for NIS) for 30 min and then treated with <sup>125</sup>I as described above.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Clonogenic Assay with <sup>131</sup>I</h3><div class="NLM_p last">The cells were seeded into six-well plates and left for 24 h to attach. At 24 h after treatment with 6 μM compound <b>35</b>, the drug-containing medium was discarded and cells were washed twice in phosphate-buffered saline (PBS). The medium was then replaced with DMEM in the presence or absence of 50 μCi <sup>131</sup>I (KIRAMS, Korea) for 6 h. Cells were washed and left in regular culture medium for the time corresponding to six doublings. Finally, cells were fixed in 4% paraformaldehyde solution and stained with 0.05% crystal violet. Control and <sup>131</sup>I-treated colonies with more than 50 cells were counted.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Analysis of mRNA Expression</h3><div class="NLM_p">The cells were seeded in 100 π dishes for 24 h. Cells were then treated with various concentrations of compound <b>35</b>. Total RNA was isolated using the TRIzol reagent (Invitrogen Co.) according to the manufacture’s protocol. Real-time quantitative PCR (Q-PCR) was performed with cDNA template (2 μL) and 2× Power SYBR Green (6 μL; Toyobo Co.) containing specific primers. Primer sequences for 36B4 (control gene), NIS, TSHR, TG, TPO, PAX-8, and TTF-1 are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Q-PCR was carried out for 40 cycles using the following parameters: denaturation (95 °C for 15 s), annealing (60 °C for 1 min), and extension (60 °C for 1 min). Fluorescence intensity was measured at the end of the extension phase of each cycle. The threshold value for the fluorescence intensity of all samples was set manually. The reaction cycle at which PCR products exceeded this fluorescence intensity threshold during the exponential phase of PCR amplification was considered to be the threshold cycle (CT). Real-time PCR system instrument (Applied Biosystems) was used with the following primer sets:</div><div class="NLM_p last">ERRγ (forward, 5′-AGGACAATTCAAGGCAATATAGA-3′; reverse, 5′-TCAAGACGCACCCCTTCTTT-3′), NIS (forward, 5′-CTG CCC CAG ACC AGT ACA TGC C-3′; reverse, 5′-TGA CGG TGA AGG AGC CCT GAA G-3′), TSHR (forward, 5′-ACC CTG ATG CCC TCA AAG AGC′; reverse, 5′-GCT TCA GTG TCA AGG TTT CAT TGC′), TPO (forward, 5′-CCT CTG CAA AGA TGT GAA CGA′; reverse, 5′-TCC CGG AGT CTA CGC AGG TT′), TG (forward, 5′-TCT AAC CGA TGC TCA CCT CTT CTG′; reverse, 5′-AGA TGA TGG CAC CTC CTT GAA CC′), and acidic ribosomal protein 36B4 (forward, 5′-CCA CGC TGC TGA ACA TGC T-3′; reverse, 5′-TCG AAC ACC TGC TGG ATG AC-3′). The target genes were normalized to the endogenous reference gene 36B4, and relative mRNA expression levels were calculated in the test and control samples.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Western Blot</h3><div class="NLM_p last">The cells were treated with either vehicle or compound <b>35</b> for 24 h, and protein samples were prepared with radioimmunoprecipitation assay buffer containing complete protease inhibitor cocktail (Roche). Western blotting analysis was accomplished according to the same methods as those used in our previous work.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> PET/CT Imaging with Radioactive <sup>124</sup>I</h3><div class="NLM_p">Mice were challenged with CAL62 cells (5 × 10<sup>6</sup> cells per mouse) subcutaneously. When tumor formation was detected with inspection and palpation, tumor-bearing mice were orally given either vehicle (poly(ethylene glycol)) or compound <b>35</b> (200 mg/kg) dissolved in solution (10% ethanol, 10% Cremphol, 80% PEG) once a day for 6 days. CAL62-tumor-bearing mice received radioactive <sup>124</sup>I (50 μCi per mouse for PET imaging) via tail vein. After 2 h of circulation time, PET/CT imaging was performed.</div><div class="NLM_p last">For PET/CT study, 20 min scan was performed with the Triumph II PET-CT system (LabPET8, γ Medica-Ideas, Waukesha, WI). CT scans were performed with an X-ray detector immediately following the acquisition of PET images. PET images were reconstructed by 3D-OSEM iterative image reconstruction, and the CT images were reconstructed using filtered back-projections. All mice were anesthetized using 1–2% isoflurane gas during imaging. PET images were coregistered with anatomical CT images using 3D image visualization and analysis software VIVID (γ Medica-Ideas, Northridge, CA). To measure the uptake for the volumes of interest (VOIs), the VOIs from each image were manually segmented from coregistered CT images by the use of VIVID.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Statistical Analysis</h3><div class="NLM_p last">All data are expressed as the means ± SD, and statistical significance was determined using an unpaired Student’s <i>t</i>-test using GraphPad Prism 5 (La Jolla, CA). <i>P</i> values less than 0.05 were considered statistically significant.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Protein Expression and Purification</h3><div class="NLM_p last">Human recombinant ERRγ-LBD (residues 222–458) was cloned in pGEX-6P1 vector plasmids and overexpressed in <i>Escherichia coli</i> BL21 DE3 cells. Single colonies of transformants were inoculated into Luria–Bertani medium at 37 °C. Once the OD<sub>600</sub> reached 0.4–0.6, 1 mM isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranosid was added to the culture, and the culture was incubated at 18 °C for 16 h. The harvested cells were resuspended with PBS containing 1 mM phenylmethanesulfonyl fluoride, 10 μg/mL DNase I, and a protease inhibitor cocktail (Roche). The cells were sonicated and centrifuged at 20 000<i>g</i> for 20 min at 4 °C, and the supernatant was filtered with 0.20 μm syringe filters. The lysates were purified via a glutathione sepharose 4B column (GE Healthcare), followed by tag-cleavage with PreScission protease. The tag-free proteins were applied to the Hitrap Q HP column and the Superdex 75 column to increase the homogeneity. The purified proteins were concentrated to 5.2 mg/mL in 20 mM sodium acetate (pH 4.5) and 100 mM sodium chloride for crystallization.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Protein Crystallization</h3><div class="NLM_p last">The purified ERRγ-LBD recombinant proteins were mixed with 3-fold molar excess of compound <b>35</b> and incubated for 1 h on ice, followed by rt incubation for 30 min. The precipitates were removed by centrifugation. The mosquito liquid handler was used for the initial screening of crystallization, and the crystal screening plates were maintained on the Rock Maker at 18 °C until crystals appeared. The cocrystals of proteins in complex with compound <b>35</b> appeared within 5 days under the condition of 0.1 M bis-Tris (pH 6.5), 16% PEG, 10 K, and 3% methanol.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Data Collection, Structure Determination, and Refinement</h3><div class="NLM_p last">Diffraction data were collected at 2.90 Å resolution of beamline BL-5C in the Pohang Accelerator Laboratory, South Korea. HKL2000 (HKL Research, Inc., Charlottesville, VA) was used for integration and scaling. Molecular replacement was used to determine the structure of human ERRγ-LBD in complex with compound <b>35</b> using a previously solved human ERRγ-LBD structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YSO">5YSO</a>) as a search model without water and ligand. Rigid body refinement, followed by simulated annealing at 5000 K, was conducted using Python-based hierarchical environment for integrated xtallography (PHENIX). Subsequently, refinement was conducted in alternating cycles for manual model building in (COOT), followed by refinement in PHENIX until the <i>R</i> factors converged. Data collection and refinement statistics are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">Table S1</a>. The coordinate and structural factors of the complex structure have been deposited in the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>). The complex structure figures were generated using Chimera.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01296" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01296" class="ext-link">10.1021/acs.jmedchem.8b01296</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Animals and cells for ATC experiments; ADMET assay methods including metabolic stability assay, CYP inhibition assay, PAMPA, hERG assay, and PK study; data collection and refinement statistics of X-ray crystallography; NMR spectra, HPLC chromatograms, and HRMS spectra of the title compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv">jm8b01296_si_001.csv (5.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_002.pdf">jm8b01296_si_002.pdf (2.7 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for compound <b>35</b> bound to ERRγ is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01296" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hayoung Hwang</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d352a3c333a35241d393a30343b732f3873362f"><span class="__cf_email__" data-cfemail="5c342b3d323b34251c383b31353a722e3972372e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Hyun Jeon</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine,
School of Medicine, 
     and , Kyungpook National University Hospital, Daegu 41404, South Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
Animal Center, Daegu-Gyeongbuk Medical Innovation
Foundation, Daegu 41061, South Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3161-7698" title="Orcid link">http://orcid.org/0000-0003-3161-7698</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4cec1cbca9d949590e4c3c9c5cdc88ac7cbc9"><span class="__cf_email__" data-cfemail="78121d17164148494c381f15191114561b1715">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jungwook Chin</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6060-0508" title="Orcid link">http://orcid.org/0000-0001-6060-0508</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#157f62767d7c7b557172787c733b67703b7e67"><span class="__cf_email__" data-cfemail="d8b2afbbb0b1b698bcbfb5b1bef6aabdf6b3aa">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sung Jin Cho</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge Research Center for
Drug Discovery and Development for Diabetes and Metabolic Disease, 
     and , Kyungpook National University Hospital, Daegu 41404, South Korea</span>; 
    <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4786-8830" title="Orcid link">http://orcid.org/0000-0002-4786-8830</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#235049404b4c6347444e4a450d51460d4851"><span class="__cf_email__" data-cfemail="f28198919a9db296959f9b94dc8097dc9980">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jina Kim</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaeyoung Song</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun Dong Ji</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine,
School of Medicine and , Kyungpook National University Hospital, Daegu 41404, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun Kyung Yoo</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge Research Center for
Drug Discovery and Development for Diabetes and Metabolic Disease and , Kyungpook National University Hospital, Daegu 41404, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae-Eon Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomaterials Science, College of Natural Resources and Life Science/Life
and Industry Convergence Research Institute, Pusan National University, Pusan 50463, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang Bong Lee</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji Min Oh</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine,
School of Medicine and , Kyungpook National University Hospital, Daegu 41404, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seungmi Lee</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge Research Center for
Drug Discovery and Development for Diabetes and Metabolic Disease and , Kyungpook National University Hospital, Daegu 41404, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji Sun Hwang</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heeseok Yoon</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Su Kim</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0388-4633" title="Orcid link">http://orcid.org/0000-0003-0388-4633</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Su-Jeong Lee</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minseon Jeong</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sungwoo Lee</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyung-Hee Kim</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hueng-Sik Choi</span> - <span class="hlFld-Affiliation affiliation">National
Creative Research Initiatives Center for Nuclear Receptor Signals
and Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 61186, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang Woo Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine,
School of Medicine and , Kyungpook National University Hospital, Daegu 41404, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keun-Gyu Park</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">In-Kyu Lee</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge Research Center for
Drug Discovery and Development for Diabetes and Metabolic Disease, 
     and , Kyungpook National University Hospital, Daegu 41404, South Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, South
Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seong Heon Kim</span> - <span class="hlFld-Affiliation affiliation">New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, South
Korea</span>; 
    <span>Present Address:
                        Boryung R&D Center, Chemistry Research Unit, Gyeonggi-do 15425, South Korea (S.H.K.)</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.K., J.S., and H.D.J.. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e8476-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HT16C0002 and HI16C1501) and was supported by National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science & ICT) (Grant Number: NRF-2017R1D1A1B03030196, NRF-2017R1D1A1B03028340, NRF-2017R1C1B1005599, and NRF-2017M3A9G7073088). This research was supported by Korea Drug Development Fund funded by the Ministry of Science, Information and Communication Technology and Future Planning; Ministry of Trade, Industry, and Energy; and Ministry of Health and Welfare (KDDF-201612-16, Republic of Korea).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ERR</td><td class="NLM_def"><p class="first last">estrogen-related receptor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last">sodium iodide symporter</p></td></tr><tr><td class="NLM_term">ATC</td><td class="NLM_def"><p class="first last">anaplastic thyroid cancer</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nuclear receptor</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">PGC-1α</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor-γ coactivator 1α</p></td></tr><tr><td class="NLM_term">TSH</td><td class="NLM_def"><p class="first last">thyroid stimulating hormone</p></td></tr><tr><td class="NLM_term">TSHR</td><td class="NLM_def"><p class="first last">thyroid stimulating hormone receptor</p></td></tr><tr><td class="NLM_term">TPO</td><td class="NLM_def"><p class="first last">thyroperoxidase</p></td></tr><tr><td class="NLM_term">TG</td><td class="NLM_def"><p class="first last">thyroglobulin</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">microsomal stability</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">4-OHT</td><td class="NLM_def"><p class="first last">4-hydroxytamoxifen</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors, RXR, and the big bang</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.cell.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=24679540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVCqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=255-266&author=R.+M.+Evansauthor=D.+J.+Mangelsdorf&title=Nuclear+receptors%2C+RXR%2C+and+the+big+bang&doi=10.1016%2Fj.cell.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Receptors, RXR, and the Big Bang</span></div><div class="casAuthors">Evans, Ronald M.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Isolation of genes encoding the receptors for steroids, retinoids, vitamin D, and thyroid hormone and their structural and functional anal. revealed an evolutionarily conserved template for nuclear hormone receptors.  This discovery sparked identification of numerous genes encoding related proteins, termed orphan receptors.  Characterization of these orphan receptors and, in particular, of the retinoid X receptor (RXR) positioned nuclear receptors at the epicenter of the "Big Bang" of mol. endocrinol.  This Review provides a personal perspective on nuclear receptors and explores their integrated and coordinated signaling networks that are essential for multicellular life, highlighting the RXR heterodimer and its assocd. ligands and transcriptional mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKjt1n6i7YYbVg90H21EOLACvtfcHk0li5Bv_PwCN5og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVCqsLw%253D&md5=875fafc223c6585cf3494d3559357a4f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%252C%2520RXR%252C%2520and%2520the%2520big%2520bang%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D255%26epage%3D266%26doi%3D10.1016%2Fj.cell.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear hormone receptors and gene expression</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1152/physrev.2001.81.3.1269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1152%2Fphysrev.2001.81.3.1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=11427696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Ohsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=1269-1304&author=A.+Arandaauthor=A.+Pascual&title=Nuclear+hormone+receptors+and+gene+expression&doi=10.1152%2Fphysrev.2001.81.3.1269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear hormone receptors and gene expression</span></div><div class="casAuthors">Aranda, Ana; Pascual, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1269-1304</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 324 refs.  The nuclear hormone receptor superfamily includes receptors for thyroid and steroid hormones, retinoids and vitamin D, as well as different orphan receptors of unknown ligand.  Ligands for some of these receptors have been recently identified, showing that products of lipid metab. such as fatty acids, prostaglandins, or cholesterol derivs. can regulate gene expression by binding to nuclear receptors.  Nuclear receptors act as ligand-inducible transcription factors by directly interacting as monomers, homodimers, or heterodimers with the retinoid X receptor with DNA response elements of target genes, as well as by cross-talking to other signaling pathways.  The effects of nuclear receptors on transcription are mediated through recruitment of coregulators.  A subset of receptors binds corepressor factors and actively represses target gene expression in the absence of ligand.  Corepressors are found within multicomponent complexes that contain histone deacetylase activity.  Deacetylation leads to chromatin compaction and transcriptional repression.  Upon ligand binding the receptors undergo a conformational change that allows the recruitment of multiple coactivator complexes.  Some of these proteins are chromatin remodeling factors or possess histone acetylase activity whereas others may interact directly with the basic transcriptional machinery.  Recruitment of coactivator complexes to the target promoter causes chromatin decompaction and transcriptional activation.  The characterization of corepressor and coactivator complexes, in concert with the identification of the.  Specific interaction motifs in the receptors, has demonstrated the existence of a general mol. mechanism by which different receptors elicit their transcriptional responses in target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXwaaEFtzqhLVg90H21EOLACvtfcHk0li5Bv_PwCN5og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Ohsrs%253D&md5=67ea9f6274b2a19bce09dd1c83a5f839</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.3.1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.3.1269%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DA.%26atitle%3DNuclear%2520hormone%2520receptors%2520and%2520gene%2520expression%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D1269%26epage%3D1304%26doi%3D10.1152%2Fphysrev.2001.81.3.1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0li3Rz92hjcx8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid-related orphan receptor RORbeta, circadian rhythm abnormalities and tumorigenesis (Review)</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2015.2155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3892%2Fijmm.2015.2155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=25816151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eitLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1493-1500&author=S.+Fengauthor=S.+Xuauthor=Z.+Wenauthor=Y.+Zhu&title=Retinoic+acid-related+orphan+receptor+RORbeta%2C+circadian+rhythm+abnormalities+and+tumorigenesis+%28Review%29&doi=10.3892%2Fijmm.2015.2155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review)</span></div><div class="casAuthors">Feng, Shujiong; Xu, Song; Wen, Zhenzhen; Zhu, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Nuclear receptors are a superfamily of transcription factors including the steroid hormone receptors, non-steroid hormone receptors and the orphan nuclear receptor family.  Retinoic acid-related orphan receptor (ROR)β, as a member of the orphan nuclear receptor family, plays an important regula-tory role in the maintenance of a variety of physiol. and pathol. processes.  RORI3 has been detd. to act as an osteogenic repressor in regulating bone formation, and is involved in regulating circadian rhythm.  The findings of recent studies concerning the assocn. between tumorigenesis and circadian rhythm have shown that an aberrant circadian rhythm may promote tumorigenesis and tumor progression.  The mechanisms discussed in this review demonstrate how aberrant RORβ-induced circadian rhythm may become a new direction for future studies on tumorigenesis and strategy design for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzI3oYhyHld7Vg90H21EOLACvtfcHk0li3Rz92hjcx8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eitLvL&md5=ee44b76aa3fcea0343764f6d46b03836</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2015.2155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2015.2155%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DRetinoic%2520acid-related%2520orphan%2520receptor%2520RORbeta%252C%2520circadian%2520rhythm%2520abnormalities%2520and%2520tumorigenesis%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2015%26volume%3D35%26spage%3D1493%26epage%3D1500%26doi%3D10.3892%2Fijmm.2015.2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranhotra, H. S.</span></span> <span> </span><span class="NLM_article-title">The orphan estrogen-related receptor alpha and metabolic regulation: new frontiers</span>. <i>J. Recept. Signal Transduction</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1024853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3109%2F10799893.2015.1024853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26037200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=565-568&author=H.+S.+Ranhotra&title=The+orphan+estrogen-related+receptor+alpha+and+metabolic+regulation%3A+new+frontiers&doi=10.3109%2F10799893.2015.1024853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan estrogen-related receptor alpha and metabolic regulation: new frontiers</span></div><div class="casAuthors">Ranhotra, Harmit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-568</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabolic homeostasis during long-term adaptation in animals is primarily achieved by controlling the expression of metabolic genes by a plethora of cellular transcription factors.  The nuclear receptor (NR) superfamily in eukaryotes is an assembly of diverse receptors working as transcriptional regulators of multiple genes.  The orphan estrogen-related receptor alpha (ERRα) is one such receptor of the NR superfamily with significant influence on numerous metabolic and other genes.  Although it is presently unknown as to which endogenous hormones or ligands activate ERRα, nevertheless it regulates a host of genes whose products participate in various metabolic pathways.  Studies over the years show new and interesting data that add to the growing knowledge on ERRα and metabolic regulation.  For instance, novel findings indicate existence of mTOR/ERRα regulatory axis and also that ERRα control PGC-1α expression which potentially have significant impact on cellular metab.  Data show that ERRα exerts its metabolic control by regulating the expression of SIRT5 that influences oxygen consumption and ATP generation.  Moreover, ERRα has a role in creatine and lactate uptake in skeletal muscle which is important towards energy generation and contraction.  This review is focused on the new insights gained into ERRα regulation of metab., networks and pathways that have important consequences in maintaining metabolic homeostasis including development of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE9kEODsXHf7Vg90H21EOLACvtfcHk0li3Rz92hjcx8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbfO&md5=77824a440093411cc336cdef753e923e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1024853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1024853%26sid%3Dliteratum%253Aachs%26aulast%3DRanhotra%26aufirst%3DH.%2BS.%26atitle%3DThe%2520orphan%2520estrogen-related%2520receptor%2520alpha%2520and%2520metabolic%2520regulation%253A%2520new%2520frontiers%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%26date%3D2015%26volume%3D35%26spage%3D565%26epage%3D568%26doi%3D10.3109%2F10799893.2015.1024853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. G.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3789</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2329-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1007%2Fs00018-016-2329-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=27544210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyksr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=3789-3800&author=K.+Yinauthor=A.+G.+Smith&title=Nuclear+receptor+function+in+skin+health+and+disease%3A+therapeutic+opportunities+in+the+orphan+and+adopted+receptor+classes&doi=10.1007%2Fs00018-016-2329-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes</span></div><div class="casAuthors">Yin, Kelvin; Smith, Aaron G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3789-3800</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The skin forms a vital barrier between an organism's external environment, providing protection from pathogens and numerous phys. and chem. threats.  Moreover, the intact barrier is essential to prevent water and electrolyte loss without which terrestrial life could not be maintained.  Accordingly, acute disruption of the skin through phys. or chem. trauma needs to be repaired timely and efficiently as sustained skin pathologies ranging from mild irritations and inflammation through to malignancy impact considerably on morbidity and mortality.  The Nuclear Hormone Receptor Family of transcriptional regulators has proven to be highly valuable targets for addressing a range of pathologies, including metabolic syndrome and cancer.  Indeed members of the classic endocrine sub-group, such as the glucocorticoid, retinoid, and Vitamin D receptors, represent mainstay treatment strategies for numerous inflammatory skin disorders, though side effects from prolonged use are common.  Emerging evidence has now highlighted important functional roles for nuclear receptors belonging to the adopted and orphan subgroups in skin physiol. and patho-physiol.  This review will focus on these subgroups and explore the current evidence that suggests these nuclear receptor hold great promise as future stand-alone or complementary drug targets in treating common skin diseases and maintaining skin homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprK9n3-jdJ9bVg90H21EOLACvtfcHk0li3Rz92hjcx8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyksr%252FN&md5=75dd7e6c4466bdd61d64702dd8a6ce22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2329-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2329-4%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DA.%2BG.%26atitle%3DNuclear%2520receptor%2520function%2520in%2520skin%2520health%2520and%2520disease%253A%2520therapeutic%2520opportunities%2520in%2520the%2520orphan%2520and%2520adopted%2520receptor%2520classes%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D3789%26epage%3D3800%26doi%3D10.1007%2Fs00018-016-2329-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.</span>; <span class="NLM_string-name">Ye, X.</span>; <span class="NLM_string-name">Liao, D.</span>; <span class="NLM_string-name">Huang, S.</span>; <span class="NLM_string-name">Mao, H.</span>; <span class="NLM_string-name">Zhao, D.</span>; <span class="NLM_string-name">Zeng, H.</span></span>, <span> </span><span class="NLM_article-title">Orphan nuclear receptor TR3/Nur77 is a specific therapeutic target for hepatic cancers</span>.  <i>J. Clin. Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume">06</span> ().<span class="refDoi"> DOI: 10.4172/2324-9110.1000184</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.4172%2F2324-9110.1000184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=06&publication_year=2017&author=Y.+Zeng&author=X.+Ye&author=D.+Liao&author=S.+Huang&author=H.+Mao&author=D.+Zhao&author=H.+Zeng&title=Orphan+nuclear+receptor+TR3%2FNur77+is+a+specific+therapeutic+target+for+hepatic+cancers&doi=10.4172%2F2324-9110.1000184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4172%2F2324-9110.1000184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2324-9110.1000184%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DY.%26atitle%3DOrphan%2520nuclear%2520receptor%2520TR3%252FNur77%2520is%2520a%2520specific%2520therapeutic%2520target%2520for%2520hepatic%2520cancers%26jtitle%3DJ.%2520Clin.%2520Exp.%2520Oncol.%26date%3D2017%26volume%3D06%26doi%3D10.4172%2F2324-9110.1000184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor γt (RORγt) agonists as potential small molecule therapeutics for cancer immunotherapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Wnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5794-5804&author=R.+Qiuauthor=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+%28ROR%CE%B3t%29+agonists+as+potential+small+molecule+therapeutics+for+cancer+immunotherapy&doi=10.1021%2Facs.jmedchem.7b01314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy</span></div><div class="casAuthors">Qiu, Ruomeng; Wang, Yonghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5794-5804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer.  These results also encourage the development of small mol. immunomodulators for cancer immunotherapy.  RORγt is a key transcription factor mediating Th17 cell differentiation and IL-17 prodn., which is able to activate CD8+ T cells and elicit antitumor efficacy.  Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy.  In this review, we summarize RORγt sterol and synthetic agonists, analyze the common ground of their mode of actions, and discuss the potential role of RORγt agonists as small mol. therapeutics for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoubiR1DDmchLVg90H21EOLACvtfcHk0lgjQ-D9XuI6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Wnsb8%253D&md5=dff04c62af5effc6d400f8a57d20136b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01314%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520agonists%2520as%2520potential%2520small%2520molecule%2520therapeutics%2520for%2520cancer%2520immunotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5794%26epage%3D5804%26doi%3D10.1021%2Facs.jmedchem.7b01314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges for fatty acid mimetics in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5235</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1elsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5235-5266&author=E.+Proschakauthor=P.+Heitelauthor=L.+Kalinowskyauthor=D.+Merk&title=Opportunities+and+challenges+for+fatty+acid+mimetics+in+drug+discovery&doi=10.1021%2Facs.jmedchem.6b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery</span></div><div class="casAuthors">Proschak, Ewgenij; Heitel, Pascal; Kalinowsky, Lena; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5235-5266</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acids beyond their role as an endogenous energy source and storage are increasingly considered as signaling mols. regulating various physiol. effects in metab. and inflammation.  Accordingly, the mol. targets involved in formation and physiol. activities of fatty acids hold significant therapeutic potential.  A no. of these fatty acid targets are addressed by some of the oldest and most widely used drugs such as cyclooxygenase inhibiting NSAIDs, whereas others remain unexploited.  Compds. orthosterically binding to proteins that endogenously bind fatty acids are considered as fatty acid mimetics.  On the basis of their structural resemblance, fatty acid mimetics constitute a family of bioactive compds. showing specific binding thermodn. and following similar pharmacokinetic mechanisms.  This perspective systematically evaluates targets for fatty acid mimetics, investigates their common structural characteristics, and highlights demands in their discovery and design.  In summary, fatty acid mimetics share particularly favorable characteristics justifying the conclusion that their therapeutic potential vastly outweighs the challenges in their design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjMjaOmukt7bVg90H21EOLACvtfcHk0lgjQ-D9XuI6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1elsrw%253D&md5=78a3a6be0a9d9bfd672c5e851abffc3e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01287%26sid%3Dliteratum%253Aachs%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DOpportunities%2520and%2520challenges%2520for%2520fatty%2520acid%2520mimetics%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5235%26epage%3D5266%26doi%3D10.1021%2Facs.jmedchem.6b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razzaque, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osumi, T.</span></span> <span> </span><span class="NLM_article-title">Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2004.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.gene.2004.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=15475169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1yjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2004&pages=275-282&author=M.+A.+Razzaqueauthor=N.+Masudaauthor=Y.+Maedaauthor=Y.+Endoauthor=T.+Tsukamotoauthor=T.+Osumi&title=Estrogen+receptor-related+receptor+gamma+has+an+exceptionally+broad+specificity+of+DNA+sequence+recognition&doi=10.1016%2Fj.gene.2004.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor-related receptor γ has an exceptionally broad specificity of DNA sequence recognition</span></div><div class="casAuthors">Razzaque, Md. Abdur; Masuda, Nobuyuki; Maeda, Yusaku; Endo, Yaeta; Tsukamoto, Toshiro; Osumi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Estrogen receptor-related receptors (ERRs) constitute a subfamily of the nuclear hormone receptor superfamily.  ERRs are closely related to estrogen receptors (ERs), but apparently lack ligand dependence.  In this study, we cloned rat ERRγ as an interacting partner of an orphan nuclear receptor, small heterodimer partner (SHP).  ERRγ exhibited significant binding affinities with a wide spectrum of sequences: inverted and direct repeat motifs composed of AGGTCA half-sites with various spacings, as well as a monovalent motif of the same sequence carrying extra T(C/G)A trinucleotides on the 5' side.  On the other hand, inverted repeat spaced by three nucleotides was dominantly efficient for the binding of ERα.  These results were mostly consistent with those of gene reporter assays.  ERRγ bound as a homodimer to all binding sequences tested, including a monovalent binding site, and ERRγ did not heterodimerize with ERα.  Taken together, ERRγ recognizes a tremendously broad range of sequences as a homodimer.  Finally, we found that SHP efficiently represses the transcriptional activity of ERRγ, even at a far lower concn. than that of ERRγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgCZnXWOm_3bVg90H21EOLACvtfcHk0lgjQ-D9XuI6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1yjs7Y%253D&md5=6b058035e446c242e907799d908d69f7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2004.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2004.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaque%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DOsumi%26aufirst%3DT.%26atitle%3DEstrogen%2520receptor-related%2520receptor%2520gamma%2520has%2520an%2520exceptionally%2520broad%2520specificity%2520of%2520DNA%2520sequence%2520recognition%26jtitle%3DGene%26date%3D2004%26volume%3D340%26spage%3D275%26epage%3D282%26doi%3D10.1016%2Fj.gene.2004.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giguére, V.</span></span> <span> </span><span class="NLM_article-title">To ERR in the estrogen pathway</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/S1043-2760(02)00592-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS1043-2760%2802%2900592-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=12185669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=220-225&author=V.+Gigu%C3%A9re&title=To+ERR+in+the+estrogen+pathway&doi=10.1016%2FS1043-2760%2802%2900592-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">To ERR in the estrogen pathway</span></div><div class="casAuthors">Giguere, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">220-225</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Estrogens control a variety of physiol. and disease-linked processes, most notably reprodn., bone remodeling and breast cancer, and their effects are transduced through classic nuclear receptors referred to as estrogen receptor-α (ERα) and ERβ.  Recent results obtained using the estrogen-related receptors (ERRα, -β and -γ), a subfamily of orphan nuclear receptors closely related to the ERs, have shown that the ERRs share target genes, coregulatory proteins, ligands and sites of action with the ERs.  In addn., the ERRs can actively influence the estrogenic response, suggesting that pharmacol. modulation of ERR activity will be clin. useful to prevent and/or treat a variety of conditions related to women's health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGDkNFF4-jLVg90H21EOLACvtfcHk0lgZz6o_iaOvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVSmtbc%253D&md5=a38e3af2125515114e7536dd10047c9d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2802%2900592-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252802%252900592-1%26sid%3Dliteratum%253Aachs%26aulast%3DGigu%25C3%25A9re%26aufirst%3DV.%26atitle%3DTo%2520ERR%2520in%2520the%2520estrogen%2520pathway%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2002%26volume%3D13%26spage%3D220%26epage%3D225%26doi%3D10.1016%2FS1043-2760%2802%2900592-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, V.</span></span> <span> </span><span class="NLM_article-title">The NR3B subgroup: an overrview</span>. <i>Nucl. Recept. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e009</span> <span class="refDoi"> DOI: 10.1621/nrs.05009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1621%2Fnrs.05009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=18174917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&author=A.+M.+Tremblayauthor=V.+Giguere&title=The+NR3B+subgroup%3A+an+overrview&doi=10.1621%2Fnrs.05009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1621%2Fnrs.05009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.05009%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DA.%2BM.%26aulast%3DGiguere%26aufirst%3DV.%26atitle%3DThe%2520NR3B%2520subgroup%253A%2520an%2520overrview%26jtitle%3DNucl.%2520Recept.%2520Signaling%26date%3D2007%26volume%3D5%26doi%3D10.1621%2Fnrs.05009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norby, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissing, H.</span></span> <span> </span><span class="NLM_article-title">Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1210/mend.14.3.0431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fmend.14.3.0431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10707956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=382-392&author=D.+J.+Heardauthor=P.+L.+Norbyauthor=J.+Hollowayauthor=H.+Vissing&title=Human+ERRgamma%2C+a+third+member+of+the+estrogen+receptor-related+receptor+%28ERR%29+subfamily+of+orphan+nuclear+receptors%3A+tissue-specific+isoforms+are+expressed+during+development+and+in+the+adult&doi=10.1210%2Fmend.14.3.0431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult</span></div><div class="casAuthors">Heard, David J.; Norby, Peder L.; Holloway, Jim; Vissing, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-392</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The nuclear receptor protein superfamily is a large group of transcription factors involved in many aspects of animal development, tissue differentiation, and homeostasis in the higher eukaryotes.  A subfamily of receptors, ERRα and β (estrogen receptor-related receptor α and β), closely related to the ER, were among the first orphan nuclear receptors identified.  These receptors can bind DNA as monomers and are thought to activate transcription constitutively, unaffected by β-estradiol.  Studies of the expression patterns of ERRα and gene disruption expts. of ERRβ indicate that they play an important role in the development and differentiation of specific tissues in the mouse.  The authors demonstrate the existence in humans of a third member of this subfamily of receptors, termed ERRγ, which is highly expressed in a no. of diverse fetal and adult tissues including brain, kidney, pancreas, and placenta.  The ERRγ mRNA is highly alternatively spliced at the 5'-end, giving rise to a no. of tissue-specific RNA species, some of which code for protein isoforms differing in the N-terminal region.  Like ERRα and β, ERRγ binds as a monomer to an ERRE.  A GAL4-ERRγ fusion protein activates transcription in a ligand-independent manner in transfected HEK293 cells to a greater degree than either the GAL4-ERRα or -β fusion proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9jyjRg2ZayrVg90H21EOLACvtfcHk0lgZz6o_iaOvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFOqt70%253D&md5=d481b4678c899c40df620b193529aac4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fmend.14.3.0431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.14.3.0431%26sid%3Dliteratum%253Aachs%26aulast%3DHeard%26aufirst%3DD.%2BJ.%26aulast%3DNorby%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DJ.%26aulast%3DVissing%26aufirst%3DH.%26atitle%3DHuman%2520ERRgamma%252C%2520a%2520third%2520member%2520of%2520the%2520estrogen%2520receptor-related%2520receptor%2520%2528ERR%2529%2520subfamily%2520of%2520orphan%2520nuclear%2520receptors%253A%2520tissue-specific%2520isoforms%2520are%2520expressed%2520during%2520development%2520and%2520in%2520the%2520adult%26jtitle%3DMol.%2520Endocrinol.%26date%3D2000%26volume%3D14%26spage%3D382%26epage%3D392%26doi%3D10.1210%2Fmend.14.3.0431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallcup, M. R.</span></span> <span> </span><span class="NLM_article-title">Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">22618</span>– <span class="NLM_lpage">22626</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.32.22618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.274.32.22618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=22618-22626&author=H.+Hongauthor=L.+Yangauthor=M.+R.+Stallcup&title=Hormone-independent+transcriptional+activation+and+coactivator+binding+by+novel+orphan+nuclear+receptor+ERR3&doi=10.1074%2Fjbc.274.32.22618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.32.22618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.32.22618%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DHormone-independent%2520transcriptional%2520activation%2520and%2520coactivator%2520binding%2520by%2520novel%2520orphan%2520nuclear%2520receptor%2520ERR3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D22618%26epage%3D22626%26doi%3D10.1074%2Fjbc.274.32.22618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eudy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma-Edmonds, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talmadge, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimberling, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumegi, J.</span></span> <span> </span><span class="NLM_article-title">Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1006/geno.1998.5345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1006%2Fgeno.1998.5345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9676434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXks1Smtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=382-384&author=J.+D.+Eudyauthor=S.+Yaoauthor=M.+D.+Westonauthor=M.+Ma-Edmondsauthor=C.+B.+Talmadgeauthor=J.+J.+Chengauthor=W.+J.+Kimberlingauthor=J.+Sumegi&title=Isolation+of+a+gene+encoding+a+novel+member+of+the+nuclear+receptor+superfamily+from+the+critical+region+of+Usher+syndrome+type+IIa+at+1q41&doi=10.1006%2Fgeno.1998.5345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of usher syndrome type IIa at 1q41</span></div><div class="casAuthors">Eudy, James D.; Yao, SuFang; Weston, Michael D.; Ma-Edmonds, Manling; Talmadge, Catherine B.; Cheng, Jason J.; Kimberling, William J.; Sumegi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-384</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Usher syndrome is composed of a group of heterogeneous autosomal recessive disorders characterized by retinitis pigmentosa and moderate to severe congenital deafness.  Candidate exons, from cosmid subclones of YAC762a6, which extends into the USH2a crit. region, were isolated and used to screen for candidate cDNAs.  A cDNA encoding the orphan receptor estrogen-related receptor-γ ESRRG was isolated and sequenced.  However, no mutations were obsd. within this gene and it is highly unlikely that ESRRG is the USH2a gene.  Three overlapping ESTs were also detected.  High expression of ESRRG in human fetal brain was detected as compared to adult brain, suggesting that the gene may be important in embryonic CNS development.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Kd8wQMZZ2bVg90H21EOLACvtfcHk0lg87-I2RTHZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1Smtb8%253D&md5=ec30a97dbba1340d2455d089c1a11158</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1998.5345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1998.5345%26sid%3Dliteratum%253Aachs%26aulast%3DEudy%26aufirst%3DJ.%2BD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DWeston%26aufirst%3DM.%2BD.%26aulast%3DMa-Edmonds%26aufirst%3DM.%26aulast%3DTalmadge%26aufirst%3DC.%2BB.%26aulast%3DCheng%26aufirst%3DJ.%2BJ.%26aulast%3DKimberling%26aufirst%3DW.%2BJ.%26aulast%3DSumegi%26aufirst%3DJ.%26atitle%3DIsolation%2520of%2520a%2520gene%2520encoding%2520a%2520novel%2520member%2520of%2520the%2520nuclear%2520receptor%2520superfamily%2520from%2520the%2520critical%2520region%2520of%2520Usher%2520syndrome%2520type%2520IIa%2520at%25201q41%26jtitle%3DGenomics%26date%3D1998%26volume%3D50%26spage%3D382%26epage%3D384%26doi%3D10.1006%2Fgeno.1998.5345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segui, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Identification of a new class of steroid hormone receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1038/331091a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1038%2F331091a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=3267207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaL1cXktVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=91-94&author=V.+Gigu%C3%A8reauthor=N.+Yangauthor=P.+Seguiauthor=R.+M.+Evans&title=Identification+of+a+new+class+of+steroid+hormone+receptors&doi=10.1038%2F331091a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new class of steroid hormone receptors</span></div><div class="casAuthors">Giguere, Vincent; Yang, Na; Segui, Prudimar; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">6151</span>),
    <span class="NLM_cas:pages">91-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The DNA-binding domain of the human estrogen receptor was used as a probe to isolate cDNA clones encoding 2 polypeptides with structural features suggestive of cryptic steroid hormone receptors from a new potential hormone response system.  The cDNA clones were sequenced and encoded polypeptides of 57,300 mol. wt. and 47,600 mol. wt. designated hERR1 and hERR2, resp.  Using a cDNA clone as a probe, a 2.6-kb mRNA encoding hERR1 was detected in all rat and human tissues analyzed.  A 4.8-kb mRNA encoding hERR2 was found in rat kidney, heart, testis, hypothalamus, hippocampus, cerebellum, and prostate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCGqOjludiYbVg90H21EOLACvtfcHk0lg87-I2RTHZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktVWlsrY%253D&md5=f1f3aa150b6d929ffc29fb7cea002c89</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F331091a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F331091a0%26sid%3Dliteratum%253Aachs%26aulast%3DGigu%25C3%25A8re%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DSegui%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DIdentification%2520of%2520a%2520new%2520class%2520of%2520steroid%2520hormone%2520receptors%26jtitle%3DNature%26date%3D1988%26volume%3D331%26spage%3D91%26epage%3D94%26doi%3D10.1038%2F331091a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1074/jbc.M106140200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M106140200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=1739-1748&author=S.+Sanyalauthor=J.+Y.+Kimauthor=H.+J.+Kimauthor=J.+Takedaauthor=Y.+K.+Leeauthor=D.+D.+Mooreauthor=H.+S.+Choi&title=Differential+regulation+of+the+orphan+nuclear+receptor+small+heterodimer+partner+%28SHP%29+gene+promoter+by+orphan+nuclear+receptor+ERR+isoforms&doi=10.1074%2Fjbc.M106140200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106140200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106140200%26sid%3Dliteratum%253Aachs%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DTakeda%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DMoore%26aufirst%3DD.%2BD.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DDifferential%2520regulation%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520small%2520heterodimer%2520partner%2520%2528SHP%2529%2520gene%2520promoter%2520by%2520orphan%2520nuclear%2520receptor%2520ERR%2520isoforms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D1739%26epage%3D1748%26doi%3D10.1074%2Fjbc.M106140200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-S.</span></span> <span> </span><span class="NLM_article-title">An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">6756</span>– <span class="NLM_lpage">6768</span>, <span class="refDoi"> DOI: 10.1093/nar/gki976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1093%2Fnar%2Fgki976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=6756-6768&author=Y.-Y.+Parkauthor=S.-W.+Ahnauthor=H.-J.+Kimauthor=J.-M.+Kimauthor=I.-K.+Leeauthor=H.+Kangauthor=H.-S.+Choi&title=An+autoregulatory+loop+controlling+orphan+nuclear+receptor+DAX-1+gene+expression+by+orphan+nuclear+receptor+ERRgamma&doi=10.1093%2Fnar%2Fgki976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki976%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.-Y.%26aulast%3DAhn%26aufirst%3DS.-W.%26aulast%3DKim%26aufirst%3DH.-J.%26aulast%3DKim%26aufirst%3DJ.-M.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.-S.%26atitle%3DAn%2520autoregulatory%2520loop%2520controlling%2520orphan%2520nuclear%2520receptor%2520DAX-1%2520gene%2520expression%2520by%2520orphan%2520nuclear%2520receptor%2520ERRgamma%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D6756%26epage%3D6768%26doi%3D10.1093%2Fnar%2Fgki976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">28762</span>– <span class="NLM_lpage">28774</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.034165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M109.034165" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28762-28774&author=Y.+B.+Xieauthor=J.+H.+Parkauthor=D.+K.+Kimauthor=J.+H.+Hwangauthor=S.+Ohauthor=S.+B.+Parkauthor=M.+Shongauthor=I.+K.+Leeauthor=H.+S.+Choi&title=Transcriptional+corepressor+SMILE+recruits+SIRT1+to+inhibit+nuclear+receptor+estrogen+receptor-related+receptor+gamma+transactivation&doi=10.1074%2Fjbc.M109.034165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.034165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.034165%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BB.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DHwang%26aufirst%3DJ.%2BH.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DShong%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DTranscriptional%2520corepressor%2520SMILE%2520recruits%2520SIRT1%2520to%2520inhibit%2520nuclear%2520receptor%2520estrogen%2520receptor-related%2520receptor%2520gamma%2520transactivation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D28762%26epage%3D28774%26doi%3D10.1074%2Fjbc.M109.034165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dorsselaer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(02)00444-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS1097-2765%2802%2900444-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=11864604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=303-313&author=H.+Greschikauthor=J.+M.+Wurtzauthor=S.+Sanglierauthor=W.+Bourguetauthor=A.+van+Dorsselaerauthor=D.+Morasauthor=J.+P.+Renaud&title=Structural+and+functional+evidence+for+ligand-independent+transcriptional+activation+by+the+estrogen-related+receptor+3&doi=10.1016%2FS1097-2765%2802%2900444-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3</span></div><div class="casAuthors">Greschik, Holger; Wurtz, Jean-Marie; Sanglier, Sarah; Bourguet, William; Van Dorsselaer, Alain; Moras, Dino; Renaud, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-313</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The crystal structure of the ligand binding domain (LBD) of the estrogen-related receptor 3 (ERR3) complexed with a steroid receptor coactivator-1 (SRC-1) peptide reveals a transcriptionally active conformation in absence of any ligand.  The structure explains why estradiol does not bind ERRs with significant affinity.  Docking of the previously reported ERR antagonists, diethylstilbestrol and 4-hydroxytamoxifen, requires structural rearrangements enlarging the ligand binding pocket that can only be accommodated with an antagonist LBD conformation.  Mutant receptors in which the ligand binding cavity is filled up by bulkier side chains still interact with SRC-1 in vitro and are transcriptionally active in vivo, but are no longer efficiently inactivated by diethylstilbestrol or 4-hydroxytamoxifen.  These results provide structural and functional evidence for ligand-independent transcriptional activation by ERR3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZsRdHTpUyLVg90H21EOLACvtfcHk0liPMIupz-RQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKhu7g%253D&md5=8b9efbe14fe050d9e2405911e602afa3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900444-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900444-6%26sid%3Dliteratum%253Aachs%26aulast%3DGreschik%26aufirst%3DH.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DSanglier%26aufirst%3DS.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3Dvan%2BDorsselaer%26aufirst%3DA.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRenaud%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520and%2520functional%2520evidence%2520for%2520ligand-independent%2520transcriptional%2520activation%2520by%2520the%2520estrogen-related%2520receptor%25203%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D9%26spage%3D303%26epage%3D313%26doi%3D10.1016%2FS1097-2765%2802%2900444-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consler, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span> <span> </span><span class="NLM_article-title">X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">37773</span>– <span class="NLM_lpage">37781</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608410200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M608410200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16990259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KitrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=37773-37781&author=L.+Wangauthor=W.+J.+Zuercherauthor=T.+G.+Conslerauthor=M.+H.+Lambertauthor=A.+B.+Millerauthor=L.+A.+Orband-Millerauthor=D.+D.+McKeeauthor=T.+M.+Willsonauthor=R.+T.+Nolte&title=X-ray+crystal+structures+of+the+estrogen-related+receptor-gamma+ligand+binding+domain+in+three+functional+states+reveal+the+molecular+basis+of+small+molecule+regulation&doi=10.1074%2Fjbc.M608410200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Crystal Structures of the Estrogen-related Receptor-γ Ligand Binding Domain in Three Functional States Reveal the Molecular Basis of Small Molecule Regulation</span></div><div class="casAuthors">Wang, Liping; Zuercher, William J.; Consler, Thomas G.; Lambert, Millard H.; Miller, Aaron B.; Orband-Miller, Lisa A.; McKee, David D.; Willson, Timothy M.; Nolte, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">37773-37781</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">X-ray crystal structures of the ligand binding domain (LBD) of the estrogen-related receptor-γ (ERRγ) were detd. that describe this receptor in three distinct states: unliganded, inverse agonist bound, and agonist bound.  Two structures were solved for the unliganded state, the ERRγ LBD alone, and in complex with a coregulator peptide representing a portion of receptor interacting protein 140 (RIP140).  No significant differences were seen between these structures that both exhibited the conformation of ERRγ seen in studies with other coactivators.  Two structures were obtained describing the inverse agonist-bound state, the ERRγ LBD with 4-hydroxytamoxifen (4-OHT), and the ERRγ LBD with 4-OHT and a peptide representing a portion of the silencing mediator of retinoid and thyroid hormone action protein (SMRT).  The 4-OHT structure was similar to other reported inverse agonist bound structures, showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix relative to the unliganded structures with little other rearrangement occurring.  No significant changes to the LBD appear to be induced by peptide binding with the addn. of the SMRT peptide to the ERRγ plus 4-OHT complex.  The obsd. agonist-bound state contains the ERRγ LBD, a ligand (GSK4716), and the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding residues.  Thermal stability studies show that agonist binding leads to global stabilization of the ligand binding domain.  In contrast to the conventional mechanism of nuclear receptor ligand activation, activation of ERRγ by GSK4716 does not appear to involve a major rearrangement or significant stabilization of the C-terminal helix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9AW_0RzftrVg90H21EOLACvtfcHk0liPMIupz-RQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KitrfF&md5=913262d27de1430491479c294a71b3ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608410200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608410200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DConsler%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DMcKee%26aufirst%3DD.%2BD.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DX-ray%2520crystal%2520structures%2520of%2520the%2520estrogen-related%2520receptor-gamma%2520ligand%2520binding%2520domain%2520in%2520three%2520functional%2520states%2520reveal%2520the%2520molecular%2520basis%2520of%2520small%2520molecule%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D37773%26epage%3D37781%26doi%3D10.1074%2Fjbc.M608410200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bookout, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.cell.2006.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16923397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1akurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=789-799&author=A.+L.+Bookoutauthor=Y.+Jeongauthor=M.+Downesauthor=R.+T.+Yuauthor=R.+M.+Evansauthor=D.+J.+Mangelsdorf&title=Anatomical+profiling+of+nuclear+receptor+expression+reveals+a+hierarchical+transcriptional+network&doi=10.1016%2Fj.cell.2006.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network</span></div><div class="casAuthors">Bookout, Angie L.; Jeong, Yangsik; Downes, Michael; Yu, Ruth T.; Evans, Ronald M.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">789-799</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In multicellular organisms, the ability to regulate reprodn., development, and nutrient utilization coincided with the evolution of nuclear receptors (NRs), transcription factors that utilize lipophilic ligands to mediate their function.  Studying the expression profile of NRs offers a simple, powerful way to obtain highly relational information about their physiol. functions as individual proteins and as a superfamily.  We surveyed the expression of all 49 mouse NR mRNAs in 39 tissues, representing diverse anatomical systems.  The resulting data set uncovers several NR clades whose patterns of expression indicate their ability to coordinate the transcriptional programs necessary to affect distinct physiol. pathways.  Remarkably, this regulatory network divides along the following two physiol. paradigms: (1) reprodn., development, and growth and (2) nutrient uptake, metab., and excretion.  These data reveal a hierarchical transcriptional circuitry that extends beyond individual tissues to form a meganetwork governing physiol. on an organismal scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqogrckvFPX1bVg90H21EOLACvtfcHk0lhrhw5PO7qszg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1akurs%253D&md5=446a873e2349d62a2fc74fa35f68df70</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DBookout%26aufirst%3DA.%2BL.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DAnatomical%2520profiling%2520of%2520nuclear%2520receptor%2520expression%2520reveals%2520a%2520hierarchical%2520transcriptional%2520network%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D789%26epage%3D799%26doi%3D10.1016%2Fj.cell.2006.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alaynick, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remlinger, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">ERRgamma regulates cardiac, gastric, and renal potassium homeostasis</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fme.2009-0114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19965931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=299-309&author=W.+A.+Alaynickauthor=J.+M.+Wayauthor=S.+A.+Wilsonauthor=W.+G.+Bensonauthor=L.+Peiauthor=M.+Downesauthor=R.+Yuauthor=J.+W.+Jonkerauthor=J.+A.+Holtauthor=D.+K.+Rajpalauthor=H.+Liauthor=J.+Stuartauthor=R.+McPhersonauthor=K.+S.+Remlingerauthor=C.+Y.+Changauthor=D.+P.+McDonnellauthor=R.+M.+Evansauthor=A.+N.+Billin&title=ERRgamma+regulates+cardiac%2C+gastric%2C+and+renal+potassium+homeostasis&doi=10.1210%2Fme.2009-0114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">ERRγ regulates cardiac, gastric, and renal potassium homeostasis</span></div><div class="casAuthors">Alaynick, William A.; Way, James M.; Wilson, Stephanie A.; Benson, William G.; Pei, Liming; Downes, Michael; Yu, Ruth; Jonker, Johan W.; Holt, Jason A.; Rajpal, Deepak K.; Li, Hao; Stuart, Joan; McPherson, Ruth; Remlinger, Katja S.; Chang, Ching-Yi; McDonnell, Donald P.; Evans, Ronald M.; Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Energy prodn. by oxidative metab. in kidney, stomach, and heart, is primarily expended in establishing ion gradients to drive renal electrolyte homeostasis, gastric acid secretion, and cardiac muscle contraction, resp.  In addn. to orchestrating transcriptional control of oxidative metab., the orphan nuclear receptor, estrogen-related receptor γ (ERRγ), coordinates expression of genes central to ion homeostasis in oxidative tissues.  Renal, gastric, and cardiac tissues subjected to genomic anal. of expression in perinatal ERRγ null mice revealed a characteristic dysregulation of genes involved in transport processes, exemplified by the voltage-gated potassium channel, Kcne2.  Consistently, ERRγ null animals die during the first 72 h of life with elevated serum potassium, redns. in key gastric acid prodn. markers, and cardiac arrhythmia with prolonged QT intervals.  In addn., we find altered expression of several genes assocd. with hypertension in ERRγ null mice.  These findings suggest a potential role for genetic polymorphisms at the ERRγ locus and ERRγ modulators in the etiol. and treatment of renal, gastric, and cardiac dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4kOOzL489RbVg90H21EOLACvtfcHk0lhrhw5PO7qszg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslaqu7g%253D&md5=4c9a44e8750190bcef8d2c51897ac757</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0114%26sid%3Dliteratum%253Aachs%26aulast%3DAlaynick%26aufirst%3DW.%2BA.%26aulast%3DWay%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DS.%2BA.%26aulast%3DBenson%26aufirst%3DW.%2BG.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DRajpal%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DMcPherson%26aufirst%3DR.%26aulast%3DRemlinger%26aufirst%3DK.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DERRgamma%2520regulates%2520cardiac%252C%2520gastric%252C%2520and%2520renal%2520potassium%2520homeostasis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D299%26epage%3D309%26doi%3D10.1210%2Fme.2009-0114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1172/JCI67652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1172%2FJCI67652" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2564-2575&author=Z.+Ganauthor=J.+Rumseyauthor=B.+C.+Hazenauthor=L.+Laiauthor=T.+C.+Leoneauthor=R.+B.+Vegaauthor=H.+Xieauthor=K.+E.+Conleyauthor=J.+Auwerxauthor=S.+R.+Smithauthor=E.+N.+Olsonauthor=A.+Kralliauthor=D.+P.+Kelly&title=Nuclear+receptor%2FmicroRNA+circuitry+links+muscle+fiber+type+to+energy+metabolism&doi=10.1172%2FJCI67652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI67652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI67652%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DRumsey%26aufirst%3DJ.%26aulast%3DHazen%26aufirst%3DB.%2BC.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLeone%26aufirst%3DT.%2BC.%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DConley%26aufirst%3DK.%2BE.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DKralli%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DNuclear%2520receptor%252FmicroRNA%2520circuitry%2520links%2520muscle%2520fiber%2520type%2520to%2520energy%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2564%26epage%3D2575%26doi%3D10.1172%2FJCI67652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, C. R.</span></span> <span> </span><span class="NLM_article-title">Estrogen-related receptor gamma (ERRgamma) regulates oxygen-dependent expression of voltage-gated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1210/me.2013-1038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fme.2013-1038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1Khur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=940-952&author=Y.+Luoauthor=P.+Kumarauthor=C.+R.+Mendelson&title=Estrogen-related+receptor+gamma+%28ERRgamma%29+regulates+oxygen-dependent+expression+of+voltage-gated+potassium+%28K%2B%29+channels+and+tissue+kallikrein+during+human+trophoblast+differentiation&doi=10.1210%2Fme.2013-1038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen-related receptor γ (ERRγ) regulates oxygen-dependent expression of voltage-gated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation</span></div><div class="casAuthors">Luo, Yanmin; Kumar, Premlata; Mendelson, Carole R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">940-952</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Estrogen-related receptor γ (ERRγ) serves a crit. O2-dependent regulatory role in the differentiation of human cytotrophoblasts to syncytiotrophoblast.  In this study, we investigated expression of genes encoding tissue kallikrein (KLK1) and voltage-gated K+ channels (KV7) during differentiation of human trophoblasts in culture and the roles of ERRγ and O2 tension in their regulation.  Expression of KLK1 and the KV7 channel subunits, KCNQ1, KCNE1, KCNE3, and KCNE5, increased during differentiation of cultured human trophoblast cells in a 20% O2 environment.  Notably, together with ERRγ, expression of KLK1, KCNQ1, KCNE1, KCNE3, and KCNE5 was markedly reduced when cells were cultured in a hypoxic environment (2% O2).  Moreover, upon transduction of trophoblast cells with short hairpin RNAs for endogenous ERRγ, KLK1, KCNQ1, KCNE1, and KCNE3 expression was significantly decreased.  Promoter and site-directed mutagenesis studies in transfected cells identified putative ERRγ response elements within the KLK1 and KCNE1 5'-flanking regions required for ERRγ-stimulated transcriptional activity.  Binding of endogenous ERRγ to these ERRγ response elements increased during trophoblast differentiation in culture and was inhibited by hypoxia.  The KV7 blocker linopirdine reduced human chorionic gonadotropin secretion and aggregation of cultured human trophoblasts, suggesting a possible role of KV7 channels in cell fusion and differentiation.  Illumina gene expression arrays of cultured human trophoblast cells revealed several genes upregulated during syncytiotrophoblast differentiation and downregulated upon ERRγ knockdown involved in cell differentiation, adhesion, and synthesis of steroid and peptide hormones required for placental development and function.  Collectively, these findings suggest that ERRγ mediates O2-dependent expression of genes involved in human trophoblast differentiation, function, and vascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_5yO13wjx7Vg90H21EOLACvtfcHk0lhrhw5PO7qszg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1Khur4%253D&md5=48bfe7d1daad64a3fcd2907e978b4f8a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1038%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DMendelson%26aufirst%3DC.%2BR.%26atitle%3DEstrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520regulates%2520oxygen-dependent%2520expression%2520of%2520voltage-gated%2520potassium%2520%2528K%252B%2529%2520channels%2520and%2520tissue%2520kallikrein%2520during%2520human%2520trophoblast%2520differentiation%26jtitle%3DMol.%2520Endocrinol.%26date%3D2013%26volume%3D27%26spage%3D940%26epage%3D952%26doi%3D10.1210%2Fme.2013-1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Estrogen-related receptor gamma (ERRgamma) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38035</span>– <span class="NLM_lpage">38042</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.250613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M111.250613" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38035-38042&author=D.+K.+Kimauthor=J.+R.+Kimauthor=M.+Kohauthor=Y.+D.+Kimauthor=J.+M.+Leeauthor=D.+Chandaauthor=S.+B.+Parkauthor=J.+J.+Minauthor=C.+H.+Leeauthor=T.+S.+Parkauthor=H.+S.+Choi&title=Estrogen-related+receptor+gamma+%28ERRgamma%29+is+a+novel+transcriptional+regulator+of+phosphatidic+acid+phosphatase%2C+LIPIN1%2C+and+inhibits+hepatic+insulin+signaling&doi=10.1074%2Fjbc.M111.250613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.250613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.250613%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BR.%26aulast%3DKoh%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DMin%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DEstrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520is%2520a%2520novel%2520transcriptional%2520regulator%2520of%2520phosphatidic%2520acid%2520phosphatase%252C%2520LIPIN1%252C%2520and%2520inhibits%2520hepatic%2520insulin%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38035%26epage%3D38042%26doi%3D10.1074%2Fjbc.M111.250613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">21628</span>– <span class="NLM_lpage">21639</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.315168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M111.315168" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=21628-21639&author=D.+K.+Kimauthor=D.+Ryuauthor=M.+Kohauthor=M.+W.+Leeauthor=D.+Limauthor=M.+J.+Kimauthor=Y.+H.+Kimauthor=W.+J.+Choauthor=C.+H.+Leeauthor=S.+B.+Parkauthor=S.+H.+Kooauthor=H.+S.+Choi&title=Orphan+nuclear+receptor+estrogen-related+receptor+gamma+%28ERRgamma%29+is+key+regulator+of+hepatic+gluconeogenesis&doi=10.1074%2Fjbc.M111.315168"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.315168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.315168%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DRyu%26aufirst%3DD.%26aulast%3DKoh%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DCho%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DKoo%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DOrphan%2520nuclear%2520receptor%2520estrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520is%2520key%2520regulator%2520of%2520hepatic%2520gluconeogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D21628%26epage%3D21639%26doi%3D10.1074%2Fjbc.M111.315168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor oestrogen-related receptor gamma (ERRgamma) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>470</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1042/BJ20141494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1042%2FBJ20141494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2015&pages=181-193&author=Y.+Zhangauthor=D.+K.+Kimauthor=J.+M.+Leeauthor=S.+B.+Parkauthor=W.+I.+Jeongauthor=S.+H.+Kimauthor=I.+K.+Leeauthor=C.+H.+Leeauthor=J.+Y.+Chiangauthor=H.+S.+Choi&title=Orphan+nuclear+receptor+oestrogen-related+receptor+gamma+%28ERRgamma%29+plays+a+key+role+in+hepatic+cannabinoid+receptor+type+1-mediated+induction+of+CYP7A1+gene+expression&doi=10.1042%2FBJ20141494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20141494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141494%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DW.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DChiang%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DOrphan%2520nuclear%2520receptor%2520oestrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520plays%2520a%2520key%2520role%2520in%2520hepatic%2520cannabinoid%2520receptor%2520type%25201-mediated%2520induction%2520of%2520CYP7A1%2520gene%2520expression%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D470%26spage%3D181%26epage%3D193%26doi%3D10.1042%2FBJ20141494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keutgen, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebebew, E.</span></span> <span> </span><span class="NLM_article-title">Management of anaplastic thyroid cancer</span>. <i>Gland Surg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.3978/j.issn.2227-684X.2014.12.02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3978%2Fj.issn.2227-684X.2014.12.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=25713779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC2Mroslequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=44-51&author=X.+M.+Keutgenauthor=S.+M.+Sadowskiauthor=E.+Kebebew&title=Management+of+anaplastic+thyroid+cancer&doi=10.3978%2Fj.issn.2227-684X.2014.12.02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Management of anaplastic thyroid cancer</span></div><div class="casAuthors">Keutgen Xavier M; Sadowski Samira M; Kebebew Electron</div><div class="citationInfo"><span class="NLM_cas:title">Gland surgery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-51</span>
        ISSN:<span class="NLM_cas:issn">2227-684X</span>.
    </div><div class="casAbstract">Anaplastic thyroid cancer (ATC) is a deadly disease with a dismal prognosis.  Molecular analyses of ATC tumors have yielded interesting results, which could help in understanding the underlying mechanisms of this aggressive disease process.  Managing ATC can be challenging and includes rapid diagnosis, adequate staging, and interdisciplinary, multimodal treatments to optimize patient outcome.  Treatments include surgical resection to gross negative margins when possible, as well as neo- or adjuvant treatment with chemotherapy or external beam radiation (XRT) for locoregional disease.  New treatment strategies include evaluating the benefits of vascular disrupting agents and tyrosine kinase inhibitors for advanced ATC with driver mutations, which can be targeted.  This review summarizes key concepts in managing ATC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa5dwEoYu4sxKDYG3bNImrfW6udTcc2eZCwTalp9n0y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mroslequw%253D%253D&md5=8f154dfef81ec097f8982f98eb62d484</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2227-684X.2014.12.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2227-684X.2014.12.02%26sid%3Dliteratum%253Aachs%26aulast%3DKeutgen%26aufirst%3DX.%2BM.%26aulast%3DSadowski%26aufirst%3DS.%2BM.%26aulast%3DKebebew%26aufirst%3DE.%26atitle%3DManagement%2520of%2520anaplastic%2520thyroid%2520cancer%26jtitle%3DGland%2520Surg.%26date%3D2015%26volume%3D4%26spage%3D44%26epage%3D51%26doi%3D10.3978%2Fj.issn.2227-684X.2014.12.02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranganath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. R.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid cancer</span>. <i>Curr. Opin. Endocrinol., Diabetes Obes.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1097/MED.0000000000000189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1097%2FMED.0000000000000189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26313900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVeqsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=387-391&author=R.+Ranganathauthor=M.+A.+Shahauthor=A.+R.+Shah&title=Anaplastic+thyroid+cancer&doi=10.1097%2FMED.0000000000000189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid cancer</span></div><div class="casAuthors">Ranganath, Rohit; Shah, Manish A.; Shah, Ashok R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-391</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Purpose of review: Anaplastic thyroid cancer (ATC) is a rare malignancy of the thyroid with a high mortality rate.  Conventional therapy has not been effective.  Several biol. agents are being investigated.  The purpose of the review is to highlight the current stds. for treatment and review new targets for treating ATC.  Recent findings: Retrospective studies have led to formulation of guidelines for management, including those by the American Thyroid Assocn.  An expansion in the understanding of the genetic mutations has led to several newer biol. agents being tested to treat ATC.  Aurora kinase inhibitors, PPAR γ agonists, and vascular targeting agents are some of the latest therapeutic agents that have shown promise and could become std. of therapy with further supporting research.  Summary: Further well coordinated preclin. and clin. research is needed to support the emerging treatments for ATC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGeVq0KWQHoLVg90H21EOLACvtfcHk0lgQNLVf-UBLMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVeqsbrO&md5=84c0be52b55e340c91f1ce156177b575</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2FMED.0000000000000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMED.0000000000000189%26sid%3Dliteratum%253Aachs%26aulast%3DRanganath%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DA.%2BR.%26atitle%3DAnaplastic%2520thyroid%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%252C%2520Diabetes%2520Obes.%26date%3D2015%26volume%3D22%26spage%3D387%26epage%3D391%26doi%3D10.1097%2FMED.0000000000000189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smallridge, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, J. A.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid carcinoma: pathogenesis and emerging therapies</span>. <i>Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.clon.2010.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.clon.2010.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3cnovFamsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=486-497&author=R.+C.+Smallridgeauthor=J.+A.+Copland&title=Anaplastic+thyroid+carcinoma%3A+pathogenesis+and+emerging+therapies&doi=10.1016%2Fj.clon.2010.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid carcinoma: pathogenesis and emerging therapies</span></div><div class="casAuthors">Smallridge R C; Copland J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">486-97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally.  Mutations, amplifications, activation of oncogenes and silencing of tumour suppressor genes contribute to its aggressive behaviour, and recent studies (e.g. microarrays, microRNAs) have provided further insights into its complex molecular dysregulation.  Preclinical studies have identified numerous proteins over- or underexpressed that affect critical cellular processes, including transcription, signalling, mitosis, proliferation, cell cycle, apoptosis and adhesion, and a variety of agents that effectively inhibit these processes and tumour growth.  In clinical studies of 1771 patients, 64% were women, the median survival was 5 months, and 1-year survival was 20%.  The variables associated with survival in some series included age, tumour size, extent of surgery, higher dose radiotherapy, absence of distant metastases at presentation, co-existence of differentiated thyroid cancer and multimodality therapy.  However, considerable bias exists in these non-randomised studies.  Although more aggressive radiotherapy has reduced locoregional recurrences, the median overall survival has not improved in over 50 years.  Newer systemic therapies are being tried, and more effective combinations are needed to improve patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkDZSm-xdrbZPq5LRczm8ffW6udTcc2eYnpsm0WbnOCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnovFamsw%253D%253D&md5=eb3ff70b7464fd425936352ce6222024</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2010.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2010.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DSmallridge%26aufirst%3DR.%2BC.%26aulast%3DCopland%26aufirst%3DJ.%2BA.%26atitle%3DAnaplastic%2520thyroid%2520carcinoma%253A%2520pathogenesis%2520and%2520emerging%2520therapies%26jtitle%3DClin.%2520Oncol.%26date%3D2010%26volume%3D22%26spage%3D486%26epage%3D497%26doi%3D10.1016%2Fj.clon.2010.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swaak-Kragten, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wilt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontenbal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levendag, P. C.</span></span> <span> </span><span class="NLM_article-title">Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.radonc.2009.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.radonc.2009.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19328572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BD1MvivFGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2009&pages=100-104&author=A.+T.+Swaak-Kragtenauthor=J.+H.+de+Wiltauthor=P.+I.+Schmitzauthor=M.+Bontenbalauthor=P.+C.+Levendag&title=Multimodality+treatment+for+anaplastic+thyroid+carcinoma%2D%2Dtreatment+outcome+in+75+patients&doi=10.1016%2Fj.radonc.2009.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients</span></div><div class="casAuthors">Swaak-Kragten Annemarie T; de Wilt Johannes H W; Schmitz Paul I M; Bontenbal Marijke; Levendag Peter C</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To retrospectively analyze the outcome of patients with anaplastic thyroid carcinoma (ATC) treated in the Erasmus MC.  MATERIAL AND METHODS:  Seventy-five ATC-patients were treated between 1972 and 2003.  Mean age was 68 years.  Tumor stage was IVA in 9%, IVB in 51%, and IVC in 40%.  Thirty-six patients underwent up-front surgery, with 53% resulting in R0/R1 resection.  Before 1988 adjuvant treatment consisted of conventional radiotherapy (RT) and/or chemotherapy (CT).  As of 1988, 30 eligible patients were enrolled in a newly designed protocol.  This consists of locoregional RT in 46 fractions of 1.1 Gy, given twice daily, followed by prophylactic irradiation of the lungs (PLI) in 5 daily fractions of 1.5 Gy.  During radiation, low-dose Doxorubicine (15 mg/m(2)) is administered weekly and is followed by adjuvant Doxorubicine (50 mg/m(2)) 3-weekly up to a cumulative dose of 550 mg/m(2).  Twenty-five ineligible patients were treated conventionally.  RESULTS:  Overall median survival was 3 months, 1-year OS 9%.  Locoregional control was significantly higher in patients who had undergone R0/R1 resection or chemoradiation, with best results for patients who underwent both (complete remission in 89%).  However, the survival benefit of patients who reached CR remained borderline (median OS 7 months, 1-year OS 32%).  Three patients survived for more than 5 years; all had undergone R0/R1 surgical resection and chemoradiation.  Acute toxicity in the protocol group was significantly higher than in the nonprotocol group, with 46% versus 11% grade 3 pharyngeal and/or esophageal toxicity.  CONCLUSION:  Despite the ultimately dismal prognosis of ATC-patients, multimodality treatment significantly improved local control and improved the median survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQj57ou_xf_YFQKX3ooHxWjfW6udTcc2eYnpsm0WbnOCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvivFGhuw%253D%253D&md5=9f205acfd47d1ac2e9166a68a1264a77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2009.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2009.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DSwaak-Kragten%26aufirst%3DA.%2BT.%26aulast%3Dde%2BWilt%26aufirst%3DJ.%2BH.%26aulast%3DSchmitz%26aufirst%3DP.%2BI.%26aulast%3DBontenbal%26aufirst%3DM.%26aulast%3DLevendag%26aufirst%3DP.%2BC.%26atitle%3DMultimodality%2520treatment%2520for%2520anaplastic%2520thyroid%2520carcinoma--treatment%2520outcome%2520in%252075%2520patients%26jtitle%3DRadiother.%2520Oncol.%26date%3D2009%26volume%3D92%26spage%3D100%26epage%3D104%26doi%3D10.1016%2Fj.radonc.2009.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garden, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. L.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy</span>. <i>Head Neck</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1002/hed.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1002%2Fhed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19885924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3critFSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=829-836&author=A.+Bhatiaauthor=A.+Raoauthor=K.+K.+Angauthor=A.+S.+Gardenauthor=W.+H.+Morrisonauthor=D.+I.+Rosenthalauthor=D.+B.+Evansauthor=G.+Claymanauthor=S.+I.+Shermanauthor=D.+L.+Schwartz&title=Anaplastic+thyroid+cancer%3A+Clinical+outcomes+with+conformal+radiotherapy&doi=10.1002%2Fhed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy</span></div><div class="casAuthors">Bhatia Aarti; Rao Archana; Ang Kie-Kian; Garden Adam S; Morrison William H; Rosenthal David I; Evans Douglas B; Clayman Gary; Sherman Steven I; Schwartz David L</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT).  METHODS:  In all, 53 consecutive patients were analyzed.  Thirty-one (58%) patients were irradiated with curative intent.  Median radiation dose was 55 Gray (Gy; range, 4-70 Gy).  Thirteen (25%) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy).  Thirty-nine (74%) patients received chemotherapy with radiation.  RESULTS:  The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29%.  Patients without distant metastases receiving >or=50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last follow-up.  Use of IMRT versus 3DRT did not influence toxicity.  CONCLUSIONS:  Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results.  Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival.  Biologically targeted radiosensitization merits prioritized investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVXtqhMN9u0_h3YQQtAhNufW6udTcc2eYaTdD8ok52Orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3critFSquw%253D%253D&md5=d208281acac0f43cc3c3edc7f60b878f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fhed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DBhatia%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DAng%26aufirst%3DK.%2BK.%26aulast%3DGarden%26aufirst%3DA.%2BS.%26aulast%3DMorrison%26aufirst%3DW.%2BH.%26aulast%3DRosenthal%26aufirst%3DD.%2BI.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DClayman%26aufirst%3DG.%26aulast%3DSherman%26aufirst%3DS.%2BI.%26aulast%3DSchwartz%26aufirst%3DD.%2BL.%26atitle%3DAnaplastic%2520thyroid%2520cancer%253A%2520Clinical%2520outcomes%2520with%2520conformal%2520radiotherapy%26jtitle%3DHead%2520Neck%26date%3D2010%26volume%3D32%26spage%3D829%26epage%3D836%26doi%3D10.1002%2Fhed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grewal, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leboeuf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deandreis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentlow, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanzonico, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghossein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricarte-Filho, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagin, J. A.</span></span> <span> </span><span class="NLM_article-title">Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1209288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1056%2FNEJMoa1209288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23406027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVWjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=623-632&author=A.+L.+Hoauthor=R.+K.+Grewalauthor=R.+Leboeufauthor=E.+J.+Shermanauthor=D.+G.+Pfisterauthor=D.+Deandreisauthor=K.+S.+Pentlowauthor=P.+B.+Zanzonicoauthor=S.+Haqueauthor=S.+Gavaneauthor=R.+A.+Ghosseinauthor=J.+C.+Ricarte-Filhoauthor=J.+M.+Dominguezauthor=R.+Shenauthor=R.+M.+Tuttleauthor=S.+M.+Larsonauthor=J.+A.+Fagin&title=Selumetinib-enhanced+radioiodine+uptake+in+advanced+thyroid+cancer&doi=10.1056%2FNEJMoa1209288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer</span></div><div class="casAuthors">Ho, Alan L.; Grewal, Ravinder K.; Leboeuf, Rebecca; Sherman, Eric J.; Pfister, David G.; Deandreis, Desiree; Pentlow, Keith S.; Zanzonico, Pat B.; Haque, Sofia; Gavane, Somali; Ghossein, Ronald A.; Ricarte-Filho, Julio C.; Dominguez, Jose M.; Shen, Ronglai; Tuttle, R. Michael; Larson, Steve M.; Fagin, James A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">623-632</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are assocd. with a poor prognosis.  In mouse models of thyroid cancer, selective mitogen-activated protein kinase (MAPK) pathway antagonists increase the expression of the sodium-iodide symporter and uptake of iodine.  Their effects in humans are not known.  Methods: We conducted a study to det. whether the MAPK kinase (MEK) 1 and MEK2 inhibitor selumetinib (AZD6244, ARRY-142886) could reverse refractoriness to radioiodine in patients with metastatic thyroid cancer.  After stimulation with TSH alfa, dosimetry with iodine-124 positron-emission tomog. (PET) was performed before and 4 wk after treatment with selumetinib (75 mg twice daily).  If the second iodine-124 PET study indicated that a dose of iodine-131 of 2000 cGy or more could be delivered to the metastatic lesion or lesions, therapeutic radioiodine was administered while the patient was receiving selumetinib.  Results: Of 24 patients screened for the study, 20 could be evaluated.  The median age was 61 years (range, 44 to 77), and 11 patients were men.  Nine patients had tumors with BRAF mutations, and 5 patients had tumors with mutations of NRAS.  Selumetinib increased the uptake of iodine-124 in 12 of the 20 patients (4 of 9 patients with BRAF mutations and 5 of 5 patients with NRAS mutations).  Eight of these 12 patients reached the dosimetry threshold for radioiodine therapy, including all 5 patients with NRAS mutations.  Of the 8 patients treated with radioiodine, 5 had confirmed partial responses and 3 had stable disease; all patients had decreases in serum thyroglobulin levels (mean redn., 89%).  No toxic effects of grade 3 or higher attributable by the investigators to selumetinib were obsd.  One patient received a diagnosis of myelodysplastic syndrome more than 51 wk after radioiodine treatment, with progression to acute leukemia.  Conclusions: Selumetinib produces clin. meaningful increases in iodine uptake and retention in a subgroup of patients with thyroid cancer that is refractory to radioiodine; the effectiveness may be greater in patients with RAS-mutant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj4t7rt-mPbVg90H21EOLACvtfcHk0li_VS9kGWbXZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVWjsr4%253D&md5=74a2543ed1cd182b51a915331ebe4570</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209288%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DA.%2BL.%26aulast%3DGrewal%26aufirst%3DR.%2BK.%26aulast%3DLeboeuf%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DE.%2BJ.%26aulast%3DPfister%26aufirst%3DD.%2BG.%26aulast%3DDeandreis%26aufirst%3DD.%26aulast%3DPentlow%26aufirst%3DK.%2BS.%26aulast%3DZanzonico%26aufirst%3DP.%2BB.%26aulast%3DHaque%26aufirst%3DS.%26aulast%3DGavane%26aufirst%3DS.%26aulast%3DGhossein%26aufirst%3DR.%2BA.%26aulast%3DRicarte-Filho%26aufirst%3DJ.%2BC.%26aulast%3DDominguez%26aufirst%3DJ.%2BM.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTuttle%26aufirst%3DR.%2BM.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DFagin%26aufirst%3DJ.%2BA.%26atitle%3DSelumetinib-enhanced%2520radioiodine%2520uptake%2520in%2520advanced%2520thyroid%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D623%26epage%3D632%26doi%3D10.1056%2FNEJMoa1209288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. K.</span></span> <span> </span><span class="NLM_article-title">Sodium iodide symporter: its role in nuclear medicine</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=12215558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1elsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1188-1200&author=J.+K.+Chung&title=Sodium+iodide+symporter%3A+its+role+in+nuclear+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium iodide symporter: its role in nuclear medicine</span></div><div class="casAuthors">Chung, June-Key</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Thyroid iodide uptake is basic to the clin. applications of radioiodine.  Iodide uptake occurs across the membrane of the thyroid follicular cells through an active transporter process mediated by the sodium iodide symporter (NIS).  The recent cloning of the NIS gene enabled the better characterization of the mol. mechanisms underlying iodide transport, thus opening the way to the clarification and expansion of its role in nuclear medicine.  In papillary and follicular carcinoma, NIS immunostaining was pos. in only a few tumor cells, and no NIS protein expression was detected in anaplastic carcinomas.  Decreased NIS expression levels account for the reduced iodide uptake in thyroid carcinomas.  Thus, by targeting NIS expression in cancer cells, we could enable these cells to conc. iodide from plasma and in so doing offer the possibility of radioiodine therapy.  Several investigators have shown that gene transfer of NIS into a variety of cell types confers increased radioiodine uptake by up to several hundredfold that of controls in nonthyroid cancers as well as in thyroid cancer.  In addn., my group proposes that NIS may serve as an alternative imaging reporter gene in addn. to the HSVtk and dopaminergic receptor genes.  The NIS has the potential to expand the role of nuclear medicine in the future, just as it has served as the base for the development of nuclear medicine in the past.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1dNWppdLQLVg90H21EOLACvtfcHk0li_VS9kGWbXZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1elsro%253D&md5=e3921398e0edda1058a2c783269ca32f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BK.%26atitle%3DSodium%2520iodide%2520symporter%253A%2520its%2520role%2520in%2520nuclear%2520medicine%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D1188%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kogai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent, G. A.</span></span> <span> </span><span class="NLM_article-title">The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.pharmthera.2012.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=22750642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOlsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=355-370&author=T.+Kogaiauthor=G.+A.+Brent&title=The+sodium+iodide+symporter+%28NIS%29%3A+regulation+and+approaches+to+targeting+for+cancer+therapeutics&doi=10.1016%2Fj.pharmthera.2012.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics</span></div><div class="casAuthors">Kogai, Takahiko; Brent, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-370</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Expression of the sodium iodide symporter (NIS) is required for efficient iodide uptake in thyroid and lactating breast.  Since most differentiated thyroid cancer expresses NIS, β-emitting radioactive iodide is routinely utilized to target remnant thyroid cancer and metastasis after total thyroidectomy.  Stimulation of NIS expression by high levels of TSH is necessary to achieve radioiodide uptake into thyroid cancer that is sufficient for therapy.  The majority of breast cancer also expresses NIS, but at a low level insufficient for radioiodine therapy.  Retinoic acid is a potent NIS inducer in some breast cancer cells.  NIS is also modestly expressed in some non-thyroidal tissues, including salivary glands, lacrimal glands and stomach.  Selective induction of iodide uptake is required to target tumors with radioiodide.  Iodide uptake in mammalian cells is dependent on the level of NIS gene expression, but also successful translocation of NIS to the cell membrane and correct insertion.  The regulatory mechanisms of NIS expression and membrane insertion are regulated by signal transduction pathways that differ by tissue.  Differential regulation of NIS confers selective induction of functional NIS in thyroid cancer cells, as well as some breast cancer cells, leading to more efficient radioiodide therapy for thyroid cancer and a new strategy for breast cancer therapy.  The potential for systemic radioiodide treatment of a range of other cancers, that do not express endogenous NIS, has been demonstrated in models with tumor-selective introduction of exogenous NIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbVS9OHgeZ_7Vg90H21EOLACvtfcHk0lhbCrKmg0Q-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOlsbfK&md5=a9226ec2bbe17fd9e9a96f342eafbac2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKogai%26aufirst%3DT.%26aulast%3DBrent%26aufirst%3DG.%2BA.%26atitle%3DThe%2520sodium%2520iodide%2520symporter%2520%2528NIS%2529%253A%2520regulation%2520and%2520approaches%2520to%2520targeting%2520for%2520cancer%2520therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D135%26spage%3D355%26epage%3D370%26doi%3D10.1016%2Fj.pharmthera.2012.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaisman, M.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma</span>. <i>J. Endocrinol. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1007/BF03351058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1007%2FBF03351058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=334-339&author=S.+M.+Coelhoauthor=R.+Corboauthor=A.+Buescuauthor=D.+P.+Carvalhoauthor=M.+Vaisman&title=Retinoic+acid+in+patients+with+radioiodine+non-responsive+thyroid+carcinoma&doi=10.1007%2FBF03351058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF03351058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03351058%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DS.%2BM.%26aulast%3DCorbo%26aufirst%3DR.%26aulast%3DBuescu%26aufirst%3DA.%26aulast%3DCarvalho%26aufirst%3DD.%2BP.%26aulast%3DVaisman%26aufirst%3DM.%26atitle%3DRetinoic%2520acid%2520in%2520patients%2520with%2520radioiodine%2520non-responsive%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Endocrinol.%2520Invest.%26date%3D2004%26volume%3D27%26spage%3D334%26epage%3D339%26doi%3D10.1007%2FBF03351058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Pluijm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karperien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokkel, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morreau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kievit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romijn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, J. W.</span></span> <span> </span><span class="NLM_article-title">Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies</span>. <i>Clin. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2265.2006.02515.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1111%2Fj.1365-2265.2006.02515.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16712662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=617-624&author=Y.+Y.+Liuauthor=G.+van+der+Pluijmauthor=M.+Karperienauthor=M.+P.+Stokkelauthor=A.+M.+Pereiraauthor=J.+Morreauauthor=J.+Kievitauthor=J.+A.+Romijnauthor=J.+W.+Smit&title=Lithium+as+adjuvant+to+radioiodine+therapy+in+differentiated+thyroid+carcinoma%3A+clinical+and+in+vitro+studies&doi=10.1111%2Fj.1365-2265.2006.02515.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies</span></div><div class="casAuthors">Liu, Y. Y.; van der Pluijm, G.; Karperien, M.; Stokkel, M. P. M.; Pereira, A. M.; Morreau, J.; Kievit, J.; Romijn, J. A.; Smit, J. W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Endocrinology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-624</span>CODEN:
                <span class="NLM_cas:coden">CLECAP</span>;
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Objective Lithium has been reported to increase radioactive iodine (RaI) doses in benign thyroid disease and in differentiated thyroid carcinoma (DTC).  It is not known whether lithium influences the outcome of RaI therapy in DTC.  We therefore studied the clin. effects of RaI without and with lithium carbonate in patients with proven metastatic DTC.  Controversy also exists on the mechanism by which lithium increases RaI dose in DTC.  We performed an in vitro study specifically aimed at examg. the effects of lithium on the sodium iodide symporter (NIS).  Design In a clin. study, 12 patients were selected with metastases of DTC who had received previous RaI therapy without lithium (control) that had not influenced tumor progression, despite RaI accumulation in metastases.  The patients received 1200 mg lithium carbonate/day followed by 6000 MBq RaI.  Outcome parameters were RaI uptake, serum thyroglobulin (Tg) levels and radiol. dimensions of metastases compared between RaI with lithium and control.  In an in vitro study, iodide uptake was studied in the benign rat thyroid cell line FRTL-5, in the polarized non-thyroid MDCK cell line, stably transfected with human sodium iodide symporter (hNIS) to study the effects of lithium on NIS in a non-thyroid background, and the human follicular thyroid carcinoma cell line FTC133-hNIS to study lithium effects in a background of DTC.  Lithium chloride (LiCl) was added in concns. up to 2 mm for 0-48 h.  Both steady-state iodide uptake (30 min) and initial rate (2 min) were studied using a specific activity of 100 mCi/mmol I, the latter expt. to det. lithium effects on substrate dependency.  Iodide efflux studies were performed as well.  Results Despite an increased uptake of RaI in seven patients, no beneficial effect of RaI with lithium was obsd. on the clin. course as assessed by serum Tg measurements and radiog.  In the in vitro studies, no effects of LiCl on iodide uptake or efflux were obsd.  Conclusions The addn. of lithium to RaI did not have any beneficial effects on the clin. course in 12 patients with metastatic DTC.  No beneficial effects of lithium on iodide uptake were obsd. in vitro.  Therefore, the clin. value of lithium in DTC remains subject to debate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqser7HygTcqbVg90H21EOLACvtfcHk0lhbCrKmg0Q-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVylsrY%253D&md5=8b9a455a52efc7883bc248a64b2e95b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.2006.02515.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.2006.02515.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DG.%26aulast%3DKarperien%26aufirst%3DM.%26aulast%3DStokkel%26aufirst%3DM.%2BP.%26aulast%3DPereira%26aufirst%3DA.%2BM.%26aulast%3DMorreau%26aufirst%3DJ.%26aulast%3DKievit%26aufirst%3DJ.%26aulast%3DRomijn%26aufirst%3DJ.%2BA.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%26atitle%3DLithium%2520as%2520adjuvant%2520to%2520radioiodine%2520therapy%2520in%2520differentiated%2520thyroid%2520carcinoma%253A%2520clinical%2520and%2520in%2520vitro%2520studies%26jtitle%3DClin.%2520Endocrinol.%26date%3D2006%26volume%3D64%26spage%3D617%26epage%3D624%26doi%3D10.1111%2Fj.1365-2265.2006.02515.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brent, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogai, T.</span></span> <span> </span><span class="NLM_article-title">Cancer: Novel target to enhance radioiodine uptake in thyroid cancer</span>. <i>Nat. Rev. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/nrendo.2013.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1038%2Fnrendo.2013.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23817292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=508-509&author=G.+A.+Brentauthor=T.+Kogai&title=Cancer%3A+Novel+target+to+enhance+radioiodine+uptake+in+thyroid+cancer&doi=10.1038%2Fnrendo.2013.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Novel target to enhance radioiodine uptake in thyroid cancer</span></div><div class="casAuthors">Brent, Gregory A.; Kogai, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">508-509</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sodium-iodide symporter mediates iodide uptake, but its activity is reduced by the overexpression of pituitary tumor-transforming gene 1 protein-binding factor (PBF) in thyroid tumors.  A recent study shows that inhibiting PBF phosphorylation enhances radioiodine uptake in thyroid cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobUwvrwmxHerVg90H21EOLACvtfcHk0lhbCrKmg0Q-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr3L&md5=6f7f741d2596c4960e9fd02b7aa6e225</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2013.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2013.132%26sid%3Dliteratum%253Aachs%26aulast%3DBrent%26aufirst%3DG.%2BA.%26aulast%3DKogai%26aufirst%3DT.%26atitle%3DCancer%253A%2520Novel%2520target%2520to%2520enhance%2520radioiodine%2520uptake%2520in%2520thyroid%2520cancer%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2013%26volume%3D9%26spage%3D508%26epage%3D509%26doi%3D10.1038%2Fnrendo.2013.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inverse agonist of estrogen-related receptor γ enhances sodium iodide symporter function through mitogen-activated protein kinase signaling in anaplastic thyroid cancer cells</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1690</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.160366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.2967%2Fjnumed.115.160366" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1690-1696&author=T.+D.+Singhauthor=S.+Y.+Jeongauthor=S.-W.+Leeauthor=J.-H.+Haauthor=I.-K.+Leeauthor=S.+H.+Kimauthor=J.+Kimauthor=S.+J.+Choauthor=B.-C.+Ahnauthor=J.+Leeauthor=Y.+H.+Jeon&title=Inverse+agonist+of+estrogen-related+receptor+%CE%B3+enhances+sodium+iodide+symporter+function+through+mitogen-activated+protein+kinase+signaling+in+anaplastic+thyroid+cancer+cells&doi=10.2967%2Fjnumed.115.160366"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.160366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.160366%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BD.%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DS.-W.%26aulast%3DHa%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DAhn%26aufirst%3DB.-C.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26atitle%3DInverse%2520agonist%2520of%2520estrogen-related%2520receptor%2520%25CE%25B3%2520enhances%2520sodium%2520iodide%2520symporter%2520function%2520through%2520mitogen-activated%2520protein%2520kinase%2520signaling%2520in%2520anaplastic%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26spage%3D1690%26epage%3D1696%26doi%3D10.2967%2Fjnumed.115.160366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of selective ERRgamma inverse agonists</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">80</span>, <span class="refDoi"> DOI: 10.3390/molecules21010080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3390%2Fmolecules21010080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26771593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFequ77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=80&author=J.+Kimauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=M.+J.+Maauthor=S.+B.+Kimauthor=E.+Hongauthor=J.+Chinauthor=H.+Hwangauthor=S.+Leeauthor=N.+D.+Kimauthor=J.+H.+Jeonauthor=I.+K.+Leeauthor=Y.+H.+Jeonauthor=H.+S.+Choiauthor=S.+H.+Kimauthor=S.+J.+Cho&title=Identification+of+selective+ERRgamma+inverse+agonists&doi=10.3390%2Fmolecules21010080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of selective ERRγ inverse agonists</span></div><div class="casAuthors">Kim, Jina; Young, Im Chun; Kyung, Yoo Eun; Jung, Ma Min; Kim, Sang-Bum; Hong, Eunmi; Chin, Jungwook; Hwang, Hayoung; Lee, Sungwoo; Doo, Kim Nam; Jeon, Jae-Han; Lee, In-Kyu; Jeon, Yong Hyun; Choi, Hueng-Sik; Kim, Seong Heon; Cho, Sung Jin</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80/1-80/16</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">GSK5182 (4) is currently one of the lead compds. for the development of estrogen-related receptor gamma (ERR) inverse agonists.  Here, we report the design, synthesis, pharmacol. and in vitro absorption, distribution, metab., excretion, toxicity (ADMET) properties of a series of compds. related to 4.  Starting from 4, a series of analogs were structurally modified and their ERR inverse agonist activity was measured.  A key pharmacophore feature of this novel class of ligands is the introduction of a heterocyclic group for A-ring substitution in the core scaffold.  Among the tested compds., several of them are potent ERR inverse agonists as detd. by binding and functional assays.  The most promising compd., 15g, had excellent binding selectivity over related subtypes (IC50 = 0.44, >10, >10, and 10 μM at the ERR, ERRγ, ERR.varies., and ERβ subtypes, resp.).  Compd. 15g also resulted in 95% transcriptional repression at a concn. of 10 _M, while still maintaining an acceptable in vitro ADMET profile.  This novel class of ERR inverse agonists shows promise in the development of drugs targeting ERR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L-VxqfLtErVg90H21EOLACvtfcHk0li87EOwUXZMFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFequ77E&md5=831569314aa3a66274cf66b5a736a460</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010080%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DMa%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DHong%26aufirst%3DE.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520selective%2520ERRgamma%2520inverse%2520agonists%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D80%26doi%3D10.3390%2Fmolecules21010080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.ejmech.2016.04.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=338-352&author=J.+Kimauthor=J.+Chinauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=S.+Wooauthor=H.+J.+Hwangauthor=J.+H.+Choauthor=K.+A.+Seoauthor=J.+Songauthor=H.+Hwangauthor=K.+H.+Kimauthor=N.+D.+Kimauthor=S.+K.+Yoonauthor=J.+H.+Jeonauthor=S.+Y.+Yoonauthor=Y.+H.+Jeonauthor=H.+S.+Choiauthor=I.+K.+Leeauthor=S.+H.+Kimauthor=S.+J.+Cho&title=Synthesis+and+biological+evaluation+of+novel+4-hydroxytamoxifen+analogs+as+estrogen-related+receptor+gamma+inverse+agonists&doi=10.1016%2Fj.ejmech.2016.04.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DK.%2BA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DS.%2BK.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25204-hydroxytamoxifen%2520analogs%2520as%2520estrogen-related%2520receptor%2520gamma%2520inverse%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D338%26epage%3D352%26doi%3D10.1016%2Fj.ejmech.2016.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Insights of a lead optimization study and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma (ERRgamma) inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10209</span>– <span class="NLM_lpage">10227</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01204</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01204" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10209-10227&author=J.+Kimauthor=S.+Y.+Wooauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=S.+Leeauthor=H.+J.+Kimauthor=H.+J.+Hwangauthor=J.+H.+Choauthor=W.+S.+Leeauthor=H.+Yoonauthor=S.+Kimauthor=O.+B.+Kwonauthor=H.+Hwangauthor=K.+H.+Kimauthor=J.+H.+Jeonauthor=T.+D.+Singhauthor=S.+W.+Kimauthor=S.+Y.+Hwangauthor=H.+S.+Choiauthor=I.+K.+Leeauthor=S.+H.+Kimauthor=Y.+H.+Jeonauthor=J.+Chinauthor=S.+J.+Cho&title=Insights+of+a+lead+optimization+study+and+biological+evaluation+of+novel+4-hydroxytamoxifen+analogs+as+estrogen-related+receptor+gamma+%28ERRgamma%29+inverse+agonists&doi=10.1021%2Facs.jmedchem.6b01204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01204%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DHwang%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DW.%2BS.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DO.%2BB.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DSingh%26aufirst%3DT.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DHwang%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DInsights%2520of%2520a%2520lead%2520optimization%2520study%2520and%2520biological%2520evaluation%2520of%2520novel%25204-hydroxytamoxifen%2520analogs%2520as%2520estrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10209%26epage%3D10227%26doi%3D10.1021%2Facs.jmedchem.6b01204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span> <span> </span><span class="NLM_article-title">Identification of novel inverse agonists of estrogen-related receptors ERRgamma and ERRbeta</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1585</span>– <span class="NLM_lpage">1599</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.bmc.2017.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1585-1599&author=D.+D.+Yuauthor=J.+M.+Hussauthor=H.+Liauthor=B.+M.+Forman&title=Identification+of+novel+inverse+agonists+of+estrogen-related+receptors+ERRgamma+and+ERRbeta&doi=10.1016%2Fj.bmc.2017.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DD.%2BD.%26aulast%3DHuss%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DForman%26aufirst%3DB.%2BM.%26atitle%3DIdentification%2520of%2520novel%2520inverse%2520agonists%2520of%2520estrogen-related%2520receptors%2520ERRgamma%2520and%2520ERRbeta%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1585%26epage%3D1599%26doi%3D10.1016%2Fj.bmc.2017.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera--a visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%2D%2Da+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0li6deEmPTFfGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera--a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbrecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1594</span>– <span class="NLM_lpage">1604</span>, <span class="refDoi"> DOI: 10.1210/mend.12.10.0176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fmend.12.10.0176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9773982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1594-1604&author=G.+Zhouauthor=R.+Cummingsauthor=Y.+Liauthor=S.+Mitraauthor=H.+A.+Wilkinsonauthor=A.+Elbrechtauthor=J.+D.+Hermesauthor=J.+M.+Schaefferauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Nuclear+receptors+have+distinct+affinities+for+coactivators%3A+characterization+by+fluorescence+resonance+energy+transfer&doi=10.1210%2Fmend.12.10.0176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer</span></div><div class="casAuthors">Zhou, Gaochao; Cummings, Richard; Li, Ying; Mitra, Sudha; Wilkinson, Hilary A.; Elbrecht, Alex; Hermes, Jeffrey D.; Schaeffer, James M.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1594-1604</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Ligand-dependent interactions between nuclear receptors and members of a family of nuclear receptor coactivators are assocd. with transcriptional activation.  Here we used fluorescence resonance energy transfer (FRET) as an approach for detecting and quantitating such interactions.  Using the ligand-binding domain (LBD) of peroxisome proliferator-activated receptor (PPARγ) as a model, known agonists (thiazolidinediones and Δ12, 14-PGJ2) induced a specific interaction resulting in FRET between the fluorescently labeled LBD and fluorescently labeled coactivators [CREB-binding protein (CBP) or steroid receptor coactivator-1 (SRC-1)].  Specific energy transfer was dose dependent; individual ligands displayed distinct potency and maximal FRET profiles that were identical when results obtained using CBP vs, SRC-1 were compared.  In addn., half-maximally effective agonist concns. (EC50s) correlated well with reported results using cell-based assays.  A site-directed AF2 mutant of PPARγ (E471A) that abrogated ligand-stimulated transcription in transfected cells also failed to induce ligand-mediated FRET between PPARγ LBD and CBP or SRC-1.  Using estrogen receptor (ERα) as an alternative system, known agonists induced an interaction between ERα LBD and SRC-1, whereas ER antagonists disrupted agonist-induced interaction of ERα with SRC-1.  In the presence of satg. agonist concns., unlabeled CBP or SRC-1 was used to compete with fluorescently labeled coactivators with satn. kinetics.  Relative affinities for the individual receptor-coactivator pairs were detd. as follows: PPARγ-CBP = ERα-SRC-1 > PPARγ-SRC-1 » ERα-CBP.  Conclusions: (1) FRET-based coactivator assocn. is a novel approach for characterizing nuclear receptor agonists or antagonists; individual ligands display potencies that are predictive of in vivo effects and distinct profiles of maximal activity that are suggestive of alternative receptor conformations.  (2) PPARγ interacts with both CBP and SRC-1; transcriptional activation and coactivator assocn. are AF2 dependent.  (3) Nuclear receptor LBDs have distinct affinities for individual coactivators; thus, PPARγ has a greater apparent affinity for CBP than for SRC-1, whereas ERα interacts preferentially with SRC-1 but very weakly with CBP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOGCfAfDEUrVg90H21EOLACvtfcHk0li6deEmPTFfGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVygsbc%253D&md5=1e957630081a12560da5cce65838cd44</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.10.0176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.10.0176%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DH.%2BA.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DHermes%26aufirst%3DJ.%2BD.%26aulast%3DSchaeffer%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNuclear%2520receptors%2520have%2520distinct%2520affinities%2520for%2520coactivators%253A%2520characterization%2520by%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26spage%3D1594%26epage%3D1604%26doi%3D10.1210%2Fmend.12.10.0176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puigserver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">839</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81410-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS0092-8674%2800%2981410-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9529258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXit1Klsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=829-839&author=P.+Puigserverauthor=Z.+Wuauthor=C.+W.+Parkauthor=R.+Gravesauthor=M.+Wrightauthor=B.+M.+Spiegelman&title=A+cold-inducible+coactivator+of+nuclear+receptors+linked+to+adaptive+thermogenesis&doi=10.1016%2FS0092-8674%2800%2981410-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</span></div><div class="casAuthors">Puigserver, Pere; Wu, Zhidan; Park, Cheol Won; Graves, Reed; Wright, Margaret; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-839</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Adaptive thermogenesis is an important component of energy homeostasis and a metabolic defense against obesity.  The authors have cloned a novel transcriptional coactivator of nuclear receptors, termed PGC-1, from a brown fat cDNA library.  PGC-1 mRNA expression is dramatically elevated upon cold exposure of mice in both brown fat and skeletal muscle, key thermogenic tissues.  PGC-1 greatly increases the transcriptional activity of PPARγ and the thyroid hormone receptor on the uncoupling protein (UCP-1) promoter.  Ectopic expression of PGC-1 in white adipose cells activates expression of UCP-1 and key mitochondrial enzymes of the respiratory chain, and increases the cellular content of mitochondrial DNA.  These results indicate that PGC-1 plays a key role in linking nuclear receptors to the transcriptional program of adaptive thermogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhppSLZixGbVg90H21EOLACvtfcHk0ljNQANloy6btA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1Klsb8%253D&md5=b05afec840c7adad534ddc943ad12d19</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981410-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981410-5%26sid%3Dliteratum%253Aachs%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DGraves%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DA%2520cold-inducible%2520coactivator%2520of%2520nuclear%2520receptors%2520linked%2520to%2520adaptive%2520thermogenesis%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D829%26epage%3D839%26doi%3D10.1016%2FS0092-8674%2800%2981410-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, M. A.</span></span> <span> </span><span class="NLM_article-title">Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1177/1087057103256466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1177%2F1087057103256466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=14567790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=381-392&author=X.+Wuauthor=J.+F.+Glickmanauthor=B.+R.+Bowenauthor=M.+A.+Sills&title=Comparison+of+assay+technologies+for+a+nuclear+receptor+assay+screen+reveals+differences+in+the+sets+of+identified+functional+antagonists&doi=10.1177%2F1087057103256466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists</span></div><div class="casAuthors">Wu, Xiang; Glickman, J. Fraser; Bowen, Benjamin R.; Sills, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-392</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Many assay technologies currently exist to develop high-throughput screening assays, and the no. of choices continues to increase.  Results from a previous study comparing assay technologies in our lab. do not support the common assumption that the same hits would be found regardless of which assay technol. is used.  To extend this investigation, a nuclear receptor antagonist assay was developed using 3 assay formats: AlphaScreen, time-resolved fluorescence (TRF), and time-resolved fluorescence resonance energy transfer (TR-FRET).  Compds. (∼42,000) from the Novartis library were evaluated in all 3 assay formats.  A total of 128 compds. were evaluated in dose-response expts., and 109 compds. were confirmed active from all 3 formats.  The AlphaScreen, TRF, and TR-FRET assay technologies identified 104, 23, and 57 active compds., resp., with only 18 compds. active in all 3 assay formats.  A total of 128 compds. were evaluated in a cell-based functional assay, and 35 compds. demonstrated activity in this cellular assay.  Furthermore, 34, 11, and 16 hits that were originally identified in the dose-response expt. by AlphaScreen, TRF, and TR-FRET assay technologies, resp., were functionally active.  The results of the study indicated that AlphaScreen identified the greatest no. of functional antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYthpUUtzuxbVg90H21EOLACvtfcHk0ljNQANloy6btA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWrtLg%253D&md5=a9410d694c8eabf149280d8fe9fb9ca1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1177%2F1087057103256466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103256466%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBowen%26aufirst%3DB.%2BR.%26aulast%3DSills%26aufirst%3DM.%2BA.%26atitle%3DComparison%2520of%2520assay%2520technologies%2520for%2520a%2520nuclear%2520receptor%2520assay%2520screen%2520reveals%2520differences%2520in%2520the%2520sets%2520of%2520identified%2520functional%2520antagonists%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D381%26epage%3D392%26doi%3D10.1177%2F1087057103256466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinshuo  Tang</span>, <span class="hlFld-ContribAuthor ">Tong  Liu</span>, <span class="hlFld-ContribAuthor ">Xinggui  Wen</span>, <span class="hlFld-ContribAuthor ">Zhongsheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Jingtong  Yan</span>, <span class="hlFld-ContribAuthor ">Jianpeng  Gao</span>, <span class="hlFld-ContribAuthor ">Jianlin  Zuo</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine</span><span> <strong>2021,</strong> <em>27 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s10020-021-00270-x" title="DOI URL">https://doi.org/10.1186/s10020-021-00270-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s10020-021-00270-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs10020-021-00270-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%26atitle%3DEstrogen-related%252Breceptors%25253A%252Bnovel%252Bpotential%252Bregulators%252Bof%252Bosteoarthritis%252Bpathogenesis%26aulast%3DTang%26aufirst%3DJinshuo%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ki‐Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Don‐Kyu  Kim</span>, <span class="hlFld-ContribAuthor ">Soon‐Young  Na</span>, <span class="hlFld-ContribAuthor ">Yoon Seok  Jung</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Jina  Kim</span>, <span class="hlFld-ContribAuthor ">In‐Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Young‐Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Chul‐Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Won‐Il  Jeong</span>, <span class="hlFld-ContribAuthor ">Eun‐Kyeong  Jo</span>, <span class="hlFld-ContribAuthor ">Hueng‐Sik  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Frontline Science: Estrogen‐related receptor γ increases poly(I:C)‐mediated type I IFN expression in mouse macrophages. </span><span class="cited-content_cbyCitation_journal-name">Journal of Leukocyte Biology</span><span> <strong>2021,</strong> <em>109 </em>
                                    (5)
                                     , 865-875. <a href="https://doi.org/10.1002/JLB.2HI1219-762R" title="DOI URL">https://doi.org/10.1002/JLB.2HI1219-762R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/JLB.2HI1219-762R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2FJLB.2HI1219-762R%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Leukocyte%2520Biology%26atitle%3DFrontline%252BScience%25253A%252BEstrogen%2525E2%252580%252590related%252Breceptor%252B%2525CE%2525B3%252Bincreases%252Bpoly%252528I%25253AC%252529%2525E2%252580%252590mediated%252Btype%252BI%252BIFN%252Bexpression%252Bin%252Bmouse%252Bmacrophages%26aulast%3DKim%26aufirst%3DKi%25E2%2580%2590Sun%26date%3D2021%26date%3D2020%26volume%3D109%26issue%3D5%26spage%3D865%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Tianmin  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Ma</span>, <span class="hlFld-ContribAuthor ">Weiqin  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.593479" title="DOI URL">https://doi.org/10.3389/fonc.2021.593479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.593479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.593479%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DSignal%252BPathway%252Bof%252BEstrogen%252Band%252BEstrogen%252BReceptor%252Bin%252Bthe%252BDevelopment%252Bof%252BThyroid%252BCancer%26aulast%3DLiu%26aufirst%3DJian%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Qi</span>, <span class="hlFld-ContribAuthor ">Shufeng  Gao</span>, <span class="hlFld-ContribAuthor ">Sihui  Nie</span>, <span class="hlFld-ContribAuthor ">Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Lingling  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Precise engineering of cetuximab encapsulated gadollium nanoassemblies:
              in vitro
              ultrasound diagnosis and
              in vivo
              thyroid cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Drug Delivery</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     , 569-579. <a href="https://doi.org/10.1080/10717544.2021.1889721" title="DOI URL">https://doi.org/10.1080/10717544.2021.1889721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10717544.2021.1889721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10717544.2021.1889721%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Delivery%26atitle%3DPrecise%252Bengineering%252Bof%252Bcetuximab%252Bencapsulated%252Bgadollium%252Bnanoassemblies%25253A%252Bin%2525C2%2525A0vitro%252Bultrasound%252Bdiagnosis%252Band%252Bin%2525C2%2525A0vivo%252Bthyroid%252Bcancer%252Btherapy%26aulast%3DQi%26aufirst%3DMing%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1%26spage%3D569%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jina  Kim</span>, <span class="hlFld-ContribAuthor ">Hayoung  Hwang</span>, <span class="hlFld-ContribAuthor ">Heeseok  Yoon</span>, <span class="hlFld-ContribAuthor ">Jae-Eon  Lee</span>, <span class="hlFld-ContribAuthor ">Ji Min  Oh</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Hyun Dong  Ji</span>, <span class="hlFld-ContribAuthor ">Seungmi  Lee</span>, <span class="hlFld-ContribAuthor ">Eunju  Cha</span>, <span class="hlFld-ContribAuthor ">Min Jung  Ma</span>, <span class="hlFld-ContribAuthor ">Dong-Su  Kim</span>, <span class="hlFld-ContribAuthor ">Su-Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Tara Man  Kadayat</span>, <span class="hlFld-ContribAuthor ">Jaeyoung  Song</span>, <span class="hlFld-ContribAuthor ">Sang Woo  Lee</span>, <span class="hlFld-ContribAuthor ">Jae-Han  Jeon</span>, <span class="hlFld-ContribAuthor ">Keun-Gyu  Park</span>, <span class="hlFld-ContribAuthor ">In-Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Hyun  Jeon</span>, <span class="hlFld-ContribAuthor ">Jungwook  Chin</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112501. <a href="https://doi.org/10.1016/j.ejmech.2020.112501" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112501%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Borally%252Bavailable%252Binverse%252Bagonist%252Bof%252Bestrogen-related%252Breceptor%252Bgamma%252Bshowed%252Bexpanded%252Befficacy%252Bfor%252Bthe%252Bradioiodine%252Btherapy%252Bof%252Bpoorly%252Bdifferentiated%252Bthyroid%252Bcancer%26aulast%3DKim%26aufirst%3DJina%26date%3D2020%26volume%3D205%26spage%3D112501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamalakannan  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Yong-Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon Seok  Jung</span>, <span class="hlFld-ContribAuthor ">Jina  Kim</span>, <span class="hlFld-ContribAuthor ">Don-Kyu  Kim</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>, <span class="hlFld-ContribAuthor ">In-Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Steven  Dooley</span>, <span class="hlFld-ContribAuthor ">Chul-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Hueng-Sik  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Orphan Nuclear Receptor ERRγ Is a Novel Transcriptional Regulator of IL-6 Mediated Hepatic BMP6 Gene Expression in Mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7148. <a href="https://doi.org/10.3390/ijms21197148" title="DOI URL">https://doi.org/10.3390/ijms21197148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197148%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DOrphan%252BNuclear%252BReceptor%252BERR%2525CE%2525B3%252BIs%252Ba%252BNovel%252BTranscriptional%252BRegulator%252Bof%252BIL-6%252BMediated%252BHepatic%252BBMP6%252BGene%252BExpression%252Bin%252BMice%26aulast%3DRadhakrishnan%26aufirst%3DKamalakannan%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongping  Li</span>, <span class="hlFld-ContribAuthor ">Yingchun  Cai</span>, <span class="hlFld-ContribAuthor ">Dan  Teng</span>, <span class="hlFld-ContribAuthor ">Zengrui  Wu</span>, <span class="hlFld-ContribAuthor ">Weihua  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Guixia  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the interaction mechanisms of estrogen-related receptor alpha (ERRα) with ligands via molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (13)
                                     , 3867-3878. <a href="https://doi.org/10.1080/07391102.2019.1666034" title="DOI URL">https://doi.org/10.1080/07391102.2019.1666034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1666034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1666034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DInsights%252Binto%252Bthe%252Binteraction%252Bmechanisms%252Bof%252Bestrogen-related%252Breceptor%252Balpha%252B%252528ERR%2525CE%2525B1%252529%252Bwith%252Bligands%252Bvia%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DLi%26aufirst%3DDongping%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D13%26spage%3D3867%26epage%3D3878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiharu  Iwamatsu</span>, <span class="hlFld-ContribAuthor ">Daichi  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Tomomi  Kono</span>, <span class="hlFld-ContribAuthor ">Ayaka  Honjo</span>, <span class="hlFld-ContribAuthor ">Saki  Ishizaki</span>, <span class="hlFld-ContribAuthor ">Shigeto  Hirayama</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Gouda</span>, <span class="hlFld-ContribAuthor ">Hideaki  Fujii</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 3792. <a href="https://doi.org/10.3390/molecules25173792" title="DOI URL">https://doi.org/10.3390/molecules25173792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25173792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25173792%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEffects%252Bof%252BN-Substituents%252Bon%252Bthe%252BFunctional%252BActivities%252Bof%252BNaltrindole%252BDerivatives%252Bfor%252Bthe%252B%2525CE%2525B4%252BOpioid%252BReceptor%25253A%252BSynthesis%252Band%252BEvaluation%252Bof%252BSulfonamide%252BDerivatives%26aulast%3DIwamatsu%26aufirst%3DChiharu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dylan  Chew</span>, <span class="hlFld-ContribAuthor ">Victoria  Green</span>, <span class="hlFld-ContribAuthor ">Andrew  Riley</span>, <span class="hlFld-ContribAuthor ">Richard James  England</span>, <span class="hlFld-ContribAuthor ">John  Greenman</span>. </span><span class="cited-content_cbyCitation_article-title">The Changing Face of in vitro Culture Models for Thyroid Cancer Research: A Systematic Literature Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Surgery</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fsurg.2020.00043" title="DOI URL">https://doi.org/10.3389/fsurg.2020.00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fsurg.2020.00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffsurg.2020.00043%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Surgery%26atitle%3DThe%252BChanging%252BFace%252Bof%252Bin%252Bvitro%252BCulture%252BModels%252Bfor%252BThyroid%252BCancer%252BResearch%25253A%252BA%252BSystematic%252BLiterature%252BReview%26aulast%3DChew%26aufirst%3DDylan%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the three previously disclosed estrogen-related receptor-γ (ERRγ) inverse agonists: GSK5182 (<b>1</b>), a selective ERRγ inverse agonist; 4-hydroxytamoxifen (4-OHT, <b>2</b>), an estrogen receptor α (ERα) antagonist/ERRγ inverse agonist; and DY40 (<b>3</b>), a potent ERRγ inverse agonist with mixed ERRγ/ERRβ functional activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4</b>–<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF)/H<sub>2</sub>O (2:1), 45 °C, 5–79%; (b) LiAlH<sub>4</sub> or diisobutylaluminium hydride (DIBAL-H) or LiBH<sub>4</sub>, tetrahydrofuran (THF), 0 °C, 10–98%; (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 39–99%; and (e) Zn, NH<sub>4</sub>Cl, MeOH/THF (1:1), 100%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>19</b>–<b>22</b> and <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH(OAc)<sub>3</sub> or NaBH<sub>3</sub>CN, acetic acid, ketones, 1,2-dichloroethane (DCE) or THF/MeOH, rt, 37%–quant.; (b) LiAlH<sub>4</sub>, THF, 0 °C, 12–53%; (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (d) bis-Boc-thiourea, triethylamine (TEA), HgCl<sub>2</sub>, DMF, 0 °C, 36%; and (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, quant.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23</b>–<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Hünig’s base or TEA, <i>R</i>-sulfonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4–40% and (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>26</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) acetic anhydride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 7%; (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C; (c) <i>R</i>-sulfonyl chloride, TEA or pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 17–26%; (d) bis-Boc-thiourea, TEA, HgCl<sub>2</sub>, DMF, 84%; and (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 9%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>31</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) pivaloyl chloride, TEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8–72% and (b) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>34</b>–<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 45 °C, 2–28%; (b) LiAlH<sub>4</sub> or DIBAL-H THF, 0 °C, 17–94%; and (c) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>37</b>–<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodobenzene, PdCl<sub>2</sub>(PhCN)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 45 °C, 24–29%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 98–100%; (c) NaBH(OAc)<sub>3</sub>, acetic acid, acetone, DCE, 60 °C, rt, 62%; (d) LiAlH<sub>4</sub>, THF, 0 °C, 35–36%; and (e) 1 M HCl in H<sub>2</sub>O, MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 0 °C.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Increased radioiodine avidity by compound <b>35</b> in CAL62 and BHT101 cells. (A, B) <sup>125</sup>I uptake assay in compound <b>35</b>-treated cells. (C, D) Inhibition study with 300 μM KClO<sub>4</sub> in compound <b>35</b>-treated cells. Each cell line was incubated with compound <b>35</b> for 24 h, and radioiodine uptake was conducted. For inhibition study, the compound <b>35</b>-treated cell line was further incubated with KClO<sub>4</sub> for 30 min, followed by radioiodine uptake. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Upregulation of protein expression of iodide-handling genes by compound <b>35</b> in CAL62 and BHT101 cells and enhanced cytotoxic effects of radioiodine therapy. mRNA expression levels of <i>NIS</i>, <i>TPO</i>, <i>TG</i>, and <i>TSHR</i> in <b>35</b>-treated (A) CAL62 cells and (B) BHT101 cells. (C) Dose-dependent change in NIS, TSHR, TG, and TPO proteins in <b>35</b>-treated CAL62 and BHT101 cells. (D) Membranous NIS protein expression in <b>35</b>-treated CAL62 and BHT101 cells. (E) Time-dependent change in the protein expression of iodide-handling genes in compound <b>35</b>-treated CAL62 and BHT101 cells. Each cell line was incubated with compound <b>35</b> for 24 h, and RNA and protein samples were prepared for real-time PCR and western blotting analysis. (F) Clonogenic assay showing enhanced cytotoxicity of <sup>131</sup>I by compound <b>35</b> in CAL62 and BHT101 cells. Cells were pretreated with compound <b>35</b> for 24 h, followed by incubation with <sup>131</sup>I for 6 h. Colonies were stained with 0.1% crystal violet solution, and the number of colonies was counted. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, *** <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Restoration of radioiodine avidity in CAL62 tumors in response to compound <b>35</b> treatment. (A) Schematic for <sup>124</sup>I-PET/CT imaging. Prior to compound <b>35</b> treatment of tumor-bearing mice, <sup>124</sup>I-PET/CT imaging was performed to determine the basal uptake of radioiodine in CAL62 tumors. After image acquisition, CAL62-tumor-bearing mice received either vehicle or 200 mg/kg compound <b>35</b> via oral administration once a day for 6 days. After the last treatment, PET/CT imaging was performed to determine the change in radioiodine avidity in tumors. (B, C) Three-dimensional (3D)-reconstructed <sup>124</sup>I-PET/CT images of increased radioiodine avidity in CAL62 tumors following compound <b>35</b> treatment (left panel). Quantification of radioactivity in tumors of vehicle- or compound <b>35</b>-treated mice before and after treatment (right panel). The red arrow indicates the tumor. * <i>P</i> < 0.05, NS; not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/medium/jm-2018-01296x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of the ERRγ and compound <b>35</b> complex (Protein Data Bank (PDB) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01296/20190221/images/large/jm-2018-01296x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01296&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors, RXR, and the big bang</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.cell.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=24679540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVCqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=255-266&author=R.+M.+Evansauthor=D.+J.+Mangelsdorf&title=Nuclear+receptors%2C+RXR%2C+and+the+big+bang&doi=10.1016%2Fj.cell.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Receptors, RXR, and the Big Bang</span></div><div class="casAuthors">Evans, Ronald M.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Isolation of genes encoding the receptors for steroids, retinoids, vitamin D, and thyroid hormone and their structural and functional anal. revealed an evolutionarily conserved template for nuclear hormone receptors.  This discovery sparked identification of numerous genes encoding related proteins, termed orphan receptors.  Characterization of these orphan receptors and, in particular, of the retinoid X receptor (RXR) positioned nuclear receptors at the epicenter of the "Big Bang" of mol. endocrinol.  This Review provides a personal perspective on nuclear receptors and explores their integrated and coordinated signaling networks that are essential for multicellular life, highlighting the RXR heterodimer and its assocd. ligands and transcriptional mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKjt1n6i7YYbVg90H21EOLACvtfcHk0lglRM44bXJa8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVCqsLw%253D&md5=875fafc223c6585cf3494d3559357a4f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%252C%2520RXR%252C%2520and%2520the%2520big%2520bang%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D255%26epage%3D266%26doi%3D10.1016%2Fj.cell.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear hormone receptors and gene expression</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1152/physrev.2001.81.3.1269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1152%2Fphysrev.2001.81.3.1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=11427696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Ohsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=1269-1304&author=A.+Arandaauthor=A.+Pascual&title=Nuclear+hormone+receptors+and+gene+expression&doi=10.1152%2Fphysrev.2001.81.3.1269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear hormone receptors and gene expression</span></div><div class="casAuthors">Aranda, Ana; Pascual, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1269-1304</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 324 refs.  The nuclear hormone receptor superfamily includes receptors for thyroid and steroid hormones, retinoids and vitamin D, as well as different orphan receptors of unknown ligand.  Ligands for some of these receptors have been recently identified, showing that products of lipid metab. such as fatty acids, prostaglandins, or cholesterol derivs. can regulate gene expression by binding to nuclear receptors.  Nuclear receptors act as ligand-inducible transcription factors by directly interacting as monomers, homodimers, or heterodimers with the retinoid X receptor with DNA response elements of target genes, as well as by cross-talking to other signaling pathways.  The effects of nuclear receptors on transcription are mediated through recruitment of coregulators.  A subset of receptors binds corepressor factors and actively represses target gene expression in the absence of ligand.  Corepressors are found within multicomponent complexes that contain histone deacetylase activity.  Deacetylation leads to chromatin compaction and transcriptional repression.  Upon ligand binding the receptors undergo a conformational change that allows the recruitment of multiple coactivator complexes.  Some of these proteins are chromatin remodeling factors or possess histone acetylase activity whereas others may interact directly with the basic transcriptional machinery.  Recruitment of coactivator complexes to the target promoter causes chromatin decompaction and transcriptional activation.  The characterization of corepressor and coactivator complexes, in concert with the identification of the.  Specific interaction motifs in the receptors, has demonstrated the existence of a general mol. mechanism by which different receptors elicit their transcriptional responses in target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXwaaEFtzqhLVg90H21EOLACvtfcHk0lglRM44bXJa8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Ohsrs%253D&md5=67ea9f6274b2a19bce09dd1c83a5f839</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.3.1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.3.1269%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DA.%26atitle%3DNuclear%2520hormone%2520receptors%2520and%2520gene%2520expression%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D1269%26epage%3D1304%26doi%3D10.1152%2Fphysrev.2001.81.3.1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0lglRM44bXJa8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid-related orphan receptor RORbeta, circadian rhythm abnormalities and tumorigenesis (Review)</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2015.2155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3892%2Fijmm.2015.2155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=25816151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eitLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1493-1500&author=S.+Fengauthor=S.+Xuauthor=Z.+Wenauthor=Y.+Zhu&title=Retinoic+acid-related+orphan+receptor+RORbeta%2C+circadian+rhythm+abnormalities+and+tumorigenesis+%28Review%29&doi=10.3892%2Fijmm.2015.2155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review)</span></div><div class="casAuthors">Feng, Shujiong; Xu, Song; Wen, Zhenzhen; Zhu, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Nuclear receptors are a superfamily of transcription factors including the steroid hormone receptors, non-steroid hormone receptors and the orphan nuclear receptor family.  Retinoic acid-related orphan receptor (ROR)β, as a member of the orphan nuclear receptor family, plays an important regula-tory role in the maintenance of a variety of physiol. and pathol. processes.  RORI3 has been detd. to act as an osteogenic repressor in regulating bone formation, and is involved in regulating circadian rhythm.  The findings of recent studies concerning the assocn. between tumorigenesis and circadian rhythm have shown that an aberrant circadian rhythm may promote tumorigenesis and tumor progression.  The mechanisms discussed in this review demonstrate how aberrant RORβ-induced circadian rhythm may become a new direction for future studies on tumorigenesis and strategy design for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzI3oYhyHld7Vg90H21EOLACvtfcHk0ljGwoJrKrrHKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eitLvL&md5=ee44b76aa3fcea0343764f6d46b03836</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2015.2155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2015.2155%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DRetinoic%2520acid-related%2520orphan%2520receptor%2520RORbeta%252C%2520circadian%2520rhythm%2520abnormalities%2520and%2520tumorigenesis%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2015%26volume%3D35%26spage%3D1493%26epage%3D1500%26doi%3D10.3892%2Fijmm.2015.2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranhotra, H. S.</span></span> <span> </span><span class="NLM_article-title">The orphan estrogen-related receptor alpha and metabolic regulation: new frontiers</span>. <i>J. Recept. Signal Transduction</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.3109/10799893.2015.1024853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3109%2F10799893.2015.1024853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26037200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=565-568&author=H.+S.+Ranhotra&title=The+orphan+estrogen-related+receptor+alpha+and+metabolic+regulation%3A+new+frontiers&doi=10.3109%2F10799893.2015.1024853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan estrogen-related receptor alpha and metabolic regulation: new frontiers</span></div><div class="casAuthors">Ranhotra, Harmit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-568</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabolic homeostasis during long-term adaptation in animals is primarily achieved by controlling the expression of metabolic genes by a plethora of cellular transcription factors.  The nuclear receptor (NR) superfamily in eukaryotes is an assembly of diverse receptors working as transcriptional regulators of multiple genes.  The orphan estrogen-related receptor alpha (ERRα) is one such receptor of the NR superfamily with significant influence on numerous metabolic and other genes.  Although it is presently unknown as to which endogenous hormones or ligands activate ERRα, nevertheless it regulates a host of genes whose products participate in various metabolic pathways.  Studies over the years show new and interesting data that add to the growing knowledge on ERRα and metabolic regulation.  For instance, novel findings indicate existence of mTOR/ERRα regulatory axis and also that ERRα control PGC-1α expression which potentially have significant impact on cellular metab.  Data show that ERRα exerts its metabolic control by regulating the expression of SIRT5 that influences oxygen consumption and ATP generation.  Moreover, ERRα has a role in creatine and lactate uptake in skeletal muscle which is important towards energy generation and contraction.  This review is focused on the new insights gained into ERRα regulation of metab., networks and pathways that have important consequences in maintaining metabolic homeostasis including development of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE9kEODsXHf7Vg90H21EOLACvtfcHk0ljGwoJrKrrHKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbfO&md5=77824a440093411cc336cdef753e923e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3109%2F10799893.2015.1024853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2015.1024853%26sid%3Dliteratum%253Aachs%26aulast%3DRanhotra%26aufirst%3DH.%2BS.%26atitle%3DThe%2520orphan%2520estrogen-related%2520receptor%2520alpha%2520and%2520metabolic%2520regulation%253A%2520new%2520frontiers%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%26date%3D2015%26volume%3D35%26spage%3D565%26epage%3D568%26doi%3D10.3109%2F10799893.2015.1024853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. G.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3789</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2329-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1007%2Fs00018-016-2329-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=27544210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyksr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=3789-3800&author=K.+Yinauthor=A.+G.+Smith&title=Nuclear+receptor+function+in+skin+health+and+disease%3A+therapeutic+opportunities+in+the+orphan+and+adopted+receptor+classes&doi=10.1007%2Fs00018-016-2329-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes</span></div><div class="casAuthors">Yin, Kelvin; Smith, Aaron G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3789-3800</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The skin forms a vital barrier between an organism's external environment, providing protection from pathogens and numerous phys. and chem. threats.  Moreover, the intact barrier is essential to prevent water and electrolyte loss without which terrestrial life could not be maintained.  Accordingly, acute disruption of the skin through phys. or chem. trauma needs to be repaired timely and efficiently as sustained skin pathologies ranging from mild irritations and inflammation through to malignancy impact considerably on morbidity and mortality.  The Nuclear Hormone Receptor Family of transcriptional regulators has proven to be highly valuable targets for addressing a range of pathologies, including metabolic syndrome and cancer.  Indeed members of the classic endocrine sub-group, such as the glucocorticoid, retinoid, and Vitamin D receptors, represent mainstay treatment strategies for numerous inflammatory skin disorders, though side effects from prolonged use are common.  Emerging evidence has now highlighted important functional roles for nuclear receptors belonging to the adopted and orphan subgroups in skin physiol. and patho-physiol.  This review will focus on these subgroups and explore the current evidence that suggests these nuclear receptor hold great promise as future stand-alone or complementary drug targets in treating common skin diseases and maintaining skin homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprK9n3-jdJ9bVg90H21EOLACvtfcHk0ljGwoJrKrrHKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyksr%252FN&md5=75dd7e6c4466bdd61d64702dd8a6ce22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2329-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2329-4%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DA.%2BG.%26atitle%3DNuclear%2520receptor%2520function%2520in%2520skin%2520health%2520and%2520disease%253A%2520therapeutic%2520opportunities%2520in%2520the%2520orphan%2520and%2520adopted%2520receptor%2520classes%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D3789%26epage%3D3800%26doi%3D10.1007%2Fs00018-016-2329-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.</span>; <span class="NLM_string-name">Ye, X.</span>; <span class="NLM_string-name">Liao, D.</span>; <span class="NLM_string-name">Huang, S.</span>; <span class="NLM_string-name">Mao, H.</span>; <span class="NLM_string-name">Zhao, D.</span>; <span class="NLM_string-name">Zeng, H.</span></span>, <span> </span><span class="NLM_article-title">Orphan nuclear receptor TR3/Nur77 is a specific therapeutic target for hepatic cancers</span>.  <i>J. Clin. Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume">06</span> ().<span class="refDoi"> DOI: 10.4172/2324-9110.1000184</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.4172%2F2324-9110.1000184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=06&publication_year=2017&author=Y.+Zeng&author=X.+Ye&author=D.+Liao&author=S.+Huang&author=H.+Mao&author=D.+Zhao&author=H.+Zeng&title=Orphan+nuclear+receptor+TR3%2FNur77+is+a+specific+therapeutic+target+for+hepatic+cancers&doi=10.4172%2F2324-9110.1000184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4172%2F2324-9110.1000184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2324-9110.1000184%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DY.%26atitle%3DOrphan%2520nuclear%2520receptor%2520TR3%252FNur77%2520is%2520a%2520specific%2520therapeutic%2520target%2520for%2520hepatic%2520cancers%26jtitle%3DJ.%2520Clin.%2520Exp.%2520Oncol.%26date%3D2017%26volume%3D06%26doi%3D10.4172%2F2324-9110.1000184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor γt (RORγt) agonists as potential small molecule therapeutics for cancer immunotherapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Wnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5794-5804&author=R.+Qiuauthor=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+%28ROR%CE%B3t%29+agonists+as+potential+small+molecule+therapeutics+for+cancer+immunotherapy&doi=10.1021%2Facs.jmedchem.7b01314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy</span></div><div class="casAuthors">Qiu, Ruomeng; Wang, Yonghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5794-5804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer.  These results also encourage the development of small mol. immunomodulators for cancer immunotherapy.  RORγt is a key transcription factor mediating Th17 cell differentiation and IL-17 prodn., which is able to activate CD8+ T cells and elicit antitumor efficacy.  Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy.  In this review, we summarize RORγt sterol and synthetic agonists, analyze the common ground of their mode of actions, and discuss the potential role of RORγt agonists as small mol. therapeutics for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoubiR1DDmchLVg90H21EOLACvtfcHk0lhs3vTLgdjQMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Wnsb8%253D&md5=dff04c62af5effc6d400f8a57d20136b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01314%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520agonists%2520as%2520potential%2520small%2520molecule%2520therapeutics%2520for%2520cancer%2520immunotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5794%26epage%3D5804%26doi%3D10.1021%2Facs.jmedchem.7b01314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges for fatty acid mimetics in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5235</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1elsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5235-5266&author=E.+Proschakauthor=P.+Heitelauthor=L.+Kalinowskyauthor=D.+Merk&title=Opportunities+and+challenges+for+fatty+acid+mimetics+in+drug+discovery&doi=10.1021%2Facs.jmedchem.6b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery</span></div><div class="casAuthors">Proschak, Ewgenij; Heitel, Pascal; Kalinowsky, Lena; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5235-5266</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acids beyond their role as an endogenous energy source and storage are increasingly considered as signaling mols. regulating various physiol. effects in metab. and inflammation.  Accordingly, the mol. targets involved in formation and physiol. activities of fatty acids hold significant therapeutic potential.  A no. of these fatty acid targets are addressed by some of the oldest and most widely used drugs such as cyclooxygenase inhibiting NSAIDs, whereas others remain unexploited.  Compds. orthosterically binding to proteins that endogenously bind fatty acids are considered as fatty acid mimetics.  On the basis of their structural resemblance, fatty acid mimetics constitute a family of bioactive compds. showing specific binding thermodn. and following similar pharmacokinetic mechanisms.  This perspective systematically evaluates targets for fatty acid mimetics, investigates their common structural characteristics, and highlights demands in their discovery and design.  In summary, fatty acid mimetics share particularly favorable characteristics justifying the conclusion that their therapeutic potential vastly outweighs the challenges in their design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjMjaOmukt7bVg90H21EOLACvtfcHk0lhs3vTLgdjQMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1elsrw%253D&md5=78a3a6be0a9d9bfd672c5e851abffc3e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01287%26sid%3Dliteratum%253Aachs%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DOpportunities%2520and%2520challenges%2520for%2520fatty%2520acid%2520mimetics%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5235%26epage%3D5266%26doi%3D10.1021%2Facs.jmedchem.6b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razzaque, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osumi, T.</span></span> <span> </span><span class="NLM_article-title">Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2004.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.gene.2004.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=15475169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1yjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2004&pages=275-282&author=M.+A.+Razzaqueauthor=N.+Masudaauthor=Y.+Maedaauthor=Y.+Endoauthor=T.+Tsukamotoauthor=T.+Osumi&title=Estrogen+receptor-related+receptor+gamma+has+an+exceptionally+broad+specificity+of+DNA+sequence+recognition&doi=10.1016%2Fj.gene.2004.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor-related receptor γ has an exceptionally broad specificity of DNA sequence recognition</span></div><div class="casAuthors">Razzaque, Md. Abdur; Masuda, Nobuyuki; Maeda, Yusaku; Endo, Yaeta; Tsukamoto, Toshiro; Osumi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Estrogen receptor-related receptors (ERRs) constitute a subfamily of the nuclear hormone receptor superfamily.  ERRs are closely related to estrogen receptors (ERs), but apparently lack ligand dependence.  In this study, we cloned rat ERRγ as an interacting partner of an orphan nuclear receptor, small heterodimer partner (SHP).  ERRγ exhibited significant binding affinities with a wide spectrum of sequences: inverted and direct repeat motifs composed of AGGTCA half-sites with various spacings, as well as a monovalent motif of the same sequence carrying extra T(C/G)A trinucleotides on the 5' side.  On the other hand, inverted repeat spaced by three nucleotides was dominantly efficient for the binding of ERα.  These results were mostly consistent with those of gene reporter assays.  ERRγ bound as a homodimer to all binding sequences tested, including a monovalent binding site, and ERRγ did not heterodimerize with ERα.  Taken together, ERRγ recognizes a tremendously broad range of sequences as a homodimer.  Finally, we found that SHP efficiently represses the transcriptional activity of ERRγ, even at a far lower concn. than that of ERRγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgCZnXWOm_3bVg90H21EOLACvtfcHk0lhs3vTLgdjQMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1yjs7Y%253D&md5=6b058035e446c242e907799d908d69f7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2004.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2004.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaque%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DOsumi%26aufirst%3DT.%26atitle%3DEstrogen%2520receptor-related%2520receptor%2520gamma%2520has%2520an%2520exceptionally%2520broad%2520specificity%2520of%2520DNA%2520sequence%2520recognition%26jtitle%3DGene%26date%3D2004%26volume%3D340%26spage%3D275%26epage%3D282%26doi%3D10.1016%2Fj.gene.2004.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giguére, V.</span></span> <span> </span><span class="NLM_article-title">To ERR in the estrogen pathway</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/S1043-2760(02)00592-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS1043-2760%2802%2900592-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=12185669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=220-225&author=V.+Gigu%C3%A9re&title=To+ERR+in+the+estrogen+pathway&doi=10.1016%2FS1043-2760%2802%2900592-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">To ERR in the estrogen pathway</span></div><div class="casAuthors">Giguere, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">220-225</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Estrogens control a variety of physiol. and disease-linked processes, most notably reprodn., bone remodeling and breast cancer, and their effects are transduced through classic nuclear receptors referred to as estrogen receptor-α (ERα) and ERβ.  Recent results obtained using the estrogen-related receptors (ERRα, -β and -γ), a subfamily of orphan nuclear receptors closely related to the ERs, have shown that the ERRs share target genes, coregulatory proteins, ligands and sites of action with the ERs.  In addn., the ERRs can actively influence the estrogenic response, suggesting that pharmacol. modulation of ERR activity will be clin. useful to prevent and/or treat a variety of conditions related to women's health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGDkNFF4-jLVg90H21EOLACvtfcHk0lhkF2myTa_EiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVSmtbc%253D&md5=a38e3af2125515114e7536dd10047c9d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2802%2900592-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252802%252900592-1%26sid%3Dliteratum%253Aachs%26aulast%3DGigu%25C3%25A9re%26aufirst%3DV.%26atitle%3DTo%2520ERR%2520in%2520the%2520estrogen%2520pathway%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2002%26volume%3D13%26spage%3D220%26epage%3D225%26doi%3D10.1016%2FS1043-2760%2802%2900592-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, V.</span></span> <span> </span><span class="NLM_article-title">The NR3B subgroup: an overrview</span>. <i>Nucl. Recept. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e009</span> <span class="refDoi"> DOI: 10.1621/nrs.05009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1621%2Fnrs.05009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=18174917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&author=A.+M.+Tremblayauthor=V.+Giguere&title=The+NR3B+subgroup%3A+an+overrview&doi=10.1621%2Fnrs.05009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1621%2Fnrs.05009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.05009%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DA.%2BM.%26aulast%3DGiguere%26aufirst%3DV.%26atitle%3DThe%2520NR3B%2520subgroup%253A%2520an%2520overrview%26jtitle%3DNucl.%2520Recept.%2520Signaling%26date%3D2007%26volume%3D5%26doi%3D10.1621%2Fnrs.05009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norby, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissing, H.</span></span> <span> </span><span class="NLM_article-title">Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1210/mend.14.3.0431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fmend.14.3.0431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10707956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=382-392&author=D.+J.+Heardauthor=P.+L.+Norbyauthor=J.+Hollowayauthor=H.+Vissing&title=Human+ERRgamma%2C+a+third+member+of+the+estrogen+receptor-related+receptor+%28ERR%29+subfamily+of+orphan+nuclear+receptors%3A+tissue-specific+isoforms+are+expressed+during+development+and+in+the+adult&doi=10.1210%2Fmend.14.3.0431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult</span></div><div class="casAuthors">Heard, David J.; Norby, Peder L.; Holloway, Jim; Vissing, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-392</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The nuclear receptor protein superfamily is a large group of transcription factors involved in many aspects of animal development, tissue differentiation, and homeostasis in the higher eukaryotes.  A subfamily of receptors, ERRα and β (estrogen receptor-related receptor α and β), closely related to the ER, were among the first orphan nuclear receptors identified.  These receptors can bind DNA as monomers and are thought to activate transcription constitutively, unaffected by β-estradiol.  Studies of the expression patterns of ERRα and gene disruption expts. of ERRβ indicate that they play an important role in the development and differentiation of specific tissues in the mouse.  The authors demonstrate the existence in humans of a third member of this subfamily of receptors, termed ERRγ, which is highly expressed in a no. of diverse fetal and adult tissues including brain, kidney, pancreas, and placenta.  The ERRγ mRNA is highly alternatively spliced at the 5'-end, giving rise to a no. of tissue-specific RNA species, some of which code for protein isoforms differing in the N-terminal region.  Like ERRα and β, ERRγ binds as a monomer to an ERRE.  A GAL4-ERRγ fusion protein activates transcription in a ligand-independent manner in transfected HEK293 cells to a greater degree than either the GAL4-ERRα or -β fusion proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9jyjRg2ZayrVg90H21EOLACvtfcHk0lhkF2myTa_EiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFOqt70%253D&md5=d481b4678c899c40df620b193529aac4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fmend.14.3.0431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.14.3.0431%26sid%3Dliteratum%253Aachs%26aulast%3DHeard%26aufirst%3DD.%2BJ.%26aulast%3DNorby%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DJ.%26aulast%3DVissing%26aufirst%3DH.%26atitle%3DHuman%2520ERRgamma%252C%2520a%2520third%2520member%2520of%2520the%2520estrogen%2520receptor-related%2520receptor%2520%2528ERR%2529%2520subfamily%2520of%2520orphan%2520nuclear%2520receptors%253A%2520tissue-specific%2520isoforms%2520are%2520expressed%2520during%2520development%2520and%2520in%2520the%2520adult%26jtitle%3DMol.%2520Endocrinol.%26date%3D2000%26volume%3D14%26spage%3D382%26epage%3D392%26doi%3D10.1210%2Fmend.14.3.0431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallcup, M. R.</span></span> <span> </span><span class="NLM_article-title">Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">22618</span>– <span class="NLM_lpage">22626</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.32.22618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.274.32.22618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=22618-22626&author=H.+Hongauthor=L.+Yangauthor=M.+R.+Stallcup&title=Hormone-independent+transcriptional+activation+and+coactivator+binding+by+novel+orphan+nuclear+receptor+ERR3&doi=10.1074%2Fjbc.274.32.22618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.32.22618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.32.22618%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DHormone-independent%2520transcriptional%2520activation%2520and%2520coactivator%2520binding%2520by%2520novel%2520orphan%2520nuclear%2520receptor%2520ERR3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D22618%26epage%3D22626%26doi%3D10.1074%2Fjbc.274.32.22618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eudy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma-Edmonds, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talmadge, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimberling, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumegi, J.</span></span> <span> </span><span class="NLM_article-title">Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1006/geno.1998.5345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1006%2Fgeno.1998.5345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9676434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXks1Smtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=382-384&author=J.+D.+Eudyauthor=S.+Yaoauthor=M.+D.+Westonauthor=M.+Ma-Edmondsauthor=C.+B.+Talmadgeauthor=J.+J.+Chengauthor=W.+J.+Kimberlingauthor=J.+Sumegi&title=Isolation+of+a+gene+encoding+a+novel+member+of+the+nuclear+receptor+superfamily+from+the+critical+region+of+Usher+syndrome+type+IIa+at+1q41&doi=10.1006%2Fgeno.1998.5345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of usher syndrome type IIa at 1q41</span></div><div class="casAuthors">Eudy, James D.; Yao, SuFang; Weston, Michael D.; Ma-Edmonds, Manling; Talmadge, Catherine B.; Cheng, Jason J.; Kimberling, William J.; Sumegi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">382-384</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Usher syndrome is composed of a group of heterogeneous autosomal recessive disorders characterized by retinitis pigmentosa and moderate to severe congenital deafness.  Candidate exons, from cosmid subclones of YAC762a6, which extends into the USH2a crit. region, were isolated and used to screen for candidate cDNAs.  A cDNA encoding the orphan receptor estrogen-related receptor-γ ESRRG was isolated and sequenced.  However, no mutations were obsd. within this gene and it is highly unlikely that ESRRG is the USH2a gene.  Three overlapping ESTs were also detected.  High expression of ESRRG in human fetal brain was detected as compared to adult brain, suggesting that the gene may be important in embryonic CNS development.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Kd8wQMZZ2bVg90H21EOLACvtfcHk0liZlQBn_PmbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1Smtb8%253D&md5=ec30a97dbba1340d2455d089c1a11158</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1998.5345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1998.5345%26sid%3Dliteratum%253Aachs%26aulast%3DEudy%26aufirst%3DJ.%2BD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DWeston%26aufirst%3DM.%2BD.%26aulast%3DMa-Edmonds%26aufirst%3DM.%26aulast%3DTalmadge%26aufirst%3DC.%2BB.%26aulast%3DCheng%26aufirst%3DJ.%2BJ.%26aulast%3DKimberling%26aufirst%3DW.%2BJ.%26aulast%3DSumegi%26aufirst%3DJ.%26atitle%3DIsolation%2520of%2520a%2520gene%2520encoding%2520a%2520novel%2520member%2520of%2520the%2520nuclear%2520receptor%2520superfamily%2520from%2520the%2520critical%2520region%2520of%2520Usher%2520syndrome%2520type%2520IIa%2520at%25201q41%26jtitle%3DGenomics%26date%3D1998%26volume%3D50%26spage%3D382%26epage%3D384%26doi%3D10.1006%2Fgeno.1998.5345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segui, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span> <span> </span><span class="NLM_article-title">Identification of a new class of steroid hormone receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1038/331091a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1038%2F331091a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=3267207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaL1cXktVWlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=91-94&author=V.+Gigu%C3%A8reauthor=N.+Yangauthor=P.+Seguiauthor=R.+M.+Evans&title=Identification+of+a+new+class+of+steroid+hormone+receptors&doi=10.1038%2F331091a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new class of steroid hormone receptors</span></div><div class="casAuthors">Giguere, Vincent; Yang, Na; Segui, Prudimar; Evans, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">6151</span>),
    <span class="NLM_cas:pages">91-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The DNA-binding domain of the human estrogen receptor was used as a probe to isolate cDNA clones encoding 2 polypeptides with structural features suggestive of cryptic steroid hormone receptors from a new potential hormone response system.  The cDNA clones were sequenced and encoded polypeptides of 57,300 mol. wt. and 47,600 mol. wt. designated hERR1 and hERR2, resp.  Using a cDNA clone as a probe, a 2.6-kb mRNA encoding hERR1 was detected in all rat and human tissues analyzed.  A 4.8-kb mRNA encoding hERR2 was found in rat kidney, heart, testis, hypothalamus, hippocampus, cerebellum, and prostate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCGqOjludiYbVg90H21EOLACvtfcHk0liZlQBn_PmbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktVWlsrY%253D&md5=f1f3aa150b6d929ffc29fb7cea002c89</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F331091a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F331091a0%26sid%3Dliteratum%253Aachs%26aulast%3DGigu%25C3%25A8re%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DSegui%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DIdentification%2520of%2520a%2520new%2520class%2520of%2520steroid%2520hormone%2520receptors%26jtitle%3DNature%26date%3D1988%26volume%3D331%26spage%3D91%26epage%3D94%26doi%3D10.1038%2F331091a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1074/jbc.M106140200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M106140200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=1739-1748&author=S.+Sanyalauthor=J.+Y.+Kimauthor=H.+J.+Kimauthor=J.+Takedaauthor=Y.+K.+Leeauthor=D.+D.+Mooreauthor=H.+S.+Choi&title=Differential+regulation+of+the+orphan+nuclear+receptor+small+heterodimer+partner+%28SHP%29+gene+promoter+by+orphan+nuclear+receptor+ERR+isoforms&doi=10.1074%2Fjbc.M106140200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106140200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106140200%26sid%3Dliteratum%253Aachs%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DTakeda%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DMoore%26aufirst%3DD.%2BD.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DDifferential%2520regulation%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520small%2520heterodimer%2520partner%2520%2528SHP%2529%2520gene%2520promoter%2520by%2520orphan%2520nuclear%2520receptor%2520ERR%2520isoforms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D1739%26epage%3D1748%26doi%3D10.1074%2Fjbc.M106140200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-S.</span></span> <span> </span><span class="NLM_article-title">An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">6756</span>– <span class="NLM_lpage">6768</span>, <span class="refDoi"> DOI: 10.1093/nar/gki976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1093%2Fnar%2Fgki976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=6756-6768&author=Y.-Y.+Parkauthor=S.-W.+Ahnauthor=H.-J.+Kimauthor=J.-M.+Kimauthor=I.-K.+Leeauthor=H.+Kangauthor=H.-S.+Choi&title=An+autoregulatory+loop+controlling+orphan+nuclear+receptor+DAX-1+gene+expression+by+orphan+nuclear+receptor+ERRgamma&doi=10.1093%2Fnar%2Fgki976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgki976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgki976%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.-Y.%26aulast%3DAhn%26aufirst%3DS.-W.%26aulast%3DKim%26aufirst%3DH.-J.%26aulast%3DKim%26aufirst%3DJ.-M.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.-S.%26atitle%3DAn%2520autoregulatory%2520loop%2520controlling%2520orphan%2520nuclear%2520receptor%2520DAX-1%2520gene%2520expression%2520by%2520orphan%2520nuclear%2520receptor%2520ERRgamma%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2005%26volume%3D33%26spage%3D6756%26epage%3D6768%26doi%3D10.1093%2Fnar%2Fgki976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">28762</span>– <span class="NLM_lpage">28774</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.034165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M109.034165" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=28762-28774&author=Y.+B.+Xieauthor=J.+H.+Parkauthor=D.+K.+Kimauthor=J.+H.+Hwangauthor=S.+Ohauthor=S.+B.+Parkauthor=M.+Shongauthor=I.+K.+Leeauthor=H.+S.+Choi&title=Transcriptional+corepressor+SMILE+recruits+SIRT1+to+inhibit+nuclear+receptor+estrogen+receptor-related+receptor+gamma+transactivation&doi=10.1074%2Fjbc.M109.034165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.034165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.034165%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BB.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DHwang%26aufirst%3DJ.%2BH.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DShong%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DTranscriptional%2520corepressor%2520SMILE%2520recruits%2520SIRT1%2520to%2520inhibit%2520nuclear%2520receptor%2520estrogen%2520receptor-related%2520receptor%2520gamma%2520transactivation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D28762%26epage%3D28774%26doi%3D10.1074%2Fjbc.M109.034165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dorsselaer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(02)00444-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS1097-2765%2802%2900444-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=11864604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=303-313&author=H.+Greschikauthor=J.+M.+Wurtzauthor=S.+Sanglierauthor=W.+Bourguetauthor=A.+van+Dorsselaerauthor=D.+Morasauthor=J.+P.+Renaud&title=Structural+and+functional+evidence+for+ligand-independent+transcriptional+activation+by+the+estrogen-related+receptor+3&doi=10.1016%2FS1097-2765%2802%2900444-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3</span></div><div class="casAuthors">Greschik, Holger; Wurtz, Jean-Marie; Sanglier, Sarah; Bourguet, William; Van Dorsselaer, Alain; Moras, Dino; Renaud, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-313</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The crystal structure of the ligand binding domain (LBD) of the estrogen-related receptor 3 (ERR3) complexed with a steroid receptor coactivator-1 (SRC-1) peptide reveals a transcriptionally active conformation in absence of any ligand.  The structure explains why estradiol does not bind ERRs with significant affinity.  Docking of the previously reported ERR antagonists, diethylstilbestrol and 4-hydroxytamoxifen, requires structural rearrangements enlarging the ligand binding pocket that can only be accommodated with an antagonist LBD conformation.  Mutant receptors in which the ligand binding cavity is filled up by bulkier side chains still interact with SRC-1 in vitro and are transcriptionally active in vivo, but are no longer efficiently inactivated by diethylstilbestrol or 4-hydroxytamoxifen.  These results provide structural and functional evidence for ligand-independent transcriptional activation by ERR3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZsRdHTpUyLVg90H21EOLACvtfcHk0liqtipJdnOxhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKhu7g%253D&md5=8b9efbe14fe050d9e2405911e602afa3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900444-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900444-6%26sid%3Dliteratum%253Aachs%26aulast%3DGreschik%26aufirst%3DH.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DSanglier%26aufirst%3DS.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3Dvan%2BDorsselaer%26aufirst%3DA.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRenaud%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520and%2520functional%2520evidence%2520for%2520ligand-independent%2520transcriptional%2520activation%2520by%2520the%2520estrogen-related%2520receptor%25203%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D9%26spage%3D303%26epage%3D313%26doi%3D10.1016%2FS1097-2765%2802%2900444-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Consler, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span> <span> </span><span class="NLM_article-title">X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">37773</span>– <span class="NLM_lpage">37781</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608410200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M608410200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16990259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KitrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=37773-37781&author=L.+Wangauthor=W.+J.+Zuercherauthor=T.+G.+Conslerauthor=M.+H.+Lambertauthor=A.+B.+Millerauthor=L.+A.+Orband-Millerauthor=D.+D.+McKeeauthor=T.+M.+Willsonauthor=R.+T.+Nolte&title=X-ray+crystal+structures+of+the+estrogen-related+receptor-gamma+ligand+binding+domain+in+three+functional+states+reveal+the+molecular+basis+of+small+molecule+regulation&doi=10.1074%2Fjbc.M608410200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Crystal Structures of the Estrogen-related Receptor-γ Ligand Binding Domain in Three Functional States Reveal the Molecular Basis of Small Molecule Regulation</span></div><div class="casAuthors">Wang, Liping; Zuercher, William J.; Consler, Thomas G.; Lambert, Millard H.; Miller, Aaron B.; Orband-Miller, Lisa A.; McKee, David D.; Willson, Timothy M.; Nolte, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">37773-37781</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">X-ray crystal structures of the ligand binding domain (LBD) of the estrogen-related receptor-γ (ERRγ) were detd. that describe this receptor in three distinct states: unliganded, inverse agonist bound, and agonist bound.  Two structures were solved for the unliganded state, the ERRγ LBD alone, and in complex with a coregulator peptide representing a portion of receptor interacting protein 140 (RIP140).  No significant differences were seen between these structures that both exhibited the conformation of ERRγ seen in studies with other coactivators.  Two structures were obtained describing the inverse agonist-bound state, the ERRγ LBD with 4-hydroxytamoxifen (4-OHT), and the ERRγ LBD with 4-OHT and a peptide representing a portion of the silencing mediator of retinoid and thyroid hormone action protein (SMRT).  The 4-OHT structure was similar to other reported inverse agonist bound structures, showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix relative to the unliganded structures with little other rearrangement occurring.  No significant changes to the LBD appear to be induced by peptide binding with the addn. of the SMRT peptide to the ERRγ plus 4-OHT complex.  The obsd. agonist-bound state contains the ERRγ LBD, a ligand (GSK4716), and the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding residues.  Thermal stability studies show that agonist binding leads to global stabilization of the ligand binding domain.  In contrast to the conventional mechanism of nuclear receptor ligand activation, activation of ERRγ by GSK4716 does not appear to involve a major rearrangement or significant stabilization of the C-terminal helix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9AW_0RzftrVg90H21EOLACvtfcHk0liqtipJdnOxhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KitrfF&md5=913262d27de1430491479c294a71b3ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608410200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608410200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DConsler%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DMcKee%26aufirst%3DD.%2BD.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DX-ray%2520crystal%2520structures%2520of%2520the%2520estrogen-related%2520receptor-gamma%2520ligand%2520binding%2520domain%2520in%2520three%2520functional%2520states%2520reveal%2520the%2520molecular%2520basis%2520of%2520small%2520molecule%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D37773%26epage%3D37781%26doi%3D10.1074%2Fjbc.M608410200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bookout, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span> <span> </span><span class="NLM_article-title">Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.cell.2006.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16923397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1akurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=789-799&author=A.+L.+Bookoutauthor=Y.+Jeongauthor=M.+Downesauthor=R.+T.+Yuauthor=R.+M.+Evansauthor=D.+J.+Mangelsdorf&title=Anatomical+profiling+of+nuclear+receptor+expression+reveals+a+hierarchical+transcriptional+network&doi=10.1016%2Fj.cell.2006.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network</span></div><div class="casAuthors">Bookout, Angie L.; Jeong, Yangsik; Downes, Michael; Yu, Ruth T.; Evans, Ronald M.; Mangelsdorf, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">789-799</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In multicellular organisms, the ability to regulate reprodn., development, and nutrient utilization coincided with the evolution of nuclear receptors (NRs), transcription factors that utilize lipophilic ligands to mediate their function.  Studying the expression profile of NRs offers a simple, powerful way to obtain highly relational information about their physiol. functions as individual proteins and as a superfamily.  We surveyed the expression of all 49 mouse NR mRNAs in 39 tissues, representing diverse anatomical systems.  The resulting data set uncovers several NR clades whose patterns of expression indicate their ability to coordinate the transcriptional programs necessary to affect distinct physiol. pathways.  Remarkably, this regulatory network divides along the following two physiol. paradigms: (1) reprodn., development, and growth and (2) nutrient uptake, metab., and excretion.  These data reveal a hierarchical transcriptional circuitry that extends beyond individual tissues to form a meganetwork governing physiol. on an organismal scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqogrckvFPX1bVg90H21EOLACvtfcHk0lh9KS5y0YcFHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1akurs%253D&md5=446a873e2349d62a2fc74fa35f68df70</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DBookout%26aufirst%3DA.%2BL.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26atitle%3DAnatomical%2520profiling%2520of%2520nuclear%2520receptor%2520expression%2520reveals%2520a%2520hierarchical%2520transcriptional%2520network%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D789%26epage%3D799%26doi%3D10.1016%2Fj.cell.2006.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alaynick, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remlinger, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A. N.</span></span> <span> </span><span class="NLM_article-title">ERRgamma regulates cardiac, gastric, and renal potassium homeostasis</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fme.2009-0114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19965931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=299-309&author=W.+A.+Alaynickauthor=J.+M.+Wayauthor=S.+A.+Wilsonauthor=W.+G.+Bensonauthor=L.+Peiauthor=M.+Downesauthor=R.+Yuauthor=J.+W.+Jonkerauthor=J.+A.+Holtauthor=D.+K.+Rajpalauthor=H.+Liauthor=J.+Stuartauthor=R.+McPhersonauthor=K.+S.+Remlingerauthor=C.+Y.+Changauthor=D.+P.+McDonnellauthor=R.+M.+Evansauthor=A.+N.+Billin&title=ERRgamma+regulates+cardiac%2C+gastric%2C+and+renal+potassium+homeostasis&doi=10.1210%2Fme.2009-0114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">ERRγ regulates cardiac, gastric, and renal potassium homeostasis</span></div><div class="casAuthors">Alaynick, William A.; Way, James M.; Wilson, Stephanie A.; Benson, William G.; Pei, Liming; Downes, Michael; Yu, Ruth; Jonker, Johan W.; Holt, Jason A.; Rajpal, Deepak K.; Li, Hao; Stuart, Joan; McPherson, Ruth; Remlinger, Katja S.; Chang, Ching-Yi; McDonnell, Donald P.; Evans, Ronald M.; Billin, Andrew N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Energy prodn. by oxidative metab. in kidney, stomach, and heart, is primarily expended in establishing ion gradients to drive renal electrolyte homeostasis, gastric acid secretion, and cardiac muscle contraction, resp.  In addn. to orchestrating transcriptional control of oxidative metab., the orphan nuclear receptor, estrogen-related receptor γ (ERRγ), coordinates expression of genes central to ion homeostasis in oxidative tissues.  Renal, gastric, and cardiac tissues subjected to genomic anal. of expression in perinatal ERRγ null mice revealed a characteristic dysregulation of genes involved in transport processes, exemplified by the voltage-gated potassium channel, Kcne2.  Consistently, ERRγ null animals die during the first 72 h of life with elevated serum potassium, redns. in key gastric acid prodn. markers, and cardiac arrhythmia with prolonged QT intervals.  In addn., we find altered expression of several genes assocd. with hypertension in ERRγ null mice.  These findings suggest a potential role for genetic polymorphisms at the ERRγ locus and ERRγ modulators in the etiol. and treatment of renal, gastric, and cardiac dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4kOOzL489RbVg90H21EOLACvtfcHk0lh9KS5y0YcFHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslaqu7g%253D&md5=4c9a44e8750190bcef8d2c51897ac757</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0114%26sid%3Dliteratum%253Aachs%26aulast%3DAlaynick%26aufirst%3DW.%2BA.%26aulast%3DWay%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DS.%2BA.%26aulast%3DBenson%26aufirst%3DW.%2BG.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DJonker%26aufirst%3DJ.%2BW.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DRajpal%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DMcPherson%26aufirst%3DR.%26aulast%3DRemlinger%26aufirst%3DK.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26atitle%3DERRgamma%2520regulates%2520cardiac%252C%2520gastric%252C%2520and%2520renal%2520potassium%2520homeostasis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D299%26epage%3D309%26doi%3D10.1210%2Fme.2009-0114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1172/JCI67652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1172%2FJCI67652" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2564-2575&author=Z.+Ganauthor=J.+Rumseyauthor=B.+C.+Hazenauthor=L.+Laiauthor=T.+C.+Leoneauthor=R.+B.+Vegaauthor=H.+Xieauthor=K.+E.+Conleyauthor=J.+Auwerxauthor=S.+R.+Smithauthor=E.+N.+Olsonauthor=A.+Kralliauthor=D.+P.+Kelly&title=Nuclear+receptor%2FmicroRNA+circuitry+links+muscle+fiber+type+to+energy+metabolism&doi=10.1172%2FJCI67652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI67652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI67652%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DRumsey%26aufirst%3DJ.%26aulast%3DHazen%26aufirst%3DB.%2BC.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLeone%26aufirst%3DT.%2BC.%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DConley%26aufirst%3DK.%2BE.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DKralli%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3DNuclear%2520receptor%252FmicroRNA%2520circuitry%2520links%2520muscle%2520fiber%2520type%2520to%2520energy%2520metabolism%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2564%26epage%3D2575%26doi%3D10.1172%2FJCI67652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, C. R.</span></span> <span> </span><span class="NLM_article-title">Estrogen-related receptor gamma (ERRgamma) regulates oxygen-dependent expression of voltage-gated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1210/me.2013-1038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fme.2013-1038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1Khur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=940-952&author=Y.+Luoauthor=P.+Kumarauthor=C.+R.+Mendelson&title=Estrogen-related+receptor+gamma+%28ERRgamma%29+regulates+oxygen-dependent+expression+of+voltage-gated+potassium+%28K%2B%29+channels+and+tissue+kallikrein+during+human+trophoblast+differentiation&doi=10.1210%2Fme.2013-1038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen-related receptor γ (ERRγ) regulates oxygen-dependent expression of voltage-gated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation</span></div><div class="casAuthors">Luo, Yanmin; Kumar, Premlata; Mendelson, Carole R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">940-952</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Estrogen-related receptor γ (ERRγ) serves a crit. O2-dependent regulatory role in the differentiation of human cytotrophoblasts to syncytiotrophoblast.  In this study, we investigated expression of genes encoding tissue kallikrein (KLK1) and voltage-gated K+ channels (KV7) during differentiation of human trophoblasts in culture and the roles of ERRγ and O2 tension in their regulation.  Expression of KLK1 and the KV7 channel subunits, KCNQ1, KCNE1, KCNE3, and KCNE5, increased during differentiation of cultured human trophoblast cells in a 20% O2 environment.  Notably, together with ERRγ, expression of KLK1, KCNQ1, KCNE1, KCNE3, and KCNE5 was markedly reduced when cells were cultured in a hypoxic environment (2% O2).  Moreover, upon transduction of trophoblast cells with short hairpin RNAs for endogenous ERRγ, KLK1, KCNQ1, KCNE1, and KCNE3 expression was significantly decreased.  Promoter and site-directed mutagenesis studies in transfected cells identified putative ERRγ response elements within the KLK1 and KCNE1 5'-flanking regions required for ERRγ-stimulated transcriptional activity.  Binding of endogenous ERRγ to these ERRγ response elements increased during trophoblast differentiation in culture and was inhibited by hypoxia.  The KV7 blocker linopirdine reduced human chorionic gonadotropin secretion and aggregation of cultured human trophoblasts, suggesting a possible role of KV7 channels in cell fusion and differentiation.  Illumina gene expression arrays of cultured human trophoblast cells revealed several genes upregulated during syncytiotrophoblast differentiation and downregulated upon ERRγ knockdown involved in cell differentiation, adhesion, and synthesis of steroid and peptide hormones required for placental development and function.  Collectively, these findings suggest that ERRγ mediates O2-dependent expression of genes involved in human trophoblast differentiation, function, and vascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa_5yO13wjx7Vg90H21EOLACvtfcHk0lh9KS5y0YcFHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1Khur4%253D&md5=48bfe7d1daad64a3fcd2907e978b4f8a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1038%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DMendelson%26aufirst%3DC.%2BR.%26atitle%3DEstrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520regulates%2520oxygen-dependent%2520expression%2520of%2520voltage-gated%2520potassium%2520%2528K%252B%2529%2520channels%2520and%2520tissue%2520kallikrein%2520during%2520human%2520trophoblast%2520differentiation%26jtitle%3DMol.%2520Endocrinol.%26date%3D2013%26volume%3D27%26spage%3D940%26epage%3D952%26doi%3D10.1210%2Fme.2013-1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Estrogen-related receptor gamma (ERRgamma) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38035</span>– <span class="NLM_lpage">38042</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.250613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M111.250613" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38035-38042&author=D.+K.+Kimauthor=J.+R.+Kimauthor=M.+Kohauthor=Y.+D.+Kimauthor=J.+M.+Leeauthor=D.+Chandaauthor=S.+B.+Parkauthor=J.+J.+Minauthor=C.+H.+Leeauthor=T.+S.+Parkauthor=H.+S.+Choi&title=Estrogen-related+receptor+gamma+%28ERRgamma%29+is+a+novel+transcriptional+regulator+of+phosphatidic+acid+phosphatase%2C+LIPIN1%2C+and+inhibits+hepatic+insulin+signaling&doi=10.1074%2Fjbc.M111.250613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.250613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.250613%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BR.%26aulast%3DKoh%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DMin%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DEstrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520is%2520a%2520novel%2520transcriptional%2520regulator%2520of%2520phosphatidic%2520acid%2520phosphatase%252C%2520LIPIN1%252C%2520and%2520inhibits%2520hepatic%2520insulin%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38035%26epage%3D38042%26doi%3D10.1074%2Fjbc.M111.250613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">21628</span>– <span class="NLM_lpage">21639</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.315168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1074%2Fjbc.M111.315168" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=21628-21639&author=D.+K.+Kimauthor=D.+Ryuauthor=M.+Kohauthor=M.+W.+Leeauthor=D.+Limauthor=M.+J.+Kimauthor=Y.+H.+Kimauthor=W.+J.+Choauthor=C.+H.+Leeauthor=S.+B.+Parkauthor=S.+H.+Kooauthor=H.+S.+Choi&title=Orphan+nuclear+receptor+estrogen-related+receptor+gamma+%28ERRgamma%29+is+key+regulator+of+hepatic+gluconeogenesis&doi=10.1074%2Fjbc.M111.315168"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.315168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.315168%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DRyu%26aufirst%3DD.%26aulast%3DKoh%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DCho%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DKoo%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DOrphan%2520nuclear%2520receptor%2520estrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520is%2520key%2520regulator%2520of%2520hepatic%2520gluconeogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D21628%26epage%3D21639%26doi%3D10.1074%2Fjbc.M111.315168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span> <span> </span><span class="NLM_article-title">Orphan nuclear receptor oestrogen-related receptor gamma (ERRgamma) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>470</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1042/BJ20141494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1042%2FBJ20141494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2015&pages=181-193&author=Y.+Zhangauthor=D.+K.+Kimauthor=J.+M.+Leeauthor=S.+B.+Parkauthor=W.+I.+Jeongauthor=S.+H.+Kimauthor=I.+K.+Leeauthor=C.+H.+Leeauthor=J.+Y.+Chiangauthor=H.+S.+Choi&title=Orphan+nuclear+receptor+oestrogen-related+receptor+gamma+%28ERRgamma%29+plays+a+key+role+in+hepatic+cannabinoid+receptor+type+1-mediated+induction+of+CYP7A1+gene+expression&doi=10.1042%2FBJ20141494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20141494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141494%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DW.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DChiang%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26atitle%3DOrphan%2520nuclear%2520receptor%2520oestrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520plays%2520a%2520key%2520role%2520in%2520hepatic%2520cannabinoid%2520receptor%2520type%25201-mediated%2520induction%2520of%2520CYP7A1%2520gene%2520expression%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D470%26spage%3D181%26epage%3D193%26doi%3D10.1042%2FBJ20141494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keutgen, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebebew, E.</span></span> <span> </span><span class="NLM_article-title">Management of anaplastic thyroid cancer</span>. <i>Gland Surg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.3978/j.issn.2227-684X.2014.12.02</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3978%2Fj.issn.2227-684X.2014.12.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=25713779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC2Mroslequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=44-51&author=X.+M.+Keutgenauthor=S.+M.+Sadowskiauthor=E.+Kebebew&title=Management+of+anaplastic+thyroid+cancer&doi=10.3978%2Fj.issn.2227-684X.2014.12.02"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Management of anaplastic thyroid cancer</span></div><div class="casAuthors">Keutgen Xavier M; Sadowski Samira M; Kebebew Electron</div><div class="citationInfo"><span class="NLM_cas:title">Gland surgery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-51</span>
        ISSN:<span class="NLM_cas:issn">2227-684X</span>.
    </div><div class="casAbstract">Anaplastic thyroid cancer (ATC) is a deadly disease with a dismal prognosis.  Molecular analyses of ATC tumors have yielded interesting results, which could help in understanding the underlying mechanisms of this aggressive disease process.  Managing ATC can be challenging and includes rapid diagnosis, adequate staging, and interdisciplinary, multimodal treatments to optimize patient outcome.  Treatments include surgical resection to gross negative margins when possible, as well as neo- or adjuvant treatment with chemotherapy or external beam radiation (XRT) for locoregional disease.  New treatment strategies include evaluating the benefits of vascular disrupting agents and tyrosine kinase inhibitors for advanced ATC with driver mutations, which can be targeted.  This review summarizes key concepts in managing ATC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa5dwEoYu4sxKDYG3bNImrfW6udTcc2eaaJ0RxsEDxb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mroslequw%253D%253D&md5=8f154dfef81ec097f8982f98eb62d484</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2227-684X.2014.12.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2227-684X.2014.12.02%26sid%3Dliteratum%253Aachs%26aulast%3DKeutgen%26aufirst%3DX.%2BM.%26aulast%3DSadowski%26aufirst%3DS.%2BM.%26aulast%3DKebebew%26aufirst%3DE.%26atitle%3DManagement%2520of%2520anaplastic%2520thyroid%2520cancer%26jtitle%3DGland%2520Surg.%26date%3D2015%26volume%3D4%26spage%3D44%26epage%3D51%26doi%3D10.3978%2Fj.issn.2227-684X.2014.12.02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranganath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. R.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid cancer</span>. <i>Curr. Opin. Endocrinol., Diabetes Obes.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1097/MED.0000000000000189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1097%2FMED.0000000000000189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26313900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVeqsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=387-391&author=R.+Ranganathauthor=M.+A.+Shahauthor=A.+R.+Shah&title=Anaplastic+thyroid+cancer&doi=10.1097%2FMED.0000000000000189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid cancer</span></div><div class="casAuthors">Ranganath, Rohit; Shah, Manish A.; Shah, Ashok R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-391</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Purpose of review: Anaplastic thyroid cancer (ATC) is a rare malignancy of the thyroid with a high mortality rate.  Conventional therapy has not been effective.  Several biol. agents are being investigated.  The purpose of the review is to highlight the current stds. for treatment and review new targets for treating ATC.  Recent findings: Retrospective studies have led to formulation of guidelines for management, including those by the American Thyroid Assocn.  An expansion in the understanding of the genetic mutations has led to several newer biol. agents being tested to treat ATC.  Aurora kinase inhibitors, PPAR γ agonists, and vascular targeting agents are some of the latest therapeutic agents that have shown promise and could become std. of therapy with further supporting research.  Summary: Further well coordinated preclin. and clin. research is needed to support the emerging treatments for ATC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGeVq0KWQHoLVg90H21EOLACvtfcHk0lh5Vgx8xMjOFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVeqsbrO&md5=84c0be52b55e340c91f1ce156177b575</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1097%2FMED.0000000000000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMED.0000000000000189%26sid%3Dliteratum%253Aachs%26aulast%3DRanganath%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DA.%2BR.%26atitle%3DAnaplastic%2520thyroid%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%252C%2520Diabetes%2520Obes.%26date%3D2015%26volume%3D22%26spage%3D387%26epage%3D391%26doi%3D10.1097%2FMED.0000000000000189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smallridge, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, J. A.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid carcinoma: pathogenesis and emerging therapies</span>. <i>Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.clon.2010.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.clon.2010.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3cnovFamsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=486-497&author=R.+C.+Smallridgeauthor=J.+A.+Copland&title=Anaplastic+thyroid+carcinoma%3A+pathogenesis+and+emerging+therapies&doi=10.1016%2Fj.clon.2010.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid carcinoma: pathogenesis and emerging therapies</span></div><div class="casAuthors">Smallridge R C; Copland J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">486-97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally.  Mutations, amplifications, activation of oncogenes and silencing of tumour suppressor genes contribute to its aggressive behaviour, and recent studies (e.g. microarrays, microRNAs) have provided further insights into its complex molecular dysregulation.  Preclinical studies have identified numerous proteins over- or underexpressed that affect critical cellular processes, including transcription, signalling, mitosis, proliferation, cell cycle, apoptosis and adhesion, and a variety of agents that effectively inhibit these processes and tumour growth.  In clinical studies of 1771 patients, 64% were women, the median survival was 5 months, and 1-year survival was 20%.  The variables associated with survival in some series included age, tumour size, extent of surgery, higher dose radiotherapy, absence of distant metastases at presentation, co-existence of differentiated thyroid cancer and multimodality therapy.  However, considerable bias exists in these non-randomised studies.  Although more aggressive radiotherapy has reduced locoregional recurrences, the median overall survival has not improved in over 50 years.  Newer systemic therapies are being tried, and more effective combinations are needed to improve patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkDZSm-xdrbZPq5LRczm8ffW6udTcc2eYhck1BL-dnb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnovFamsw%253D%253D&md5=eb3ff70b7464fd425936352ce6222024</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2010.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2010.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DSmallridge%26aufirst%3DR.%2BC.%26aulast%3DCopland%26aufirst%3DJ.%2BA.%26atitle%3DAnaplastic%2520thyroid%2520carcinoma%253A%2520pathogenesis%2520and%2520emerging%2520therapies%26jtitle%3DClin.%2520Oncol.%26date%3D2010%26volume%3D22%26spage%3D486%26epage%3D497%26doi%3D10.1016%2Fj.clon.2010.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swaak-Kragten, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wilt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontenbal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levendag, P. C.</span></span> <span> </span><span class="NLM_article-title">Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.radonc.2009.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.radonc.2009.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19328572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BD1MvivFGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2009&pages=100-104&author=A.+T.+Swaak-Kragtenauthor=J.+H.+de+Wiltauthor=P.+I.+Schmitzauthor=M.+Bontenbalauthor=P.+C.+Levendag&title=Multimodality+treatment+for+anaplastic+thyroid+carcinoma%2D%2Dtreatment+outcome+in+75+patients&doi=10.1016%2Fj.radonc.2009.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients</span></div><div class="casAuthors">Swaak-Kragten Annemarie T; de Wilt Johannes H W; Schmitz Paul I M; Bontenbal Marijke; Levendag Peter C</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To retrospectively analyze the outcome of patients with anaplastic thyroid carcinoma (ATC) treated in the Erasmus MC.  MATERIAL AND METHODS:  Seventy-five ATC-patients were treated between 1972 and 2003.  Mean age was 68 years.  Tumor stage was IVA in 9%, IVB in 51%, and IVC in 40%.  Thirty-six patients underwent up-front surgery, with 53% resulting in R0/R1 resection.  Before 1988 adjuvant treatment consisted of conventional radiotherapy (RT) and/or chemotherapy (CT).  As of 1988, 30 eligible patients were enrolled in a newly designed protocol.  This consists of locoregional RT in 46 fractions of 1.1 Gy, given twice daily, followed by prophylactic irradiation of the lungs (PLI) in 5 daily fractions of 1.5 Gy.  During radiation, low-dose Doxorubicine (15 mg/m(2)) is administered weekly and is followed by adjuvant Doxorubicine (50 mg/m(2)) 3-weekly up to a cumulative dose of 550 mg/m(2).  Twenty-five ineligible patients were treated conventionally.  RESULTS:  Overall median survival was 3 months, 1-year OS 9%.  Locoregional control was significantly higher in patients who had undergone R0/R1 resection or chemoradiation, with best results for patients who underwent both (complete remission in 89%).  However, the survival benefit of patients who reached CR remained borderline (median OS 7 months, 1-year OS 32%).  Three patients survived for more than 5 years; all had undergone R0/R1 surgical resection and chemoradiation.  Acute toxicity in the protocol group was significantly higher than in the nonprotocol group, with 46% versus 11% grade 3 pharyngeal and/or esophageal toxicity.  CONCLUSION:  Despite the ultimately dismal prognosis of ATC-patients, multimodality treatment significantly improved local control and improved the median survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQj57ou_xf_YFQKX3ooHxWjfW6udTcc2eYhck1BL-dnb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvivFGhuw%253D%253D&md5=9f205acfd47d1ac2e9166a68a1264a77</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2009.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2009.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DSwaak-Kragten%26aufirst%3DA.%2BT.%26aulast%3Dde%2BWilt%26aufirst%3DJ.%2BH.%26aulast%3DSchmitz%26aufirst%3DP.%2BI.%26aulast%3DBontenbal%26aufirst%3DM.%26aulast%3DLevendag%26aufirst%3DP.%2BC.%26atitle%3DMultimodality%2520treatment%2520for%2520anaplastic%2520thyroid%2520carcinoma--treatment%2520outcome%2520in%252075%2520patients%26jtitle%3DRadiother.%2520Oncol.%26date%3D2009%26volume%3D92%26spage%3D100%26epage%3D104%26doi%3D10.1016%2Fj.radonc.2009.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garden, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. L.</span></span> <span> </span><span class="NLM_article-title">Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy</span>. <i>Head Neck</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1002/hed.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1002%2Fhed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=19885924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3critFSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=829-836&author=A.+Bhatiaauthor=A.+Raoauthor=K.+K.+Angauthor=A.+S.+Gardenauthor=W.+H.+Morrisonauthor=D.+I.+Rosenthalauthor=D.+B.+Evansauthor=G.+Claymanauthor=S.+I.+Shermanauthor=D.+L.+Schwartz&title=Anaplastic+thyroid+cancer%3A+Clinical+outcomes+with+conformal+radiotherapy&doi=10.1002%2Fhed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy</span></div><div class="casAuthors">Bhatia Aarti; Rao Archana; Ang Kie-Kian; Garden Adam S; Morrison William H; Rosenthal David I; Evans Douglas B; Clayman Gary; Sherman Steven I; Schwartz David L</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was to review institutional outcomes for anaplastic thyroid cancer treated with conformal 3-dimensional radiotherapy (3DRT) or intensity-modulated radiotherapy (IMRT).  METHODS:  In all, 53 consecutive patients were analyzed.  Thirty-one (58%) patients were irradiated with curative intent.  Median radiation dose was 55 Gray (Gy; range, 4-70 Gy).  Thirteen (25%) patients received IMRT to a median 60 Gy (range, 39.9-69.0 Gy).  Thirty-nine (74%) patients received chemotherapy with radiation.  RESULTS:  The Kaplan-Meier estimate of overall survival (OS) at 1 year for definitively irradiated patients was 29%.  Patients without distant metastases receiving >or=50 Gy had superior survival outcomes; 5 such patients had no evidence of disease at last follow-up.  Use of IMRT versus 3DRT did not influence toxicity.  CONCLUSIONS:  Outcomes for anaplastic thyroid cancer treated with 3DRT or IMRT remain equivalent to historical results.  Healthy patients with localized disease who tolerate full dose irradiation can potentially enjoy prolonged survival.  Biologically targeted radiosensitization merits prioritized investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVXtqhMN9u0_h3YQQtAhNufW6udTcc2eYhck1BL-dnb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3critFSquw%253D%253D&md5=d208281acac0f43cc3c3edc7f60b878f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fhed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DBhatia%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DAng%26aufirst%3DK.%2BK.%26aulast%3DGarden%26aufirst%3DA.%2BS.%26aulast%3DMorrison%26aufirst%3DW.%2BH.%26aulast%3DRosenthal%26aufirst%3DD.%2BI.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DClayman%26aufirst%3DG.%26aulast%3DSherman%26aufirst%3DS.%2BI.%26aulast%3DSchwartz%26aufirst%3DD.%2BL.%26atitle%3DAnaplastic%2520thyroid%2520cancer%253A%2520Clinical%2520outcomes%2520with%2520conformal%2520radiotherapy%26jtitle%3DHead%2520Neck%26date%3D2010%26volume%3D32%26spage%3D829%26epage%3D836%26doi%3D10.1002%2Fhed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grewal, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leboeuf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deandreis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentlow, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanzonico, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghossein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricarte-Filho, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagin, J. A.</span></span> <span> </span><span class="NLM_article-title">Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1209288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1056%2FNEJMoa1209288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23406027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVWjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=623-632&author=A.+L.+Hoauthor=R.+K.+Grewalauthor=R.+Leboeufauthor=E.+J.+Shermanauthor=D.+G.+Pfisterauthor=D.+Deandreisauthor=K.+S.+Pentlowauthor=P.+B.+Zanzonicoauthor=S.+Haqueauthor=S.+Gavaneauthor=R.+A.+Ghosseinauthor=J.+C.+Ricarte-Filhoauthor=J.+M.+Dominguezauthor=R.+Shenauthor=R.+M.+Tuttleauthor=S.+M.+Larsonauthor=J.+A.+Fagin&title=Selumetinib-enhanced+radioiodine+uptake+in+advanced+thyroid+cancer&doi=10.1056%2FNEJMoa1209288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer</span></div><div class="casAuthors">Ho, Alan L.; Grewal, Ravinder K.; Leboeuf, Rebecca; Sherman, Eric J.; Pfister, David G.; Deandreis, Desiree; Pentlow, Keith S.; Zanzonico, Pat B.; Haque, Sofia; Gavane, Somali; Ghossein, Ronald A.; Ricarte-Filho, Julio C.; Dominguez, Jose M.; Shen, Ronglai; Tuttle, R. Michael; Larson, Steve M.; Fagin, James A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">623-632</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are assocd. with a poor prognosis.  In mouse models of thyroid cancer, selective mitogen-activated protein kinase (MAPK) pathway antagonists increase the expression of the sodium-iodide symporter and uptake of iodine.  Their effects in humans are not known.  Methods: We conducted a study to det. whether the MAPK kinase (MEK) 1 and MEK2 inhibitor selumetinib (AZD6244, ARRY-142886) could reverse refractoriness to radioiodine in patients with metastatic thyroid cancer.  After stimulation with TSH alfa, dosimetry with iodine-124 positron-emission tomog. (PET) was performed before and 4 wk after treatment with selumetinib (75 mg twice daily).  If the second iodine-124 PET study indicated that a dose of iodine-131 of 2000 cGy or more could be delivered to the metastatic lesion or lesions, therapeutic radioiodine was administered while the patient was receiving selumetinib.  Results: Of 24 patients screened for the study, 20 could be evaluated.  The median age was 61 years (range, 44 to 77), and 11 patients were men.  Nine patients had tumors with BRAF mutations, and 5 patients had tumors with mutations of NRAS.  Selumetinib increased the uptake of iodine-124 in 12 of the 20 patients (4 of 9 patients with BRAF mutations and 5 of 5 patients with NRAS mutations).  Eight of these 12 patients reached the dosimetry threshold for radioiodine therapy, including all 5 patients with NRAS mutations.  Of the 8 patients treated with radioiodine, 5 had confirmed partial responses and 3 had stable disease; all patients had decreases in serum thyroglobulin levels (mean redn., 89%).  No toxic effects of grade 3 or higher attributable by the investigators to selumetinib were obsd.  One patient received a diagnosis of myelodysplastic syndrome more than 51 wk after radioiodine treatment, with progression to acute leukemia.  Conclusions: Selumetinib produces clin. meaningful increases in iodine uptake and retention in a subgroup of patients with thyroid cancer that is refractory to radioiodine; the effectiveness may be greater in patients with RAS-mutant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj4t7rt-mPbVg90H21EOLACvtfcHk0lhrzQcMVwoGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVWjsr4%253D&md5=74a2543ed1cd182b51a915331ebe4570</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209288%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DA.%2BL.%26aulast%3DGrewal%26aufirst%3DR.%2BK.%26aulast%3DLeboeuf%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DE.%2BJ.%26aulast%3DPfister%26aufirst%3DD.%2BG.%26aulast%3DDeandreis%26aufirst%3DD.%26aulast%3DPentlow%26aufirst%3DK.%2BS.%26aulast%3DZanzonico%26aufirst%3DP.%2BB.%26aulast%3DHaque%26aufirst%3DS.%26aulast%3DGavane%26aufirst%3DS.%26aulast%3DGhossein%26aufirst%3DR.%2BA.%26aulast%3DRicarte-Filho%26aufirst%3DJ.%2BC.%26aulast%3DDominguez%26aufirst%3DJ.%2BM.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTuttle%26aufirst%3DR.%2BM.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DFagin%26aufirst%3DJ.%2BA.%26atitle%3DSelumetinib-enhanced%2520radioiodine%2520uptake%2520in%2520advanced%2520thyroid%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D623%26epage%3D632%26doi%3D10.1056%2FNEJMoa1209288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. K.</span></span> <span> </span><span class="NLM_article-title">Sodium iodide symporter: its role in nuclear medicine</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=12215558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1elsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1188-1200&author=J.+K.+Chung&title=Sodium+iodide+symporter%3A+its+role+in+nuclear+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium iodide symporter: its role in nuclear medicine</span></div><div class="casAuthors">Chung, June-Key</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Thyroid iodide uptake is basic to the clin. applications of radioiodine.  Iodide uptake occurs across the membrane of the thyroid follicular cells through an active transporter process mediated by the sodium iodide symporter (NIS).  The recent cloning of the NIS gene enabled the better characterization of the mol. mechanisms underlying iodide transport, thus opening the way to the clarification and expansion of its role in nuclear medicine.  In papillary and follicular carcinoma, NIS immunostaining was pos. in only a few tumor cells, and no NIS protein expression was detected in anaplastic carcinomas.  Decreased NIS expression levels account for the reduced iodide uptake in thyroid carcinomas.  Thus, by targeting NIS expression in cancer cells, we could enable these cells to conc. iodide from plasma and in so doing offer the possibility of radioiodine therapy.  Several investigators have shown that gene transfer of NIS into a variety of cell types confers increased radioiodine uptake by up to several hundredfold that of controls in nonthyroid cancers as well as in thyroid cancer.  In addn., my group proposes that NIS may serve as an alternative imaging reporter gene in addn. to the HSVtk and dopaminergic receptor genes.  The NIS has the potential to expand the role of nuclear medicine in the future, just as it has served as the base for the development of nuclear medicine in the past.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1dNWppdLQLVg90H21EOLACvtfcHk0lhrzQcMVwoGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1elsro%253D&md5=e3921398e0edda1058a2c783269ca32f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BK.%26atitle%3DSodium%2520iodide%2520symporter%253A%2520its%2520role%2520in%2520nuclear%2520medicine%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D1188%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kogai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent, G. A.</span></span> <span> </span><span class="NLM_article-title">The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.pharmthera.2012.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=22750642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOlsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=355-370&author=T.+Kogaiauthor=G.+A.+Brent&title=The+sodium+iodide+symporter+%28NIS%29%3A+regulation+and+approaches+to+targeting+for+cancer+therapeutics&doi=10.1016%2Fj.pharmthera.2012.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics</span></div><div class="casAuthors">Kogai, Takahiko; Brent, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-370</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Expression of the sodium iodide symporter (NIS) is required for efficient iodide uptake in thyroid and lactating breast.  Since most differentiated thyroid cancer expresses NIS, β-emitting radioactive iodide is routinely utilized to target remnant thyroid cancer and metastasis after total thyroidectomy.  Stimulation of NIS expression by high levels of TSH is necessary to achieve radioiodide uptake into thyroid cancer that is sufficient for therapy.  The majority of breast cancer also expresses NIS, but at a low level insufficient for radioiodine therapy.  Retinoic acid is a potent NIS inducer in some breast cancer cells.  NIS is also modestly expressed in some non-thyroidal tissues, including salivary glands, lacrimal glands and stomach.  Selective induction of iodide uptake is required to target tumors with radioiodide.  Iodide uptake in mammalian cells is dependent on the level of NIS gene expression, but also successful translocation of NIS to the cell membrane and correct insertion.  The regulatory mechanisms of NIS expression and membrane insertion are regulated by signal transduction pathways that differ by tissue.  Differential regulation of NIS confers selective induction of functional NIS in thyroid cancer cells, as well as some breast cancer cells, leading to more efficient radioiodide therapy for thyroid cancer and a new strategy for breast cancer therapy.  The potential for systemic radioiodide treatment of a range of other cancers, that do not express endogenous NIS, has been demonstrated in models with tumor-selective introduction of exogenous NIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbVS9OHgeZ_7Vg90H21EOLACvtfcHk0lhrzQcMVwoGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOlsbfK&md5=a9226ec2bbe17fd9e9a96f342eafbac2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKogai%26aufirst%3DT.%26aulast%3DBrent%26aufirst%3DG.%2BA.%26atitle%3DThe%2520sodium%2520iodide%2520symporter%2520%2528NIS%2529%253A%2520regulation%2520and%2520approaches%2520to%2520targeting%2520for%2520cancer%2520therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D135%26spage%3D355%26epage%3D370%26doi%3D10.1016%2Fj.pharmthera.2012.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaisman, M.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma</span>. <i>J. Endocrinol. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1007/BF03351058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1007%2FBF03351058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=334-339&author=S.+M.+Coelhoauthor=R.+Corboauthor=A.+Buescuauthor=D.+P.+Carvalhoauthor=M.+Vaisman&title=Retinoic+acid+in+patients+with+radioiodine+non-responsive+thyroid+carcinoma&doi=10.1007%2FBF03351058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF03351058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03351058%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DS.%2BM.%26aulast%3DCorbo%26aufirst%3DR.%26aulast%3DBuescu%26aufirst%3DA.%26aulast%3DCarvalho%26aufirst%3DD.%2BP.%26aulast%3DVaisman%26aufirst%3DM.%26atitle%3DRetinoic%2520acid%2520in%2520patients%2520with%2520radioiodine%2520non-responsive%2520thyroid%2520carcinoma%26jtitle%3DJ.%2520Endocrinol.%2520Invest.%26date%3D2004%26volume%3D27%26spage%3D334%26epage%3D339%26doi%3D10.1007%2FBF03351058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Pluijm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karperien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokkel, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morreau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kievit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romijn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, J. W.</span></span> <span> </span><span class="NLM_article-title">Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies</span>. <i>Clin. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2265.2006.02515.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1111%2Fj.1365-2265.2006.02515.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=16712662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVylsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=617-624&author=Y.+Y.+Liuauthor=G.+van+der+Pluijmauthor=M.+Karperienauthor=M.+P.+Stokkelauthor=A.+M.+Pereiraauthor=J.+Morreauauthor=J.+Kievitauthor=J.+A.+Romijnauthor=J.+W.+Smit&title=Lithium+as+adjuvant+to+radioiodine+therapy+in+differentiated+thyroid+carcinoma%3A+clinical+and+in+vitro+studies&doi=10.1111%2Fj.1365-2265.2006.02515.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies</span></div><div class="casAuthors">Liu, Y. Y.; van der Pluijm, G.; Karperien, M.; Stokkel, M. P. M.; Pereira, A. M.; Morreau, J.; Kievit, J.; Romijn, J. A.; Smit, J. W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Endocrinology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-624</span>CODEN:
                <span class="NLM_cas:coden">CLECAP</span>;
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Objective Lithium has been reported to increase radioactive iodine (RaI) doses in benign thyroid disease and in differentiated thyroid carcinoma (DTC).  It is not known whether lithium influences the outcome of RaI therapy in DTC.  We therefore studied the clin. effects of RaI without and with lithium carbonate in patients with proven metastatic DTC.  Controversy also exists on the mechanism by which lithium increases RaI dose in DTC.  We performed an in vitro study specifically aimed at examg. the effects of lithium on the sodium iodide symporter (NIS).  Design In a clin. study, 12 patients were selected with metastases of DTC who had received previous RaI therapy without lithium (control) that had not influenced tumor progression, despite RaI accumulation in metastases.  The patients received 1200 mg lithium carbonate/day followed by 6000 MBq RaI.  Outcome parameters were RaI uptake, serum thyroglobulin (Tg) levels and radiol. dimensions of metastases compared between RaI with lithium and control.  In an in vitro study, iodide uptake was studied in the benign rat thyroid cell line FRTL-5, in the polarized non-thyroid MDCK cell line, stably transfected with human sodium iodide symporter (hNIS) to study the effects of lithium on NIS in a non-thyroid background, and the human follicular thyroid carcinoma cell line FTC133-hNIS to study lithium effects in a background of DTC.  Lithium chloride (LiCl) was added in concns. up to 2 mm for 0-48 h.  Both steady-state iodide uptake (30 min) and initial rate (2 min) were studied using a specific activity of 100 mCi/mmol I, the latter expt. to det. lithium effects on substrate dependency.  Iodide efflux studies were performed as well.  Results Despite an increased uptake of RaI in seven patients, no beneficial effect of RaI with lithium was obsd. on the clin. course as assessed by serum Tg measurements and radiog.  In the in vitro studies, no effects of LiCl on iodide uptake or efflux were obsd.  Conclusions The addn. of lithium to RaI did not have any beneficial effects on the clin. course in 12 patients with metastatic DTC.  No beneficial effects of lithium on iodide uptake were obsd. in vitro.  Therefore, the clin. value of lithium in DTC remains subject to debate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqser7HygTcqbVg90H21EOLACvtfcHk0ljao7fWWWUfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVylsrY%253D&md5=8b9a455a52efc7883bc248a64b2e95b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.2006.02515.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.2006.02515.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DG.%26aulast%3DKarperien%26aufirst%3DM.%26aulast%3DStokkel%26aufirst%3DM.%2BP.%26aulast%3DPereira%26aufirst%3DA.%2BM.%26aulast%3DMorreau%26aufirst%3DJ.%26aulast%3DKievit%26aufirst%3DJ.%26aulast%3DRomijn%26aufirst%3DJ.%2BA.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%26atitle%3DLithium%2520as%2520adjuvant%2520to%2520radioiodine%2520therapy%2520in%2520differentiated%2520thyroid%2520carcinoma%253A%2520clinical%2520and%2520in%2520vitro%2520studies%26jtitle%3DClin.%2520Endocrinol.%26date%3D2006%26volume%3D64%26spage%3D617%26epage%3D624%26doi%3D10.1111%2Fj.1365-2265.2006.02515.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brent, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogai, T.</span></span> <span> </span><span class="NLM_article-title">Cancer: Novel target to enhance radioiodine uptake in thyroid cancer</span>. <i>Nat. Rev. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/nrendo.2013.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1038%2Fnrendo.2013.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=23817292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=508-509&author=G.+A.+Brentauthor=T.+Kogai&title=Cancer%3A+Novel+target+to+enhance+radioiodine+uptake+in+thyroid+cancer&doi=10.1038%2Fnrendo.2013.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Novel target to enhance radioiodine uptake in thyroid cancer</span></div><div class="casAuthors">Brent, Gregory A.; Kogai, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">508-509</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sodium-iodide symporter mediates iodide uptake, but its activity is reduced by the overexpression of pituitary tumor-transforming gene 1 protein-binding factor (PBF) in thyroid tumors.  A recent study shows that inhibiting PBF phosphorylation enhances radioiodine uptake in thyroid cancer models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobUwvrwmxHerVg90H21EOLACvtfcHk0ljao7fWWWUfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr3L&md5=6f7f741d2596c4960e9fd02b7aa6e225</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2013.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2013.132%26sid%3Dliteratum%253Aachs%26aulast%3DBrent%26aufirst%3DG.%2BA.%26aulast%3DKogai%26aufirst%3DT.%26atitle%3DCancer%253A%2520Novel%2520target%2520to%2520enhance%2520radioiodine%2520uptake%2520in%2520thyroid%2520cancer%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2013%26volume%3D9%26spage%3D508%26epage%3D509%26doi%3D10.1038%2Fnrendo.2013.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inverse agonist of estrogen-related receptor γ enhances sodium iodide symporter function through mitogen-activated protein kinase signaling in anaplastic thyroid cancer cells</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1690</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.160366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.2967%2Fjnumed.115.160366" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1690-1696&author=T.+D.+Singhauthor=S.+Y.+Jeongauthor=S.-W.+Leeauthor=J.-H.+Haauthor=I.-K.+Leeauthor=S.+H.+Kimauthor=J.+Kimauthor=S.+J.+Choauthor=B.-C.+Ahnauthor=J.+Leeauthor=Y.+H.+Jeon&title=Inverse+agonist+of+estrogen-related+receptor+%CE%B3+enhances+sodium+iodide+symporter+function+through+mitogen-activated+protein+kinase+signaling+in+anaplastic+thyroid+cancer+cells&doi=10.2967%2Fjnumed.115.160366"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.160366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.160366%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BD.%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DS.-W.%26aulast%3DHa%26aufirst%3DJ.-H.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DAhn%26aufirst%3DB.-C.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26atitle%3DInverse%2520agonist%2520of%2520estrogen-related%2520receptor%2520%25CE%25B3%2520enhances%2520sodium%2520iodide%2520symporter%2520function%2520through%2520mitogen-activated%2520protein%2520kinase%2520signaling%2520in%2520anaplastic%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26spage%3D1690%26epage%3D1696%26doi%3D10.2967%2Fjnumed.115.160366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of selective ERRgamma inverse agonists</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">80</span>, <span class="refDoi"> DOI: 10.3390/molecules21010080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.3390%2Fmolecules21010080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=26771593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFequ77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=80&author=J.+Kimauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=M.+J.+Maauthor=S.+B.+Kimauthor=E.+Hongauthor=J.+Chinauthor=H.+Hwangauthor=S.+Leeauthor=N.+D.+Kimauthor=J.+H.+Jeonauthor=I.+K.+Leeauthor=Y.+H.+Jeonauthor=H.+S.+Choiauthor=S.+H.+Kimauthor=S.+J.+Cho&title=Identification+of+selective+ERRgamma+inverse+agonists&doi=10.3390%2Fmolecules21010080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of selective ERRγ inverse agonists</span></div><div class="casAuthors">Kim, Jina; Young, Im Chun; Kyung, Yoo Eun; Jung, Ma Min; Kim, Sang-Bum; Hong, Eunmi; Chin, Jungwook; Hwang, Hayoung; Lee, Sungwoo; Doo, Kim Nam; Jeon, Jae-Han; Lee, In-Kyu; Jeon, Yong Hyun; Choi, Hueng-Sik; Kim, Seong Heon; Cho, Sung Jin</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80/1-80/16</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">GSK5182 (4) is currently one of the lead compds. for the development of estrogen-related receptor gamma (ERR) inverse agonists.  Here, we report the design, synthesis, pharmacol. and in vitro absorption, distribution, metab., excretion, toxicity (ADMET) properties of a series of compds. related to 4.  Starting from 4, a series of analogs were structurally modified and their ERR inverse agonist activity was measured.  A key pharmacophore feature of this novel class of ligands is the introduction of a heterocyclic group for A-ring substitution in the core scaffold.  Among the tested compds., several of them are potent ERR inverse agonists as detd. by binding and functional assays.  The most promising compd., 15g, had excellent binding selectivity over related subtypes (IC50 = 0.44, >10, >10, and 10 μM at the ERR, ERRγ, ERR.varies., and ERβ subtypes, resp.).  Compd. 15g also resulted in 95% transcriptional repression at a concn. of 10 _M, while still maintaining an acceptable in vitro ADMET profile.  This novel class of ERR inverse agonists shows promise in the development of drugs targeting ERR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L-VxqfLtErVg90H21EOLACvtfcHk0lgPfHyI1wmPpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFequ77E&md5=831569314aa3a66274cf66b5a736a460</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010080%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DMa%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DHong%26aufirst%3DE.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520selective%2520ERRgamma%2520inverse%2520agonists%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D80%26doi%3D10.3390%2Fmolecules21010080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.ejmech.2016.04.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2016&pages=338-352&author=J.+Kimauthor=J.+Chinauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=S.+Wooauthor=H.+J.+Hwangauthor=J.+H.+Choauthor=K.+A.+Seoauthor=J.+Songauthor=H.+Hwangauthor=K.+H.+Kimauthor=N.+D.+Kimauthor=S.+K.+Yoonauthor=J.+H.+Jeonauthor=S.+Y.+Yoonauthor=Y.+H.+Jeonauthor=H.+S.+Choiauthor=I.+K.+Leeauthor=S.+H.+Kimauthor=S.+J.+Cho&title=Synthesis+and+biological+evaluation+of+novel+4-hydroxytamoxifen+analogs+as+estrogen-related+receptor+gamma+inverse+agonists&doi=10.1016%2Fj.ejmech.2016.04.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DSeo%26aufirst%3DK.%2BA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DS.%2BK.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25204-hydroxytamoxifen%2520analogs%2520as%2520estrogen-related%2520receptor%2520gamma%2520inverse%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D120%26spage%3D338%26epage%3D352%26doi%3D10.1016%2Fj.ejmech.2016.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span> <span> </span><span class="NLM_article-title">Insights of a lead optimization study and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma (ERRgamma) inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10209</span>– <span class="NLM_lpage">10227</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01204</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01204" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10209-10227&author=J.+Kimauthor=S.+Y.+Wooauthor=C.+Y.+Imauthor=E.+K.+Yooauthor=S.+Leeauthor=H.+J.+Kimauthor=H.+J.+Hwangauthor=J.+H.+Choauthor=W.+S.+Leeauthor=H.+Yoonauthor=S.+Kimauthor=O.+B.+Kwonauthor=H.+Hwangauthor=K.+H.+Kimauthor=J.+H.+Jeonauthor=T.+D.+Singhauthor=S.+W.+Kimauthor=S.+Y.+Hwangauthor=H.+S.+Choiauthor=I.+K.+Leeauthor=S.+H.+Kimauthor=Y.+H.+Jeonauthor=J.+Chinauthor=S.+J.+Cho&title=Insights+of+a+lead+optimization+study+and+biological+evaluation+of+novel+4-hydroxytamoxifen+analogs+as+estrogen-related+receptor+gamma+%28ERRgamma%29+inverse+agonists&doi=10.1021%2Facs.jmedchem.6b01204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01204%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DS.%2BY.%26aulast%3DIm%26aufirst%3DC.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DHwang%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DW.%2BS.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DO.%2BB.%26aulast%3DHwang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DSingh%26aufirst%3DT.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DHwang%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26atitle%3DInsights%2520of%2520a%2520lead%2520optimization%2520study%2520and%2520biological%2520evaluation%2520of%2520novel%25204-hydroxytamoxifen%2520analogs%2520as%2520estrogen-related%2520receptor%2520gamma%2520%2528ERRgamma%2529%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10209%26epage%3D10227%26doi%3D10.1021%2Facs.jmedchem.6b01204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, B. M.</span></span> <span> </span><span class="NLM_article-title">Identification of novel inverse agonists of estrogen-related receptors ERRgamma and ERRbeta</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1585</span>– <span class="NLM_lpage">1599</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2Fj.bmc.2017.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1585-1599&author=D.+D.+Yuauthor=J.+M.+Hussauthor=H.+Liauthor=B.+M.+Forman&title=Identification+of+novel+inverse+agonists+of+estrogen-related+receptors+ERRgamma+and+ERRbeta&doi=10.1016%2Fj.bmc.2017.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DD.%2BD.%26aulast%3DHuss%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DForman%26aufirst%3DB.%2BM.%26atitle%3DIdentification%2520of%2520novel%2520inverse%2520agonists%2520of%2520estrogen-related%2520receptors%2520ERRgamma%2520and%2520ERRbeta%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1585%26epage%3D1599%26doi%3D10.1016%2Fj.bmc.2017.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera--a visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%2D%2Da+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lhQCnF6ie7G3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera--a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbrecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moller, D. E.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1594</span>– <span class="NLM_lpage">1604</span>, <span class="refDoi"> DOI: 10.1210/mend.12.10.0176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1210%2Fmend.12.10.0176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9773982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1594-1604&author=G.+Zhouauthor=R.+Cummingsauthor=Y.+Liauthor=S.+Mitraauthor=H.+A.+Wilkinsonauthor=A.+Elbrechtauthor=J.+D.+Hermesauthor=J.+M.+Schaefferauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Nuclear+receptors+have+distinct+affinities+for+coactivators%3A+characterization+by+fluorescence+resonance+energy+transfer&doi=10.1210%2Fmend.12.10.0176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer</span></div><div class="casAuthors">Zhou, Gaochao; Cummings, Richard; Li, Ying; Mitra, Sudha; Wilkinson, Hilary A.; Elbrecht, Alex; Hermes, Jeffrey D.; Schaeffer, James M.; Smith, Roy G.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1594-1604</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Ligand-dependent interactions between nuclear receptors and members of a family of nuclear receptor coactivators are assocd. with transcriptional activation.  Here we used fluorescence resonance energy transfer (FRET) as an approach for detecting and quantitating such interactions.  Using the ligand-binding domain (LBD) of peroxisome proliferator-activated receptor (PPARγ) as a model, known agonists (thiazolidinediones and Δ12, 14-PGJ2) induced a specific interaction resulting in FRET between the fluorescently labeled LBD and fluorescently labeled coactivators [CREB-binding protein (CBP) or steroid receptor coactivator-1 (SRC-1)].  Specific energy transfer was dose dependent; individual ligands displayed distinct potency and maximal FRET profiles that were identical when results obtained using CBP vs, SRC-1 were compared.  In addn., half-maximally effective agonist concns. (EC50s) correlated well with reported results using cell-based assays.  A site-directed AF2 mutant of PPARγ (E471A) that abrogated ligand-stimulated transcription in transfected cells also failed to induce ligand-mediated FRET between PPARγ LBD and CBP or SRC-1.  Using estrogen receptor (ERα) as an alternative system, known agonists induced an interaction between ERα LBD and SRC-1, whereas ER antagonists disrupted agonist-induced interaction of ERα with SRC-1.  In the presence of satg. agonist concns., unlabeled CBP or SRC-1 was used to compete with fluorescently labeled coactivators with satn. kinetics.  Relative affinities for the individual receptor-coactivator pairs were detd. as follows: PPARγ-CBP = ERα-SRC-1 > PPARγ-SRC-1 » ERα-CBP.  Conclusions: (1) FRET-based coactivator assocn. is a novel approach for characterizing nuclear receptor agonists or antagonists; individual ligands display potencies that are predictive of in vivo effects and distinct profiles of maximal activity that are suggestive of alternative receptor conformations.  (2) PPARγ interacts with both CBP and SRC-1; transcriptional activation and coactivator assocn. are AF2 dependent.  (3) Nuclear receptor LBDs have distinct affinities for individual coactivators; thus, PPARγ has a greater apparent affinity for CBP than for SRC-1, whereas ERα interacts preferentially with SRC-1 but very weakly with CBP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOGCfAfDEUrVg90H21EOLACvtfcHk0lhQCnF6ie7G3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVygsbc%253D&md5=1e957630081a12560da5cce65838cd44</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.10.0176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.10.0176%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DH.%2BA.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DHermes%26aufirst%3DJ.%2BD.%26aulast%3DSchaeffer%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNuclear%2520receptors%2520have%2520distinct%2520affinities%2520for%2520coactivators%253A%2520characterization%2520by%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26spage%3D1594%26epage%3D1604%26doi%3D10.1210%2Fmend.12.10.0176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puigserver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">839</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81410-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1016%2FS0092-8674%2800%2981410-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=9529258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADyaK1cXit1Klsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=829-839&author=P.+Puigserverauthor=Z.+Wuauthor=C.+W.+Parkauthor=R.+Gravesauthor=M.+Wrightauthor=B.+M.+Spiegelman&title=A+cold-inducible+coactivator+of+nuclear+receptors+linked+to+adaptive+thermogenesis&doi=10.1016%2FS0092-8674%2800%2981410-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis</span></div><div class="casAuthors">Puigserver, Pere; Wu, Zhidan; Park, Cheol Won; Graves, Reed; Wright, Margaret; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-839</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Adaptive thermogenesis is an important component of energy homeostasis and a metabolic defense against obesity.  The authors have cloned a novel transcriptional coactivator of nuclear receptors, termed PGC-1, from a brown fat cDNA library.  PGC-1 mRNA expression is dramatically elevated upon cold exposure of mice in both brown fat and skeletal muscle, key thermogenic tissues.  PGC-1 greatly increases the transcriptional activity of PPARγ and the thyroid hormone receptor on the uncoupling protein (UCP-1) promoter.  Ectopic expression of PGC-1 in white adipose cells activates expression of UCP-1 and key mitochondrial enzymes of the respiratory chain, and increases the cellular content of mitochondrial DNA.  These results indicate that PGC-1 plays a key role in linking nuclear receptors to the transcriptional program of adaptive thermogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhppSLZixGbVg90H21EOLACvtfcHk0lhQCnF6ie7G3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1Klsb8%253D&md5=b05afec840c7adad534ddc943ad12d19</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981410-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981410-5%26sid%3Dliteratum%253Aachs%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DGraves%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DA%2520cold-inducible%2520coactivator%2520of%2520nuclear%2520receptors%2520linked%2520to%2520adaptive%2520thermogenesis%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D829%26epage%3D839%26doi%3D10.1016%2FS0092-8674%2800%2981410-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, M. A.</span></span> <span> </span><span class="NLM_article-title">Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1177/1087057103256466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=10.1177%2F1087057103256466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=14567790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=381-392&author=X.+Wuauthor=J.+F.+Glickmanauthor=B.+R.+Bowenauthor=M.+A.+Sills&title=Comparison+of+assay+technologies+for+a+nuclear+receptor+assay+screen+reveals+differences+in+the+sets+of+identified+functional+antagonists&doi=10.1177%2F1087057103256466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists</span></div><div class="casAuthors">Wu, Xiang; Glickman, J. Fraser; Bowen, Benjamin R.; Sills, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-392</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Many assay technologies currently exist to develop high-throughput screening assays, and the no. of choices continues to increase.  Results from a previous study comparing assay technologies in our lab. do not support the common assumption that the same hits would be found regardless of which assay technol. is used.  To extend this investigation, a nuclear receptor antagonist assay was developed using 3 assay formats: AlphaScreen, time-resolved fluorescence (TRF), and time-resolved fluorescence resonance energy transfer (TR-FRET).  Compds. (∼42,000) from the Novartis library were evaluated in all 3 assay formats.  A total of 128 compds. were evaluated in dose-response expts., and 109 compds. were confirmed active from all 3 formats.  The AlphaScreen, TRF, and TR-FRET assay technologies identified 104, 23, and 57 active compds., resp., with only 18 compds. active in all 3 assay formats.  A total of 128 compds. were evaluated in a cell-based functional assay, and 35 compds. demonstrated activity in this cellular assay.  Furthermore, 34, 11, and 16 hits that were originally identified in the dose-response expt. by AlphaScreen, TRF, and TR-FRET assay technologies, resp., were functionally active.  The results of the study indicated that AlphaScreen identified the greatest no. of functional antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYthpUUtzuxbVg90H21EOLACvtfcHk0lhusXPTC9OGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWrtLg%253D&md5=a9410d694c8eabf149280d8fe9fb9ca1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1177%2F1087057103256466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103256466%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBowen%26aufirst%3DB.%2BR.%26aulast%3DSills%26aufirst%3DM.%2BA.%26atitle%3DComparison%2520of%2520assay%2520technologies%2520for%2520a%2520nuclear%2520receptor%2520assay%2520screen%2520reveals%2520differences%2520in%2520the%2520sets%2520of%2520identified%2520functional%2520antagonists%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D381%26epage%3D392%26doi%3D10.1177%2F1087057103256466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K','PDB','6A6K'); return false;">PDB: 6A6K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YSO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5YSO','PDB','5YSO'); return false;">PDB: 5YSO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i111"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01296">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02021"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01296">10.1021/acs.jmedchem.8b01296</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv">CSV</a>)</p></li><li><p class="inline">Animals and cells for ATC experiments; ADMET assay methods including metabolic stability assay, CYP inhibition assay, PAMPA, hERG assay, and PK study; data collection and refinement statistics of X-ray crystallography; NMR spectra, HPLC chromatograms, and HRMS spectra of the title compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_001.csv">jm8b01296_si_001.csv (5.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01296/suppl_file/jm8b01296_si_002.pdf">jm8b01296_si_002.pdf (2.7 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for compound <b>35</b> bound to ERRγ is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6A6K">6A6K</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01296&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01296%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01296" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ab9110b23d96a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
